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Abstract
Metal complexes currently are currently of much interest in the field of
anticancer drug development. Platinum complexes such as cisplatin, are now
widely used in the clinic and have led to a focus on the synthesis of new classes of
other metal-based complexes, such as ruthenium anticancer drugs. In order to
understand the mechanism of action of these complexes and to improve structure-
activity relationships thereof, a comprehensive study of the solution chemistry is
important.
In this thesis the mechanism and kinetic detail of the exchange of amino
protons on one such class of complex, [(η
6-biphenyl)Ru(N,N’-
ethylenediamine)Cl]+ was investigated in detail. Stereospecific assignment of NH
protons was carried out by NOESY NMR on a pyridine adduct [(η
6-
biphenyl)Ru(N,N’-ethylendiamine)(N-pyridine)]2+. Using 1H and 2H NMR
spectroscopy, rates of exchange were observed at different pH values,
temperatures and ionic strengths a series of N-H/2H exchange reactions were
studied and the data collected. The data are consistent with an exchange
mechanism involving proton abstraction from the amine, followed by favourable
reprotonation on the lowerface (relative to the overhanging arene) of the Ru(N,N’-
ethylendiamine) five membered ring. In chlorido complexes this leads to the
exchange of lower proton at a rate of three times that of those on the upperface at
298 K. To investigate the effects of electron density on the ruthenium on the
exchange rates a series of π-donor pyridine ligands (pyridine, 4-methylpyridine, 4-
tert-butylpyridine, and 4-methoxypyridine) in the place of the chloride were
studied. The exchange rates were also investigated and showed a correlation
between the basicity of the pyridine derivative and the favourability of exchange
xxiv
on the lower face, increasing this bias upto 11 fold. Density functional theory
calculations suggests that there is an overlap between the p-orbital of the
(ethylenediamine) nitrogen and the π*-antibonding orbital on the Ru-N(Pyridine) 
bond and σ*- antibonding orbital on the Ru-Cl bond, in their respective complexes. 
This overlap is proposed as a stabilising force on the deprotonated nitrogen
allowing for a negative charge to be more stabile in one lobe of the p-orbital
preferential to another. Following abstraction of the proton, the lone pair on the
nitrogen is stabilised by an antibonding orbital, the top face less is susceptible to
proton addition.
Since DNA is a potential target for these complexes, the changes in shape
induced by metal binding were investigated using Ion-Mobility Mass
Spectrometry for the first time. Also in this work, the first ion-mobility mass
spectrometry studies of the collisional cross sections (CCSs) of small complexes
(<100 Å2) is also presented. This was developed using a new glycine based
calibrant. Following binding of [(η
6-biphenyl)Ru(N,N’- ethylenediamine)Cl]+ to
the DNA hexamer d(CACGTG) changes in CCS values between ruthenated and
non-ruthenated hexamers were studied. The change in CCS between these was not
additive and suggestive of some folding or intercalation occurring upon ruthenium
binding.
Finally, attempts were madeto investigate shape change induced in DNA
by binding to cisplatin using Förster Resonance Energy Transfer Methods are
described. To date these results are inconclusive but work in this field is ongoing.
xxv
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Introduction
This thesis is principally concerned with the mechanism of exchange of amino
protons on the ethylenediamine ligand on [(η
6-biphenyl)RuII(ethylenediamine)Cl]+
([(η
6-bip)Ru(en)Cl]+) and o-pyridine derivates ([(η6-bip)Ru(en)(p-R-pyridine)]2+)
complexes in solution. The effects of exchanging the chlorido ligand for a
pyridine derivative on the exchange rates were also investigated. In addition,
studies into shape modifications by metallodrugs on short strands of DNA
oligonucleotides were also carried out. This chapter is an introduction into the
rationale behind the development of metal based anticancer complexes and
structure activity relationships that can be used to increase their cytotoxicity.
1.1 Metals in Medicine
Traditionally, designed compounds for medicinal purposes have been
organic molecules, with relatively very few inorganic compounds in use.1 Perhaps
this is because it has long been viewed that inorganic complexes and biology were
mutually exclusive. In part, this was blamed on the tendency for many inorganic
complexes to be air and moisture sensitive, two materials which are ubiquitous in
biology. Other drawbacks with inorganic medicinal chemistry are issues with
speciation (for example; in solution is the metal complex a chlorido, hydroxido or
aqua adduct or a mixture of these?). So, for most of the last century the majority
of designed synthetic medicinal compounds were organic based.
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A further obstacle was the belief that the words “heavy metal” and “body”,
immediately meant death! Opinions of this nature have not been helped by such
quotes as “Heavy metals are among the most dangerous and least understood of
all contaminants”.2 The commonly known fact about “mad hatters” and the
residents of Minamata3,4 (Hg poisoning), lead contamination in water and the
questions about the murder of Napoleon (As)5, have further heightened the general
public’s, and indeed some scientists’, fears about the dangers of mixing metals
and biology.
However, long before the deliberate study of metal based anticancer drugs,
there existed plenty of cases in nature where metals and biology quite happily
interacted. Gold false teeth were regularly used by the ancient Egyptians and
Chinese, mercury was also used by the ancient Greeks and in the middle ages as a
cure for lice and scabies. Before the early 20th century the use of mercury in the
treatment of syphilis was a wide spread practise, cinnabar (HgS) was painted onto
lesions caused by syphilis to cure the illness unfortunately this lead to mercury
poisoning in many cases. In fact, it is with interest to note that the first
metallodrug which was discovered through systematic screening was also for the
treatment of syphilis, this was Paul Ehrlich’s discovery of Salvarsan in 19096
while much debate over exact structure of Salvarsan existed for some time, in
20057 it was confirmed to be the following;
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Figure 1.1: The structure of Salvarsan as determined by Lloyd et al.7
Not only have metals been used in medicine in the past, both through
serendipity and systematic discovery but metals play a vital role in many
biological systems. Nature uses metals in many ways, and many are vital to life,
for example many other enzymes contain metal centres, including; haemoglobin
(Fe), carbonic anhydrase (Zn and Ni), vitamin-B12 (Co), superoxide dismutase (Cu,
Fe, Mn, Ni or Zn) to name just a few. In these cases the metal is the catalytic
centre of these enzymes and therefore deficiency in these elements can lead to
serious health complications even death!
The toxicity of a metal is rarely a hard and fast rule. It is all about the
packaging (complexation). Thought must be given to the nature and number of the
ligands, the oxidation state as well as the dose of any compound8. A classic
example of this would be iron, of which we have about 4 g in our body9. We need
FeII in haemoglobin in order to transport oxygen around the body; we get our iron
as FeII (ferrous iron) from our food (meat, green root vegetables etc). However not
every iron containing complex is beneficial for health, complexes such as
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ironpentacarbonyl are toxic due to the ability to deliver carbon monoxide to the
body. Perhaps it is best summarised in the words of Paracelsus (1493 – 1541) of
the University of Basel. “Alle Ding sind Gift und nichts ohn Gift; alein die Dosis
macht das ein Ding von Gift ist” [All these things are poison and not without
poison, it is only the doses that makes a thing not a poison]10. With iron, if there is
too little in the body, a person can suffer from anaemia, too much can lead to
haemochromatosis (an accumulation of iron in the organs) and long term
accumulation of iron has been linked to Alzheimer’s disease11,12.
The usefulness of metals in the body is due to their ability to take up a
number of different physical and chemical characteristics.
1 One of the key chemical properties with metals is they can undergo
changes in oxidation states, since there are many different reducing and
oxidising agents in cells and in blood.
2 Metals can also undergo ligand exchange and bind to different ligands
other than those they entered the body with. In fact, metals cannot only
bind to many different electron donating ligands, the coordination number
of these ligands can change depending on the oxidation state of the metal
and on steric and electronic effects from the ligand. Further to this metals
can bind through a number of modes to the ligands, i.e. π- bonding and σ-
bonding.
These traits give metals the flexibility in their steric, electronic and
bonding structure that is not available to organic molecules. Therefore the
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potential for application is wider in comparison with most organic compounds,
which do not have such chemical dexterity.
In recent years the study and progression of metal-based pharmaceutical
agents has increased and has lead to a more varied approach to the use of metals in
biological and medicinal systems being adopted.13-18 Some metal-based
complexes in clinical use utilise the features discussed above to harness and
increase their biological activity. These include; cisplatin19 (cis-
diamminedichloridoplatinium(II), [Pt(NH3)2Cl2]), one of the world’s leading
anticancer drugs and radiopharmaceuticals containing technetium and rhenium20
for imaging use in patients and gadolinium MRI contrast agents.21-23 All of which
have successfully overcome problems that organic chemistry alone could not have
solved due to their ability to form dative bonds via the metal’s d-orbitals, undergo
radioactive decay or ligand exchange and therefore induce magnetic relaxation in
water molecules in close proximity.
1.2 Platinum anticancer drugs
After the discovery of cisplatin’s anticancer properties19,24 in the 1960s and
its subsequent success in treating many forms of cancer, a huge amount of
research into the mechanism of cell uptake, activation and lethal lesion formation
on DNA strands have been carried out, with over 7,000 reviews alone written on
the subject to date (almost 70,000 papers). It has opened up a whole field of study
into metal based anticancer drugs.
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Figure 1.2 Chemical Structure of cisplatin
With over forty years having past since the initial discovery and thirty
since the use of cisplatin (1) in clinical trials was licensed to Bristol-Myers Squibb
in 1972, a complete mechanism of action has yet to be fully confirmed, but in
brief it is believed to be as follows.25
Firstly, in aqueous solutions cisplatin undergoes hydrolysis26, producing
the active species cis-[Pt(NH3)2(OH2)2]2+ and [Pt(NH3)2(OH2)Cl]+ where one or
more chlorido ligands undergo substitution by a water molecule. These mono- and
di- aqua complexes can then bind to the N7 of guanine residues of DNA strands27
(Figure 1.3), forming 1,2-G,G and 1,3-G,G intrastrand crosslinks on DNA causing
distortion in the shape of the strand and the duplex.28
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Figure 1.3. A) Guanine residues of DNA strands with N7 highlighted. B) A
representation of the structure of binding of cisplatin via the N7 site on guanine
bases, where the N7, the most electron rich regions on DNA are highlighted.
This kinking of the DNA as a consequence of metal binding leads to
recognition by High Mobility Group (HMG) proteins (Figure 1.4). This
recognition by the HMG proteins protects the DNA from the nucleotide
excision/repair mechanism this in turn leads to cell death via apoptotic pathways.
Cisplatin, however has many side effects29, including loss of high frequency
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hearing and nephrotoxicity and cells can develop resistance and can also be
intrinsically resistant (unresponsive) to treatment. To add to this the presence of
sulfur containing biomolecules such as glutathione which can bind to the platinum
centre and block the active sites and cells also have an efflux mechanism30 which
can remove cisplatin from cells and reduce its cytotoxicity.
Bound Cisplatin
Kinked DNA
HMG Protein
Figure 1.4 DNA kinked after binding to cisplatin and recognition by HMG
protein. Image is modified from that by Lippard et al.31
It was these problems with side effects, resistance within cancer cells and the
limitation on the number of cancer types that can be treated with cisplatin has led
to the search for other metal-based complexes that may show anticancer activity.
Part of this research has led to the discovery of ruthenium-based drugs.
1.3 Ruthenium anticancer drugs
In an effort to overcome the toxicity issues with platinum complexes, other
metal complexes were studied to see if similar activity with fewer side effects
could be observed. Given the fact that the rates of ligand exchange play a crucial
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role in the activation of cisplatin (i.e.: it is in the “goldilocks” region where
hydrolysis of the chlorido ligands occurs at just the right rate) metals with similar
rates of ligand exchange were investigated. Ruthenium undergoes ligand exchange
at a similar order of magnitude to rate platinum making it an ideal candidate for
further study.15
One of the first references to ruthenium anticancer drugs in the literature is
in 197532 when the activity of cisplatin, was compared to that of [RuCl2DMSO4]
(Fig. 1.5). The study showed that they both had comparable activity in causing
filamentous growth in E. coli., implying that the ruthenium complexes can also
have an effect on the replication activity in cells.
Ru
S
SS
S Cl
Cl
O
O
O
O
Pt
NH3
NH3
Cl
Cl
Figure 1.4. The chemical structure of cisplatin and cis-[RuCl2(S-DMSO)4]
These discoveries about the effects of ruthenium complexes on cellular processes
have triggered much research into alternatives to cisplatin. Efforts have been made
to “tune” the anti-cancer activity of ruthenium complexes and understand its
mechanism of action33. This has lead to the development of Ru(III) anti-metastatic
agents NAMI-A34 and the anticancer agent KP101935 (Fig. 1.6).
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Figure 1.6. Chemical structure of NAMI-A and KP1019
NAMI-A has been shown to have antimetastatic properties, and while it
does not inhibit the growth of primary cancer cells, it does however prevent the
spread of cancer cells around the body to form secondary tumours. KP1019 on
the other hand has shown cytotoxic activity in colorectal cancer cells36 and both
these complexes are currently undergoing clinical trials37.
These complexes are believed to enter cells via binding to transferrin and
serum albumin38-40. Cancer cells are fast growing and so require more iron and
other biomolecules; this is why targeting of transferrin or using biomolecules (or
derivatives close to biologically relevant molecules) as ligands, is an increasing
approach for metal-based anticancer therapies.18,41-43 Evidence has shown that in
vivo Ru(III) complexes are reduced to Ru(II) by reducing agents which would be
available in the cell,44 such as glutathione. Given there are many reducing agents
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in cells, the possibility of a mechanism in vivo involving reduction of Ru(III) to
Ru(II) is highly probable. This field of study has recently taken an exciting new
development with the relatively recent completion of Phase I clinical trials of
KP101918,37,45,46. These trials observed patients capable of taking a high dose of
ruthenium complexes and a stabilising effect on the size of solid tumours, with
complete remission in approximately a third of all observed tumours37. This has
highlighted the potential for patient tolerance of ruthenium drugs and the
feasibility of using such complexes in the clinic.
Looking at NAMI-A on the otherhand, a different mechanism of action
appears to be at work. Some schools of thought have suggested that the
mechanism for the antimetastatic activity of NAMI-A is more based on the
interaction with extracellular components such as actin,47 chorio allantoic
membrane,48 and intercornial matrigel sponge, which has been observed in rabbit
studies.49 It is this adhesion as opposed to invasive action upon the cell that in
believed to explain why NAMI-A is a metastatic agent as opposed to an
antitumour one50. This is itself is another area of interest for
metallopharmaceutical agents but will not be discussed further in this thesis.
Given the fact that in vivo reduction of Ru(III) → Ru(II) occurs, it appears 
that in fact the Ru(II) species is the form of ruthenium with anticancer activity (in
the case of KP1019), with this in mind and the previous observations of potential
drugs from Ru(II) complexes51-53, much work in the area of Ru(II) anticancer
agents has been undertaken in recent years14,15. Of particular interest to this work
are ruthenium(II) η
6-arene anticancer complexes.
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1.4 Ruthenium(II) η
6-arene anticancer drugs
Ruthenium(II) aminophosphines54 were synthesised and had shown some
cytotoxicity, however it was noted that there were issues with solubility and
stability of these complexes. To overcome these hurdles, η
6-arene ligands were
introduced to these complexes as they can stabilise Ru(II) to prevent oxidation to
Ru(III) species55 and the formation of Ru(II) complexes with a positive charge
allows for an increased solubility in water. This led to the synthesis of Ru(II) η
6-
arene complexes with 3 other ligands attached in a “Piano-Stool” formation.
(Figure 1.7).
Figure 1.7. A typical structure of a [Ru(II)(η6-arene)(XY)Z]n complex, where XY
= bidentate ligand, Z is a leaving group and n is the charge which can be 0, +1 or
+2 in most cases.
The first complexes of this type to show cytotoxicity comparable to that of
cisplatin56 were [Ru(η6-p-cym)(en)Cl]PF6 (1), [Ru(η6-bip)(en)Cl]PF6 (2) and
[Ru(η
6-tha)(en)Cl]PF6 (3) (Figure 1.8), where bip = biphenyl; p-cym = para-
cymene; tha = tetrahydroanthracene and en = ethylenediamine. In experiments to
investigate their IC50 values, (minimum concentration of complex required to
inhibit cell growth of 50% of the cells compared to control), in a variety of human
cancer cell lines, the complexes where found to all have IC50 values close to those
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of cisplatin, the leading anticancer metallodrug in use in the clinic. The first
reported IC50 values for this class of compounds are shown below and showed
some interesting trends.
+ +
+
5 6 7
0.5510
Complex
IC50
1 2 3
IC50 (µM)
Figure 1.8. The structures of 1, 2 and 3 and their IC50 values (μM) in A2780, a 
human ovarian cancer cell line after 24 h exposure to the drug followed by 72 h
for cell recovery in an assay where the IC50 value for cisplatin is 0.6 μM57.
It is immediately obvious that as the size of the arene increases, so does
the cytotoxicity (i.e.: IC50 values decrease) this is one of the first structure-activity
relationships to be observed and it unveils the rich structural versatility of this
class of complexes; the ability to systematically change all the ligands on the
molecule to allow for complete “tuning” of the activity of each complex. While
these complexes have IC50 values comparable to those of cisplatin57, they only
have one coordination site or labile ligand for coordination to biomolecules
(compared to the 2 of cisplatin), this, along with activity of these complexes in
cicplatin resistant cell lines implies that the ruthenium complexes must cause cell
death by a different pathway to that induced by cisplatin.
Ruthenium(II) complexes have a number of different ways in which they
can be tuned. The four main ways the complexes can be modified are; the arene
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can be varied in size and electronic character, the XY bidentate ligand can be
varied by changing the size and electronic properties of the ligand, the leaving
group (Z) can also be changed to be more or less labile to substitution, and finally
the overall charge of the species can also be varied.
Increasing the arene size results in increased cytotoxcity, as mentioned
above, and will be discussed more in detail later on. Changes in the bidentate
ligand have a large effect on the cytotoxicity; complexes which have three
monodentate ligands showed no cytotoxicity compared to those with bidentate
ligands56,58. Likewise changes in the leaving group, X, can also affect
cytotoxcicity by having an effect on the rate and equilibrium constant of the aqua
species formation59. Recently, efforts have been made to develop osmium
analogues and these too can also be “tuned” by varying the building blocks around
the metal centre. Similar to the ruthenium complexes, it has been observed that
changes to the overall charge of the complex can also affect the activity of the
osmium analogues of these complexes60.
Over the past ten years, much work has been carried out investigating the
mechanism of action of these complexes and further refining of the complex to
increase the cytotoxicity has occurred. Studies have shown that many of these
complexes are active against cisplatin-resistant cell lines57,61 further supporting a
different mechanism of action than that of cisplatin must be occurring.
As previously mentioned, the size of the arene has an effect on the
cytotoxicity of these complexes; this is believed to be due to two major factors.
Firstly, the arenes can provide a hydrophobic face to facilitate entry through the
cell membrane. This has been seen in studies which have shown that when A2780
cancer cells are exposed to 2.7 μM of [Ru(η
6-bip)(en)Cl]PF6  and [Ru(η6-
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tha)(en)Cl]PF6 for 24 h, the more hydrophobic tetrahydroanthracene ruthenium
complex is found to be taken up over 7 times more readily than the biphenyl
analogue into the cells, with 37 pmol/106 cells compared to 5 pmol/106 cells
respetively62. Other work63 which investigated both polar and non-polar
substituents on the arene found that polar substituents had a negative effect on the
cytotoxicity of the complexes, adding further weight to the argument that the
hydrophobic nature of the arene is essential for the activity of these complexes.
The original paper reporting the anticancer activity of the ruthenium(II) η
6-arene
complexes56 showed that the complexes can bind to DNA, similarly to cisplatin,
via the guanine residues. While platinum has two coordination sites, the
ruthenium only has one so will not cause the same kinking of DNA. This links to
the other possible role the extended arene system plays in the mechanism of action,
that is the importance of π-π stacking of the intercalating arene and the purine 
rings of the nucleobases64 (Figure 1.9).
π - stacking
DHA
9-ethylguanine
Ru
Figure 1.9. A crystal structure of [Ru(η6-DHA)(en)(9-EtG-N7)]2+. The space
filling model shows the arene-guanine base π-π stacking. (DHA = 
dihydroanthracene)64
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Interaction studies of this class of complexes with Calf Thymus DNA have
shown that complexes with larger arenes are harder to remove by excision repair
processes65 and in further studies those complexes with extended arene systems
cause increased unwinding of plasmid DNA66. The same studies show that in
ethidium bromide competition experiments (EtBr is a known DNA intercalator, it
is 20 times more fluorescent when bound to DNA and when displaced by other
intercalators, the fluorescence is quenched67) the fluorescence is quenched in the
presence of complexes with extended arenes, such as biphenyl, dihydroanthracene
and tetrahydroanthracene, but with complexes containing para-cymene and
benzene as the η
6-arene, no change in fluorescence is observed.
In Figure 1.9, above, and in other crystal structures of similar 9-
Ethylguanine (9-EtG) adducts of [Ru(η
6-arene)en]2+ complexes, the close
proximity of protons on the ethylenediamine nitrogens and the exocyclic oxygen
atoms on C6 of the guanine is notable (Figure 1.10). The distance between these
nitrogen and oxygen is ca. 2.8 Å and so appears to provide evidence for hydrogen
bonding. Further studies68 found this hydrogen bonding was part of the binding
and recognition mechanism. When the ethylenediamine group is replaced by an
acetylacetone group (acac-, CH3C(O-)CHC(O)CH3) ligand), hydrogen bonding is
no longer able to occur and complexes then preferentially bind to adenine bases
on DNA strands59,68.
Chapter 1 – Introduction
18
G A
Guanine Residue Adenine Residue
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between adenine
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H-Bonding between
guanine bases and
N-H on the en
Figure 1.10. The bidentate ligand on the ruthenium can ensure the selectivity of
nucleobase binding on DNA, depending on whether the ligand is an H-bond donor
(en) or an acceptor (acac) it will bind to a nucleobase which can form the other
side of the H-bond. Charges are excluded for clarity.
The importance of this hydrogen bonding cannot be under-estimated, when
protons are removed from the nitrogens on ethylenediamine, as with
tetramethylethylenediamine (Me4-en), the cytotoxicity drops dramatically63. In
some studies where the ruthenium complexes are bearing ligands which can be
reduced to products which contain NH2 containing ligands69, this could provide a
mechanism of action which is “switched on” in the cell by reducing agents (Figure
1.11). Computational studies have suggested the activity of the complex with a
reduced ligand is linked to the ability of the new complex to H-bond to the oxygen
on guanine residues along with the expected N7-Ru bond. This shows potentials
for prodrugs, i.e. non toxic complexes delivered to the body which can be
activated in vivo by intracellular reductants.
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Cl
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Reduction + (2H+ + 2e-)
R R
Active
Figure 1.11. Complexes studied which showed activity increasing upon ligand
based reduction reduction69.
Some complexes with one substituent on a nitrogen of the ethylenediamine
ligand have shown excellent cytotoxicity, one such complex is the diruthenium
complex in which two of the initial complexes (in this example 2) are connected
by a long aliphatic chain70 to produce complex 4. Studies of supercoiled plasmid
DNA with 4 have shown significant unwinding of the plasmid compared to
mononuclear complexes.
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Figure 1.12. The chemical structure of the dinuclear complex 470. There are four
chiral centres (*) and so 16 possible isomers.
In order to further understand the mechanism of action of this dinuclear
complex, smaller model, 5, was synthesised. Due to the two chiral centres 4
different isomers exist in solution as 5A and 5B (and their respective
diastereoisomers) (Figure 1.13) with 5A being the more preferred isomer. When
these isomers are separated they will return to an equilibrium racemic mix over
time. Of key interest is the observation that these molecules have been shown to
undergo stereochemical inversion in order to selectively bind with guanine
residues (Figure 1.13). More detail on this will be discussed in the next chapter as
the mechanism of inversion is one of the main points of interest to this thesis.
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5A 5B
Figure 1.13. Ru(II) complexes with chiral amines (5A and 5B) can invert their
stereochemistry to allow for optimum H-bonding with guanine residues. (In this
example, taken from work by Chen et al.70 the guanine residue is 9-ethylguanine).
The * symbolises chiral centres.
This inversion of stereochemistry to allow for a sterically hindered product
to form, provides evidence for the importance of the hydrogen bonding between
the hydrogens on the ethylenediamine ligands and the exocyclic oxygen on the
guanine residues.
The final part of the complex that is tuneable is the Z ligand. This usually
needs to be a leaving group for the complex to show cytotoxicity. Hydrolysis of
the leaving group prior to DNA binding has been observed to play a pivitol role in
the cytotoxic behaviour of this class of complexes. Studies have shown that a
relationship between hydrolysis rates (and the extent of hydrolysis) and
cytotoxicity exists71. Complexes which do not readily hydrolyse have shown low
cytotoxicity. In fact this behaviour is employed in the development of
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photoactivated complexes72 in which non-hydrolysing complexes can be activated
by light breaking the Ru-Z bond to allow for hydrolysis to occur, or in tethered
complexes which are pH activated by breaking a single bond between the tether
and the ruthenium to allow binding of the complex to DNA73. While there are
some Ru(II) η
6-arene complexes that are active despite the lack of hydrolysis,
however these complexes are believed to have a completely different mechanism
of action, involving the potential generation of reactive oxygen species (ROS) in
cells74. Hydrolysis has been found to occur in an associative manner75.
Understanding the rate and extent of hydrolysis and the pKa of the aqua adduct is
important, since the chloride complex is itself inactive but undergoes hydrolysis to
form the active species upon entry into the cell (where the chloride concentration
is too low to suppress hydrolysis). If the pKa of the aqua complex (Ru-OH2) is too
low, inactive hydroxyl complexes (Ru-OH) can be formed as is the case with
some Osmium complexes where the formation of Os-OH-Os bridged dimers have
been observed76.
1.5 Interaction of Ruthenium anticancer drugs with DNA and other
biomolecules
Now that there is an understanding of the three key features that are required
to make Ru(II) complexes of this class with good cytotoxicity, they can be
summarised as follows
1. Extended arenes lead to better cell up take due to their hydrophobicity and
the extended arene can intercalate into duplex DNA
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2. Bidentate chelating ligands (XY), provide stability to the complex and
increase the cytotoxic behaviour. The ligand also plays a role in selective
binding to adenine or guanine base pairs on DNA.
3. A good leaving group (Z) is essential for the complex to undergo
hydrolysis, and a pKa value above 7 of the resulting aqua complex is also
essential to prevent deprotonation at physiological pH values which would
result in deactivation by forming hydroxido complexes.
As with cisplatin, the main target for Ru(II) η
6-arene complexes is believed to
be DNA, particularly guanine residues.77 Other studies have shown that binding
can also occur with enzymes78 via ruthenation of the imidazole ring of histidine
residues. Binding via the sulfur of cysteine and methionine amino acids has also
been observed.79 With this in mind, and the knowledge that cisplatin can be
deactivated by binding to glutathione, competition studies were carried out
between glutathione (GSH) and guanine in biologically relevant conditions80.
Interestingly it was found that even in large excesses of glutathione binding to
guanine was still favoured. Further work81 showed that the glutathione did initially
bind to the [Ru(η
6-arene)(en)]2+ moiety via an Ru-S bond, to form a Ru-S-G
structure. This ligand is then oxidised in solution resulting in a much more labile
GS(O)H adduct which is then substituted by guanine residues. This interesting
result shows the potential for this class of compound to be successful against
cisplatin resistant as they will not be inhibited by sulfur binding, removing one
possibly pathway of deactivation.
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DNA binding studies have shown that some distortions to the shape of the
DNA strands upon binding of Ru(II) complexes occurs, both computationally82
and experimentally83,84. There appears to be at least two modes of binding to the
DNA strands, the extended arene can either intercalate or occupy a non-
intercalating position in which a neighbouring thymine base can be twisted out of
the duplex, distorting the shape of the DNA strand (Figure. 1.14).
Intercalated
[Ru(η6-bip)en]2+
Non-
intercalated
[Ru(η6-
bip)en]2+ and
π-stacking with
the
neighbouring
thymine base
Figure 1.14. Images produced from both computational and experimental NMR
data showing the two ways in which [Ru(η
6-bip)(en)]2+ can bind to 14-mer DNA
strands. Image adapted from Liu et al. based on experimental data83.
The only similarities between the mechanism of action of this class of
complex and cisplatin appears to be the activation pathway (hydrolysis) and
binding to guanine. These ruthenium complexes only bind mono-functionally to
DNA strands and so do not cause the same amount of binding and kinking of the
strand. Evidence has also shown that the intercalation of the extended arene
Chapter 1 – Introduction
25
system plays a role in the unwinding of the DNA duplex and that the complexes
are not inhibited by the presence of sulfur containing biomolecules in the cell.
While these differences have all been observed the exact process of apoptosis
which is induced within the cell has yet to be determined.
1.6 Other potential uses of ruthenium in biology
Apart from the uses of ruthenium complexes anticancer and antimetastatic
agents, other uses for ruthenium complexes in biology have been observed. One
such use is as a nitric oxide scavenger. Work by Fricker et al85 has shown that the
ruthenium(III) complex JM1226 (Figure 1.15) can be used to control the levels of
nitric oxide in the blood which can bind to the iron in haemoglobin. Nitric oxide
binding to iron in haemoglobin is believed to contribute to health problems such
as septic shock, diabetes, arthritis, inflammation and epilepsy.86,87
Figure 1.15. The process through which JM1226 undergoes hydrolysis and then
reduction of Ru(III) to Ru(II) by binding to nitric oxide.
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JM1226 binding to the nitric oxide is fast (k > 108 M-1 s-1) and strong
(Kbinding > 108 M-1) and forms a linear nitrosonium RuII-NO adduct. JM1226 has
also shown excellent activity in cell studies.86 Other studies,88 have confirmed that
scavenging of NO is indeed the mechanism of action as opposed to interference
with the NO production pathways. The NO scavenging ability of the cytotoxic
complex NAMI-A49 may play some role in the mechanism of anti-metastatic
action of this class of Ru(III) complexes.
Another compound, Ruthenium Red (Figure 1.16) has been used for over a
century as a cytological staining agent for tumour due to its affinity to
mucopolysaccarides.40 Tests on Ruthenium Red and the commonly found
impurity Ru360 (Figure 1.16) have shown binding to a number of calcium (Ca2+)
binding proteins and has inhibited mitochondrial uptake of calcium ions.
Independently, Ru360 has been used as a probe to isolate and investigate Ca2+
uniporters in cell mitochondria.89 The mechanism of action is believed to be high
affinity binding of the Ru complexes to the highly anionic phospholipid
membrane region near the calcium channels in the mitochondria.
Figure 1.16. The chemical structure of ruthenium red and its major impurity
Ru360.
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Further to the potential use of Ru-Red and Ru-360 in blocking Ca2+
channels in mitochondria, their potential use as immunosuppressant was also
investigated.90 The activity was found to be similar to that a drug already in the
clinic, cyclosporin A. Cyclosporin A functions by interfering with the calcium
dependent steps in immune response40. The similar activity provides insight into
the potential for ruthenium complexes to interfere calcium dependent steps in
immune response processes.
Further studies91-93 have shown that by using Ru2+/Ru3+ complexes with
nitrogen based ligands that are substitution inert (NH3, pyridine or imidazole
derivatives) could inhibit antigen-stimulated T lymphocyte proliferation, but with
a lot less side effects.40 The mechanism of these complexes appears to be different
from organic molecules in the clinic. This may be due to an electron-transfer
process as the potential required for such a reaction is easily accessible within the
redox window of cell.94
1.7 Closing comments on the biological application of ruthenium
complexes
Ruthenium (II) η
6-arene complexes have been shown to possess cytotoxic
activity in a range of cancer cell lines comparable to those seen in cisplatin, which
is in widespread clinical use. Activity in cisplatin resistant cell lines has also been
observed, indicating that a different mechanism of action is responsible for cell
death for ruthenium complexes. By altering the ligands around the central
ruthenium metal the activity of the complex can be tuned and activity increased.
One potential target for these complexes is DNA and much work has
shown the ability of this class of compounds to bind to DNA bases. Other
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studies95 have shown that ruthenium complexes can catalytically induce reduction
of NAD+ (nicotineamide adenine dinucleotide) to NADH which can affect various
steps in the metabolic pathway.
The activity of ruthenium(III) complexes has not only shown anticancer
activity in reducing the size of tumour grafts on mice,96 but also antimethesatic
activity in preventing the spread of the cancer around the body.34 Excitingly, some
Ru(III) complexes now in clinical trials.45,46 Part of the activity of NAMI-A and
KP1019 has been attributed to the reduction of the Ru(III) to Ru(II) in the cell.
The ability of ruthenium(III) complexes to undergo reduction at potentials easily
accessible in the cell has been observed several times and may be a possible
pathway for cytotoxic activity. The nitric oxide scavenging and
immunosuppressant activity possessed by many of the complexes discussed above
may also be as a result of reduction of Ru(III) to Ru(II). This provides another tool
in the potential different mechanisms available to ruthenium to enhance its use in
biological systems.
1.8 Overview of the contents of this thesis
The presence of the N-H protons on the ethylenediamine ligand has been
shown to be essential for the anticancer activity of ruthenium-arene anticancer
complexes.68 Their role is to stabilise, by H-bonding, the binding of nucleobases
to ruthenium as is shown in Figure 1.10. Similar observations have been made
with cisplatin derivatives, in these studies removal of am(m)ino protons reduces
their cytotoxic activity.97 The importance of H-bonding between the exocyclic
oxygen on guanine bases and the amino protons of the ethylenediamine is
highlighted in Figure 1.13. Complexes 5A and 5B have been shown to
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interconvert in order to bind to guanine bases.70 The mechanism for this
interconversion is unknown and to date there have been no investigations into
mechanisms for interconversion of chiral amine ligands on metal centres. Chapter
3 of this thesis investigates the amino proton exchange rates of 1 ([Ru(η6-bip)(Et-
en)Cl]+) in aqueous solutions. The data are then used to infer the possible
mechanism for the interconversion of the stereocentres. The author believes this is
the first such in-depth study into a widely observed phenomenon in six co-
ordinate metal complexes. Further analysis in Chapter 4 investigates the effects of
electron donation to the metal from other ligands on the exchange rates of the
amino protons. Together both studies show evidence for a complicated
interconversion mechanism. It is believed that the determination of this
mechanism will allow for further understanding of ligand choice in the design of
ruthenium(II) anticancer complexes. Further to this, suggestions are made as to
how to control this interconversion and highlight the difficulties involved in
attempting to separate stereoisomers of this type are discussed. The discovery of
the influence of other ligands on the mechanism will provide a greater
understanding of the exchange pathway and will have implications not only in
drug discovery but also in the development of asymmetric-catalysts.
Chapter 5 investigates the shape changes that can occur for short strands of
oligonucleotides (DNA). Previous work has shown that ruthenium(II) arene
complexes can cause unwinding of supercoiled plasmid DNA.98,99 Unlike cisplatin,
there is currently no crystal structure of ruthenium bound DNA.100 As a result any
kinking, stretching or bending of the DNA by ruthenation has not been
characterised by x-ray crystallography and so other methods must be employed.
The author investigated the use of Ion-mobility Mass spectrometry (IM-MS) and
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Förster Resonance Energy Transfer spectroscopy (FRET) for determining shape
changes to DNA strands as a result of ruthenation. Understanding DNA shape
changes will provide a greater insight into the mechanism of action for this class
of compounds. Such knowledge might allow new complexes to be developed
which will selectively change the shape of DNA to give rise to the most cytotoxic
lesion on DNA, and hence the greatest anticancer activity.
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1.9 Aims
The aims of the work described in this thesis are listed below.
1) To investigate the mechanism of stereochemical inversion between (R*,S*)
and (S*,S*) isomers of [Ru(η6-bip)(Et-en)Cl]+ (c.f.: Fig. 1.13). The question
as to whether inversions occur on the chiral nitrogen or the chiral
ruthenium or both in the complex in aqueous solutions is studied by
observing the exchange rate of amino protons in [Ru(η
6-bip)(en)Cl]+ at
various pH values, temperatures and ionic strengths using nuclear
magnetic resonance spectroscopy (NMR). Knowledge of this mechanism
of exchange is important since the use of racemic mixtures is usually
avoided in pharmaceuticals. The ability to control this exchange may allow
the formation of a racemic mixture to be avoided.
2) To investigate the effects of nitrogen based π-acceptor ligands (pyridine 
derivatives) in the Z position of [Ru(η
6-bip)(en)Z]n+ on the rate and
mechanism of exchange using NMR and computational methods. A
comparison of the exchange rates using a Hammett plot provided an
understanding of the electronic effects of the monodentate ligand on the
exchange rates. A combination of the data in Chapters 3 and 4 will provide
a greater understanding of the effects of ligands on the ability of a complex
to undergo inversion. The data will also assist the design of improved
anticancer complexes and reduce the complications arising from
stereoisomers interconverting in aqueous solutions.
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3) To use Ion-Mobility Mass Spectrometry (IM-MS) to investigate changes
in the 3D conformation of the short DNA strand, d(CACGTG), as a result
of interaction with {Ru(η
6-bip)(en)}2+. This should provide an
understanding of the conformational changes to DNA molecules induced
by binding to ruthenium-arene complexes. This appears to be the first IM-
MS study of ruthenated DNA.
4) To use IM-MS to determine the collision cross sections of ruthenium-arene
complexes. This appears to be the first usage of IM-MS to determine the
collision cross section of a small molecule (< 100 Å2). To facilitate this a
new calibration process was developed. Previously this technique had only
been suitable to larger molecules.
5) To investigate the potential of Förster Resonance Energy Transfer (FRET)
to determine shape changes to 30mer oligonucleotides induced by binding
to metal-based anticancer drugs. It was hoped that these results would
allow analysis bending, kinking or any other shape changes on longer
strands of DNA. Initial studies were carried using cisplatin with the
intention of developing the technique for use with ruthenium-arene
anticancer complexes.
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Chapter 2
Experimental Methods
This chapter contains details of general analytical methods which are used
throughout this thesis. Some more specific methods will be discussed in the
relevant chapters. The synthesis and characterisation of Ru(II) arene complexes
used for investigations in later chapters is also discussed here.
2.1 Nuclear Magnetic Resonance Spectroscopy (NMR)1,2
Nuclear magnetic resonance spectroscopy is the most widely used analytical
technique in this work. NMR is still one of the most powerful tools for elucidating
the 2D and 3D structure of organic and inorganic molecules. New methods,
probes and larger magnets are constantly in development making this technique
more and more powerful. In this thesis the following nuclei are studied via NMR;
1H, 2H, 13C, 15N, 31P and 99Ru.
2.1.1 Experimental Overview
Nuclei are positively charged entities and when spinning they generate
magnetic fields. When nuclei are subjected to an external magnetic field of
strength B0 their spins lose their degeneracy and nuclei will occupy one of two
possible energy levels (α and β) (for nuclei with spin = ½. 
2H and 99Ru, which
have spins of 1 and 5/2 respectively3,4, are quadrupolar nuclei and will be
discussed in more detail later).
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Nuclei in each of the α and β states will precess around the direction of B0,
with a frequency unique to that nucleus, known as the Larmor frequency. The
precession has a directional vector aligned to (α) or opposing (β) the vector of the 
applied magnetic field. There is a small population difference between the α and β 
states, and so there is a net overall magnetisation of the sample. These population
differences are small, eg: an additional 76 protons in the α state for every million 
protons in the β state in 
1H NMR at 298 K in a 500 MHz instrument. This
population difference is crucial and is related to the susceptibility of a nuclei to
NMR. The more susceptible a nucleus is the greater the population. In NMR a
second magnetic field B1 is applied in short bursts at the Larmor frequency of
each nuclei. This in turn leads to a shift of the magnetisation vector away from the
z-axis equilibrium position to the x-y plane. (Figure 2.1)
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B0 – Applied magnetic field
More nuclei
precess in the
direction of the field
than against it.
Population of α>β
z
x
y
B0
Simplified using a rotating frame reference
viewing all the ensemble as stationary.
When a pulse B1 is applied the population
difference between α and β energy levels is  
equalised (Mz=0).
M0 –
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vector of the
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Electromagnetic radiation with a
magnetic field B1 is applied perpendicular
(from –y side) to M0, this pulse forces Mo
to flip 90o onto the y axis.
In pulsed NMR, a spectrum of B1 pulses
over a wide frequency range is applied.
In an external magnetic
field, B0 nuclei precess
around the field vector
either in the same or
opposite direction of the
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Figure 2.1. A schematic results of applying an external pulse of magnetic field B1,
onto the magnetisation vector of a sample in an external field B0. (While here is
shown a 90o pulse, many standard pulse programmes use 30o pulse, but the
principle is the same, and M0 is only flipped 30o).
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As the nuclei relax and return to equilibrium the magnetisation in the x and
y axes decays with time and the resulting Free Induction Decay (FID) is observed.
The FID is then Fourier transformed to produce an NMR spectrum. In an NMR
spectrum the signals are plotted as a function of frequency difference compared to
the Larmor frequency of a known standard. (Figure. 2.2)
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Figure 2.2. The magnetisation vector in the y-plane, My is plotted against time to
provide an FID. This FID is then processed using a Fourier transform function and
an NMR spectrum is generated.
In order to ensure accurate NMR spectra are produced, it is essential that
the nuclei can fully relax (i.e.: M0 being only in the z-axis, My = 0, Mx = 0). This
process of relaxation has two components, T1 is called the spin-lattice relaxation
time and is a measure of how long magnetisation take to return to M0
(magnetisation at equilibrium). The second relaxation parameter is T2 (Spin-spin
relaxation time) which characterises of time taken for My (and Mx) to go to zero.
As a rule T1 ≥ T2 and so when designing NMR experiments a delay of at least
three times T1 should be left between each pulse of B1. The relaxation pathways
for both these relaxations are very different. Spin-lattice relaxation occurs via
interactions between different molecules within the lattice, molecules which are
more mobile will, in general relax faster than those that are less mobile. However
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fluids are highly mobile and this reduces their ability to restore energy to the
lattice, it is for this reason that MRI contrast agents are use to promote relaxation
and lead to sharper signals. For spin-spin relaxation, this is the process by which
neighbouring nuclei relax through interactions with each other to return to their
equilibrium. Nuclei without neighbouring nuclei will relax substantially slower
than those with neighbouring nuclei. This is something that must be considered
when assigning the relaxation time for an experiment, for example, CH3 protons
which are attached to a quaternary carbon will relax substantially slower than CH3
protons in a saturated aliphatic chain.
NMR is the study of the resonance frequency required to “flip” the
directional vector of the magnetisation on each nucleus. This chemical shift is
dependent upon the local chemical environment of the nucleus. Information from
the chemical shift of the nuclei within an NMR spectrum can provide much detail
on the neighbouring atoms and the magnetic environment of each nuclide in a
molecule. Table 2.1 lists some of the NMR properties of the nuclei which will be
discussed in this thesis.
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Table 2.1. NMR properties of all nuclei investigated in this thesis
Nucleus Natural Abundance (%) Sensitivity
(based on natural %)
ν at 14.1 T 
(MHz)
Spin
1H 99.98 1 600 ½
2H 0.015 1.45 x 10-6 92.102 1
13C 1.108 1.76 x 10-4 150.864 ½
15N 0.37 3.85 x 10-6 60.796 ½
31P 100 6.63 x 10-2 242.884 ½
99Ru 12.72 2.48 x 10-5 20.338 5/2
2.1.2 Instrumentation
NMR spectra were recorded on Bruker DMX 500 (1H, 500.13 MHz, 13C, 125.72
MHz; 15N, 50.66 MHz; 99Ru, 16.949 MHz), Bruker DRX 500 (1H, 500.13 MHz;
2H, 76.753 MHz; 13C, 125.72 MHz; 15N, 50.66 MHz;), Bruker AV III 600 (1H,
600.16 MHz; 13C, 150.86 MHz; 15N, 60.79 MHz; 31P, 242.884) or Bruker AV II
700 (1H, 700.13 MHz; 13C, 176.08 MHz; 15N, 70.931 MHz) NMR spectrometers
using either TBI [1H, 13C, X] or BBO [1H, 13C, 15N] 5 mm probehead fitted with
the appropriate signal filters for the nucleus being observed.
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2.1.3 Preparation of Samples
Samples were prepared in deuterated solvents (DMSO-d6, D2O, MeOD-d4) or
H2O/D2O 90/10 mixtures or in the case of 2H NMR, H2O, in 5 mm high quality
quartz NMR tubes (Wilmad UK) with a typical volume of 0.6 – 1 mL. In D2O and
H2O/D2O samples 1H chemical shifts were internally referenced using a 1% 1,4 –
dioxane solution in D2O (δ = 3.763 ppm) for the C4H8O2 signal. In the case of
MeOD and DMSO the protonated residual solvent was used as an internal
calibrant, C(D2H)COD in MeOD-d4 (δ = 3.31 ppm)  and (CD2H)(CD3)SO (δ = 
2.50 ppm) in DMSO-d6.5 In the case of 2H NMR samples were prepared in 100%
H2O and an internal reference of MeOD-d4 was added (2 μL), all 2H chemical
shifts were calibrated to a chemical shift of CD3OD at 3.34 ppm as per the
chemical shift of CH3OH in D2O.
15N chemical shifts were externally referenced to 15NH4Cl (1 M) in HCl
(1.5 M) (δ = 0 ppm). 
31P chemical shifts were externally referenced to H3PO4 85%
solution in H2O (δ = 0 ppm). 99Ru signals were externally referenced to
K4[Ru(CN)6] (1 M in D2O) (δ = 0 ppm).   
2.1.3.1 Acquisition and processing of data
Except where specified, all data was acquired at 298 K. Spectra were
acquired using Bruker standard 90o and 30o degree pulse sequences. Standard
pulse sequences were used in this work and any major modifications to pulse
sequences are mentioned where relevant. Spectral data were acquired over 16 – 2
k scans, depending on the concentration and the nature of the experiment, with an
average of 32K data points over 6000 Hz. Measurements of T1 were carried out
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using the standard inversion recovery pulse sequences, and lead to a typical
relaxation delay of 2 seconds being used to allow full relaxation of all protons in
1H NMR experiments.
All experiments were carried out in temperature controlled conditions,
using the variable temperature and chiller unit attached to the relevant NMR
spectrometer and monitored throughout.
Free Induction Decays (FID) were processed using an exponential decay
based Fourier transformation. A line broadening value of 0.5 Hz to increase the
signal to noise ratio was used as were phasing and standard baseline correction on
all 1H spectra. All data were processed using either XWIN-NMR (version 2 or 3.6,
Bruker UK Ltd.) or Topspin (version 1.3 or 2.0 Bruker UK Ltd).
2.1.3.2 Assignment and identification of peaks
Identification of NMR peaks in this thesis has been confirmed using 2D
NMR techniques, COrrelation SpectroscopY (COSY), Hetreonuclear Spin
Quantum Spectroscopy (HSQC) (for both 13C and 15N), Total COrrelation
SpectroscopY (TOCSY), to identify pairs of nuclei that are J coupled to one
another and protons that are attached to heteroatoms.
2.1.4 Water suppression sequences6,7
In order to study small oligonucleotides by NMR, it is best to carry out these
experiments in 90% H2O/ 10% D2O solutions. However, if no special pulse
sequences were used, all 1H signals would be eclipsed by the broad signal from
the H2O protons. In order to prevent this, pulse programs were used whereby the
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1H signal for the H2O was suppressed. In this thesis the sequence used with most
success was the WATERGATE (WATER suppression by GrAdient-Tailored
Excitation) sequence developed by Sklenář and coworkers
6.
2.1.5 Nuclear Overhauser Effect Spectroscopy (NOESY)8
The Nuclear Overhauser Effect (NOE) is observed when two protons couple (i.e.
affect each others local magnetic environment). This coupling is not scalar
(through bonds) but is rather dipolar coupling (through space). NOESY is the
technique used to study this coupling and is generally a homonuclear 1H-1H
experiment in which direct dipolar couplings are observed by means of a cross
peak in a 2D NMR spectrum (Figure. 2.3). The pulse sequence for NOESY
involves 3 distinct 90o pulses, the first pulse will move M01 (of the principal
proton) into the y-axis. My1 then relaxes for a time t1, (the same applies for Mx1,
magnetisation in the x-axis) during which time there is some recovery of M0 in the
z-axis. After time (t1) another 90o pulse is applied and the My1 magnetisation
vector returns to the z-axis (Mz1). It is at this point that magnetisation transfer to
the secondary proton can occur. This happens during a mixing time τm which is
defined by the user, the longer τm the further away from the principal proton the
magnetisation can transfer, (a very useful tool in using NMR to determine the 3D
structure in large biomolecules). After the magnetisation transfer the secondary
proton now has an Mz2 magnetisation vector. This then experiences an applied a
90o pulse to yield My2, this precesses and the frequency is detected and an FID
collected yielding a 2D spectrum.
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Figure 2.3. A schematic of the steps involved in a NOESY pulse sequence. A)
The effects of each pulse on the magnetisation vector of each proton, resulting in a
2D spectrum with crosspeaks as shown. B) The pulse sequence used for all
NOESY experiments discussed in this thesis.
2.1.5.1 Experimental detail
NOESY experiments were carried out on a DPX500 MHz NMR spectrometer at
298 K. Acquisition was over 64 scans with each scan contained 200 data points.
The mixing time allowed for coupling was 600 ms.
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2.1.6 2H NMR
Deuterium NMR (2H NMR) was carried out using a BBO probe. The broadband
channel was used to record the deuterium signal by fitting the 2H filter which is
normally used on the dedicated 2H channel (used when locking to 2H solvent
signals). Samples were dissolved in H2O and referenced to MeOD-d4 at 3.34 ppm.
As no 2H signal was available for locking, samples were not locked. The
D2O/HOD peak from MeOD/H2O solvent was used for shimming purposes. The
probe-head was manually tuned to provide the best signal symmetry based on the
D2O peak using tuning and matching operations on the broadband channel. Since
2H signals are broad (I = 1, quadrupole moment = 0.2886 10-30 m2), shimming of
the signal was essential to obtain as sharp a signal as possible. Due to sensitivity
problems with 2H (9.65 x 10-3 less receptive to NMR compared to 1H) higher
concentrations of samples were used in order to obtain spectra with reasonable
signal:noise ratios to obtain data suitable for kinetic analysis. All 2H spectra were
acquired over 128 scans. Relaxation delays for 2H experiments were 2 seconds to
allow for full recovery of the MeOD-d4 signal.
2.1.7 99Ru NMR
Ruthenium has two NMR active isotopes; 99Ru and 101Ru, which are both
quadrupolar with a spin of 5/2.9 99Ru is a considerably easier isotope to work with,
as although it is less sensitive, it has a lower nuclear quadrupole moment, and
therefore gives rise to sharper lines.
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Table 2.2. Physical data for the magnetically-active isotopes of ruthenium10.
Isotope Mass Abundance
(%)
Relative
sensitivity
Relative
Magnetic
moment (μN)
Nuclear
Quadrupole
Moment
1030 Q/m2
99Ru 98.9 12.76 0.0013 0.645 + 7.9
101Ru 100.9 17.06 0.00152 0.719 + 45.7
The fact that 99Ru is quadrupolar causes considerable complications in
acquiring data. Signals are broad, with linewidths of up to 4.4 kHz being
recorded.11 The other problem is the low frequency of resonance; with a low
frequency of resonance, the Boltzmann distribution of nuclei in different states
results in smaller population differences between the higher and lower energy
states. There is also the problem of acoustic ringing due to vibrations in the probe
and the electronics of the system due to the lower frequency being applied to the
sample (vida infra). Various procedures12,13 have been used in attempts to
overcome this; however it is still a problem.
99Ru is a quadrupolar nucleus, as the number of unpaired nucleons is >1.
This has the following effects on the nucleus; not only is there a magnetic
moment, there is also an electric quadrupole moment. This electric quadrupole
moment arises from the ellipsoidal shape of the positive charge distribution. Due
to the laws of physics, positive charges are in excess at the poles of the ellipsoid
and therefore the nucleus is similar to two back-to-back dipoles. In external
electric fields which are uniform, there is no interaction between the nucleus and
Chapter 2 – Experimental Methods
54
the field. However in non-uniform external electric fields, there is an interaction
between the external field and the electric quadrupole moment of the nucleus.
At the nucleus, the electric field gradients are a result of the ligands, which
in turn affects the electron density around the nucleus. In a symmetrical
environment, all electric fields cancel out and so no quadrupolar interactions are
observed. In non-symmetrical environments, the electric field is non-uniform (i.e.
there is an electric field gradient) and a higher electron density can be found at the
points of the ellipsoid due to columbic interactions. The interaction between the
external electric fields and the electric quadrupole moment results in fast
relaxation times. The rapid relaxation leads to broad signals. Also due to rapid
relaxation there are no multiplets arising from the different energy levels found
due to the rapid interchange (Figure 2.4). All these issues lead to broadening of
the NMR signal. Unfortunately in many cases this makes the signal unobservable.
This is a regular problem with 99Ru NMR, with less than 20 published papers
containing experimentally derived data, although a number of computational
studies have been reported. 9,11,14-29
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Figure 2.4. The energy levels and transitions available to the magnetic moment of
the nucleus of 99Ru.
The NMR standard for ruthenium NMR (0 ppm) is K4[Ru(CN)6], which
gives rise to a very sharp signal due to the high symmetry of the molecule. Very
broad signals, which often occur for quadrupolar nuclei, can be easily lost if the
signal-to-noise ratio is poor or the base line is curved due to acoustic ringing. This
acoustic ringing occurs, when low frequency pulses cause vibrations in the metal
components of the probe. These in turn generate a signal which is detected by the
coil, leading to a large signal at the start of the FID (Figure 2.5). Upon Fourier
transformation, a rolling baseline is observed. In order to reduce rolling of the
base line and acoustic ringing further, sufficient time must be allowed to allow the
system to relax between pulses. Therefore a short pulse time and a relatively long
relaxation delay are often employed to reduce acoustic ringing.
Chapter 2 – Experimental Methods
56
0.01 0.02 0.03 0.04 sec
0.0080.0060.0040.002 sec
-300-200-100200 100 0 ppm
Acoustic ringing from metal
components in the probe
s
s
Distorted baseline of 99Ru
NMR spectrum
FID
Beginning of FID
δ 99Ru
Figure 2.5. The FID and subsequent 99Ru NMR spectrum of K4[Ru(CN)6] in H2O
on a Bruker DMX500 NMR spectrometer. The beginning of the FID is
highlighted to show the effect of acoustic ringing on the FID and the subsequent
baseline rolling observed in the NMR.
The first reported 99Ru NMR study was in 198116,26 and included the
introduction of K4[Ru(CN)6] as the chemical shift standard (0 ppm). In that work,
signals between -112 ppm and +7680 ppm were recorded for various
ruthenium(II) complexes. The effects of temperature and concentration on the
chemical shift of the ruthenium signal were observed. Since then, much work has
been done on the development of 99Ru NMR as a valuable analytical tool as can
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be seen in Figure 2.6, which has been compiled from previous
studies11,14,15,17,19,21,26,30.
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PPN = bis(triphenylphosphine)iminium cation ppt = 3-(pyrazin-2-yl)-5-(pyridine-2-yl)-1,2,4-
triazole
pztr = 3-(pyrazin-2-yl)-1,2,4-triazole bpy = bipyridine (2, 2’ dipyridyl)
pytr = 3-(pyridine-2-yl)-1,2,4-triazole hat = 1,4,5,8,9,12 - hexaazatriphenylene
phen = 1, 10-phenanthroline dpa = dipyridylamine
Figure. 2.6. The chemical shift range for 99Ru in a variety of Ru(II) complexes. It
should also be noted that the 39K signal of K+ appears at 13 ppm.11,14-20
Another significant use for 99Ru NMR is in distinguishing between fac and
mer isomers of ruthenium complexes which possess three identical ligands. The
common thread being that fac isomers resonate at lower field that the mer isomer.
Another interesting factor is that the concentration and counterion can also affect
the chemical shift. Studies on fac-[Ru(CO)3I3]¯ have shown that the linewidth can
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be significantly increased by increasing the concentration9 and the counterion has
effects on the chemical shift also.
From the data in Figure 2.6, the following trends have been noted. 11,14-20
1. An inverse relationship between the crystal field splitting and the chemical
shift.
2. Large δ(99Ru) values are observed with increasing Ru – C bond lengths.
3. Where back-bonding occurs via π-systems, the chemical shift is large as 
less shielding of 99Ru occurs.
It is interesting to note at this stage that no signal has been reported in the
literature for Ru(II) arene systems. It was hoped to use 99Ru NMR to monitor
changes in the electronic effects around the ruthenium centre of various Ru (II) η
6-
arene anticancer drugs.
In the course of this work, attempts were made to study [Ru(η
6-
biphenyl)2]2+ sandwich complexes with 99Ru NMR. A signal for the K4[Ru(CN)6]
was obtained but unfortunately no signal was observed for the sandwich complex
despite using a sweepwidth of over 200,000 ppm. The complex was also sent to
Dr. Christian Brevard in Bruker’s research facility in France for further analysis
and still no signal was observed.
Given the difficulty in observing broad signals, and the constraints of
using only symmetrical complexes it may be more practical to use osmium
analogues. 187Os is NMR active and with a nuclear spin of ½, however the natural
abundance and susceptibility of this isotope of osmium is very low. This can be
overcome to some extent by using polarization transfer methods and these have
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previously been demonstrated31. The use of 187Os will not only allow for an
understanding of the nuclear environment of the Os and may assist with defining
the characteristics of the ligands. Given the similarities in structures between Os
and Ru complexes comparisons could be made based on 187Os data.
2.1.8. Measurement of kinetics of H/D exchange in D2O.
Exchange rates of the amine protons for deuterons were determined using
NMR data. Samples were dissolved (t = 0) in D2O (with dioxane as a chemical
shift calibrant) and the pH meter reading recorded. Samples were then placed in
the NMR spectrometer and FIDs collected at set time intervals over about 24 h. T1
(spin lattice relaxation time) values were determined for all protons in the
spectrum to ensure that the relaxation delay times were sufficient to allow full
recovery of the magnetization to the z-axis after each pulse. FIDs were processed
and the integral volume of each peak was determined (Figure 2.7), and plotted
using Origin 8.1 (OriginLab Corporation, US). The rate constants were
determined by fitting the data to the first-order (exponential) rate equation using
Origin 8.1. First order equations provided the best fit to the data.
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Figure 2.7. 1H NMR spectrum of [1-PF6] in D2O showing the peaks that were
integrated to study N-H/D exchange rates. Highlighted in green are the peaks for
the uncoordinated phenyl ring. The value of this integral was set at 5 and used to
normalise the integrals of the bound phenyl peaks with one N-H peak (yellow)
and the other N-H peak at ca 4 ppm (red) and (CH2)2 peaks of the backbone of the
ethylenediamine.
Given the overlap of the bound phenyl and N-Hb a correction to the
integral must be made. For this purpose the integral volume of the free phenyl
peaks was subtracted from the combined bound phenyl and N-Hb integral value to
yield an accurate N-Hb intergral. This was deemed as the best approach given that
the free and bound phenyl protons would have similar relaxation times and should
therefore have a similar volume. The data were collected and analysed in the
following way; NHa and NHb integrals (normalised to the peak for the 5 unbound
phenyl protons) were plotted against time, to provide decay curves. As a second
means of normalising peaks, the integral of the two CH2 peaks from the
ethylenediamine was set to 4 and the integral of NHa and NHb peaks redetermined.
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The overall error associated with peak integration is estimated to be 5 – 10 %.
Broadened peaks are especially subject to larger integration errors.
2.2 pH measurements
All pH measurements were made using Corning 240 pH meter, a Fisher
Brand Hydrus 500 pH meter, or a Martini Instruments MI150 pH Meter with glass
electrodes filled with either a KCl (or a KNO3 for chloride free work) solution
supplies by Thermo Scientific. Electrodes were calibrated with standard buffer
solutions from Sigma-Aldrich at pH 4, 7 and 10 pH units. For NMR samples, the
pH values were recorded in D2O in the NMR tube.
Of use also was a IQ Scientific IQ125 pH electrode with Silicon chip
sensor, which is a hand held pH meter and requires 50 μL of sample. This was 
calibrated with IQ-supplied standard buffers at 4, 7 and 10 pH units. No
corrections were made for the effects of deuterium (2H) on the electrodes,
therefore all pH values recorded in D2O are termed as pH* (the meter reading).
2.3 Electrospray Ionisation Mass Spectrometry (ESI-MS)
ESI-MS is a widely used and powerful technique for the determination of
the masses of complexes. This solution-based analytical technique is very
sensitive and concentrations of 10 – 50 μM are usually sufficient to acquire data 
with a good signal-to-noise ratio. ESI-MS can not only be used to determine the
mass-to-charge ratio (m/z) of a complex, but can also induce fragmentation of a
molecule to allow for analysis of binding sites on proteins and DNA etc.
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2.3.1 Experimental detail
ESI-MS discussed in this thesis was obtained on the following instruments; a
Bruker HCT-Ultra spectrometer, a Bruker MicroToF spectrometer and a Bruker
MaXis spectrometer. Samples were injected in 50/50, MeOH/H2O solutions and
all data were processed and analysed using DataAnalysis 4.0, part of the Compass
package from Bruker Daltronics.
2.4 Ion-Mobility Mass Spectrometry (IM-MS) 32-34
Ion-mobility Mass Spectrometry (IM-MS) is the combination of two very
powerful separation techniques. IM-MS can provide a wealth of information about
small molecules and, as with all mass spectrometry, only a very small amount of
sample is required. This technique can be used to measure the collision cross
sections (CCS) of molecules.
2.4.1 Technical overview
Ion mass mobility Mass spectrometry (IM-MS) is fast becoming a widely used
technique. Ion mobility has been widely used to separate gases for decades, since
the pioneering work of E. W. Mc Daniel in the 1950s32. The principle being the
separation of ions based on their size using a counterflow gas. (Figure 2.8)
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Ions enter the electric
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Figure 2.8. The principal workings of an ion-mobility spectrometer cell (IMS
cell). A) The ions enter as a mixture into the focusing rings. B) The drift gas then
separates ions based on their size and on to the detector.
The coupling of ion-mobility to mass spectrometry has allowed CCS
values of ions with the same m/z value to be determined. The introduction of a
quadrupole and an ion trap prior to the IMS cell allows for particular m/z values to
be isolated and then separated using ion-mobility. The further addition of a Time-
of-Flight (ToF) chamber after the IMS focusing chamber allows for increased
sensitivity and resolution in the mass spectrometry data of the separated ions
(Figure 2.9).33
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Tri-Wave Chamber
ToF Chamber
Figure 2.9. A schematic diagram of a Synapt HDMS (High Definition Mass
Spectrometer), similar to the type used in this thesis.33
In the Waters Synapt device (Figure 2.9) the triwave chamber consists of;
the ion trap; for isolating a particular m/z ion, the focussing rings (as outlines in
Figure 2.7) and the transfer unit to transfer the ions to the ToF chamber. The IMS
chamber in this instance utilises travelling wave (T-wave) technology to allow for
better separation and resolution of samples. Unlike traditional IMS whereby ions
are subjected to a uniform electric field, in T-wave IMS, an electric field sweeps
through the cell one segment at a time forming in pulses. This forms an electrical
field “wave” which the ions can “surf” and be separated by their size. This
technique has very successfully used for the separation of isomers of small
molecules with excellent resolution35. IM-MS can also be used to investigate
peptide shape changes upon binding to medicinal agents36 and as is shown later in
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this thesis it can be used successfully to determine the collision cross section of
ions < 100 Å2.37
2.4.2 Experimental overview
The potential use of IM-MS to study the CCS of small molecules is
investigated in this thesis. As part of this work, a new method for calibration was
developed and this will be discussed in more detail in Chapter 5. Comparisons
were also made between the current algorithm for determining CCS values and a
new method developed by Water Corps.
All IM-MS experiments were preformed by Dr Jonathan Williams
(University of Warwick) at Waters Corp., Manchester on a Waters Synapt HDMS
instrument. Ions were released from the trap, through the mobility device and then
through the transfer focussing coils onto the orthogonal accelerated time of flight
(oa-ToF) analyser. The arrival time distributions (ATDs) are determined as the
time taken for the sample to leave the ion trap and to pass through the rest of the
Tri-wave chamber and on to the detector. The instrument was operated with a
capillary voltage of 3.0 kV and the ion source block and nitrogen desolvation gas
temperature were 80 and 100 oC respectively. This technique works best with a
high vacuum atmosphere and so the ion trap and the transfer section of the tri-
wave section were operated at 2 x 10-2 mbar of sulfur hexafluoride and the ion-
mobility cell was at 3.0 mbar of helium gas. Within the mobility cell the T-wave
was operated at a velocity of 250 m s-1 and with a pulse height optimised between
4.5 and 8.0 V. Data was acquired and processed using MassLynx (V4.1, Waters
Corp.), analysis of the data was carried out by both Dr Williams and the author.
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The conversion of arrival time distributions to collision cross section
values is through a variety of calibration steps with compounds of known CCS
values. This will be discussed in more detail in Chapter 5.
2.5. High-Performance Liquid Chromatography (HPLC)
High Performance Liquid Chromatography (HPLC) is a widely used
technique for analysing the purity of products, the analysis of mixtures, and the
subsequent separation of those mixtures. In this thesis HPLC was used for the
separation and purification of biomolecules attached to ruthenium and platinum
complexes for further analysis.
2.5.1Overview of Technique
The discovery and development of HPLC is viewed with such importance
that it was the reason the Nobel Prize was awarded to Martin and Synge in 195238.
The principle behind HPLC is the separation of molecules based on their
hydrophobicity and interactions with the stationary phase in the column. Since
hydrophobicities are the main separating feature, it is important to have complexes
that are as neutral as possible. It is for that reason that counter ion salts should be
used when separating charged complexes.
2.5.2 Technical detail
The work in this thesis was primarily performed on C8 and C18 reverse phase
columns. These columns contain silica based polymers which work well for
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separating long-chained DNA molecules. Their chemical formulae are shown in
Figure 2.10.
C8 C18
Figure 2.10. The chemical structure of the polymeric material in the C8 and C18
HPLC columns.
The difference in the length of the CH2 chain has a crucial role in the
different properties of both polymers. C18 columns tend to be more retentive for
hydrophobic compounds, due to their more hydrophobic nature. The complexes
separated in this thesis are all charged species, and so counterions of ammonium
acetate (NH4OAc) and triethylammonium acetate (NHEt3OAc) were used as ion
pairing agents to assist with their separation.
2.5.3 Experimental Detail
Reverse-Phase HPLC (RP-HPLC) was carried out on a HP 1100 Series HPLC
system (Agilent Technologies) using one of the following columns; an analytical
ACE-5-C8-300 (250 x 4.6 mm, ACE); an analytical Zorbax Eclipse Plus C18 (250
x 4.6 mm, 5 μm, Agilent Technologies) or a semi-preparative C18 PLRP-S (300 x 
7.5 mm, 300 Å / 8 μm, Polymer Laboratories). The mobile phases were HPLC 
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grade solvents; water, methanol and acetonitrile purchased from Fischer
Scientific. The gradients, flow rate, mobile phase and pairing agent used were
unique to each experiment as specified in the individual chapters.
2.6 Ultra-Violet and Visible absorption spectroscopy
Ultra-violet/visible absorption spectroscopy (UV/Vis) is a widely used technique
and has a number of functions. These functions vary from determining
concentrations of samples to distinguishing between different excitation bands for
photochemistry. In this work UV/Vis is used for determine the concentration of
DNA samples using the Beer-Lambert Law (Eqn 2.1). As will be discussed later
in this Chapter, UV-Vis spectroscopy is also useful for determining whether a
DNA sample is a duplex or single stranded.
A = ε·c·l (Equation 2.1)
The Beer-Lambert Equation, in which A is the absorbance, ε is the absorption
(extinction) co-efficent and is unique to each molecule, c corresponds to the
concentration of the sample in mol L-1 and l is the length of the light path through
the sample in cm. Since absorbance has no units ε must have units of L mol
-1 cm-1.
2.6.1 Overview of Technique39,40
While the UV/Vis region of the electromagnetic spectrum ranges from
<100 nm to 800nm, the majority of UV/Vis machines only focus on the region
from 200 – 700 nm. This is principally due to the poor reliability of results below
200 nm without a vacuum. UV/Vis electromagnetic radiation produces photons of
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energy between 170 – 600 kJ mol-1. Transitions in UV/Vis spectroscopy are
between electronic energy levels, so usually a lone pair and an unfilled non-
bonding or antibonding orbital. Transistions can also occur between a HOMO
(Highest Occupied Molecular Orbital) and the LUMO (Lowest Unoccupied
Molecular Orbital), (Figure 2.11). These electronic transitions can present
themselves in many different ways in molecules; they can be p-electrons moving
to d-orbitals or sp-hybridised electrons, (those partaking in σ-bonding), being 
excited to p-orbitals, and forming π-orbitals. Commonly seen in organic 
compounds are electrons in π-orbitals of conjugated systems, those with a large 
numbers of double bounds, being excited to anti-bonding orbitals in π → π
*
transitions.
In order for absorption to occur, the transition must be allowed by the
selection rules. (i.e.: ground and excited state must have the same symmetry and
multiplicity). However some “forbidden” transitions can occur, but when they do
it is mainly as a result of molecular vibrations and will have low intensity due to
low extinction coefficients.
HOMO
LUMO
Ground Excited
Photon with Energy = hυ
Figure 2.11. Electrons are excited by a photon from the HOMO to the LUMO, the
excited state. The absorption of this photon can provide much insight into the
electronic structure of the molecule.
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DNA absorbs radiation typically in the 200 – 300 nm region via π→π
*
transitions of the purine and pyrimidine bases. In DNA samples purines and
pyrimidines absorb close to 260 nm and so can be used as a tool to determine the
concentration of DNA solutions (Table 2.3). Interestingly, when DNA forms a
duplex the extinction coefficient decreases when compared to single strands. This
decrease in intensity is due to electrons being partially removed from the
conjugated systems as they are involved in H-bonding. Therefore UV/Vis
absorbance spectroscopy is a useful tool for investigating whether annealing has
occurred, by heating the sample slowly and monitoring the absorbance at λ = 260 
nm. If the sample is a duplex there will be a distinct melting curve, which has a
sigmodial shape as the duplex dissociates to individual DNA single strands. The
inflection point on the curve is the melting temperature, Tm, and is the temperature
above which the duplex is no longer stable and will revert to its individual
components (single strands).
Table 2.3. Values of ε and λmax for all four nucleobases in DNA
Residue (ε) L Mol
-1 cm-1 λmax(nm)
Adenine 15200 259
Guanine 12010 253
Cytosine
Thymine
7050
8400
271
267
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2.6.2 Experimental detail
All UV/Vis spectra in this thesis were measured on a Varian Cary 300 Scan
spectrometer. Data were collected using Cary WinUV software by Varian Inc, ©
2004. Samples were prepared in Ultra High Quality (UHQ) water and of volume
600 μL and run in quartz UV/Vis quality cuvettes of path length 1 cm. Spectral 
values were averaged over three scans and a background of UHQ water was
subtracted to determine the spectra of the DNA.
2.7 CD Spectroscopy41
Circular dichroism is used to determine the extent of chirality of a
molecule. In this thesis the effects of binding of complexes to strands of duplex
DNA are investigated. Electromagnetic radiation consists of two elements, electric
and magnetic components which co-exist and propagate in waves in perpendicular
planes (Figure 2.12).
Figure 2.12. A representation of the two vectors that make up light. In the vertical
plane is the electric field vector (red) and in the horizontal plan is the magnetic
vector (blue).42
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In non-polarised light the vector (sum of the electric and magnetic field
vectors) is a sine function but it propagates in the 45o plane between the vertical
and horizontal axis. In circular dichroism the light is filtered to form a universally
sized vector which propagates right- or left-handed helices (Figure 2.13) of
electromagnetic radiation.
A
B
C
Direction of wave
Figure 2.13. (A) A right and (B) left handed helix. (C) A representation43 of left-
handed circularly polarised light.
CD spectra arise form the differential absorption of left and right circularly
polarized light. Chiral molecules absorb UV/Vis circularly-polarised light
differently depending on the direction of polarity. So by recording the difference
between absorbance of left and right handed light, chirality can be detected.
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When DNA forms a helix, the helix itself is chiral, and has a unique CD
spectrum. CD is a useful technique for looking at whether a helix has been formed
or not, i.e. when annealing has taken place. Also upon binding metal complexes
some unravelling of the duplex can occur. This too will have an effect on the
chirality of the sample. Non-chiral or racemic mixes will not show any difference
between the absorption of left- and right- circularly polarised light and will not
give rise to CD spectra.
2.7.1 Experimental Detail
CD spectra were acquired on a JASCO J-815 CD Spectrometer and data
processed with J815 Spectra Manager Version 2. 07.02 (Build 4) by JASCO
Corporation. Samples of volume 180 μL were prepared using UHQ water and run 
in a CD cuvette of thickness 1 mm.
2.8 Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
ICP-MS is a highly sensitive and reliable analytical technique for
determining concentrations of elements in solution. There are more than 75
suitable elements which can have their solution concentrations determined by
ICP-MS, many to concentration in parts per trillion (ppt) ranges.
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2.8.1 Overview of Technique
First developed in 1980 by Gray44,45 and co-workers, ICP-MS uses the
main principles of breaking molecules down to their atoms, ionising the atoms and
then focusing the ion path using a quadrupole onto a mass spectrometry detector.
Once the sample is injected as a liquid into the instrument, it undergoes
nebulisation to ensure the liquid forms an aerosol. The aerosol is then desolvated
into smaller particles and from there they are vaporised to individual molecules.
These molecules are then broken to individual atoms, which are then ionised.
Once produced, the ions are then focused using a quadrupole into a mass
spectrometer and the output then analysed. A schematic of the internal parts of an
ICP-MS instrument can be seen in Figure 2.14.
Figure 2.14. A schematic diagram of an ICP-MS Instrument46 (Reproduced from
Agilent Technologies users manual)
The sample is introduced via the peristaltic pump to join the carrier gas, in
this case helium, where it enters the spray chamber. It is at this point that the
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sample is nebulised to an aerosol, where heavier and larger droplets are removed
to waste. Only the smaller droplets remain and the aerosol mixes with the
auxiliary gas, argon, and enters the plasma torch (ICP torch). Here the mix is
subjected to radiofrequency voltage, which causes the Ar ions and electrons to
oscillate and causes temperatures to exceed 10,000 K. At this temperature the
molecules form plasma as they lose some of their outer electrons.
From here the samples go through a sample and skimmer cone, the
function of which is to focus the beam of ions onto the lens of the mass
spectrometer. The quadrupole then separates out the ions by mass so that only the
ions of interest are focused onto the mass detector. This increases the sensitivity of
the signal, as it accumulates ions based on their mass, but also due to the high
vacuum, there is no interference from ion collisions which would neutralise ions.
The final step is the detection of the concentration of the sample. This is
done by recording the counts per second of the signal at the required mass. This is
then converted into ppb (or ppt) by comparing it to calibrants measured
immediately prior to measurements on the sample.
2.8.2 Experimental Details
Samples were prepared in UHQ water to an estimated concentration of 5 – 80 ppb
of the metal to be investigated. Calibration was against freshly prepared solutions
of fixed concentrations of 0.1, 1, 2, 5, 10, 20, 40, 50, 80, 100, 200, 400 and 500
ppb of metal prepared from a 1000 ppm ICP standard purchased from Alfa Aesar.
In this thesis, the primary role of ICP-MS was to determine the
concentration of solutions of ruthenium and platinum anti-cancer drugs prior to
Chapter 2 – Experimental Methods
76
addition to DNA samples. All ICP-MS analyses were carried out on an Agilent
Technologies 7500 series ICP-MS instrument. The settings of the instrument are
as described in Table 2.4.
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Table 2.4 Instrument settings for ICP-MS
Plasma conditions
Plasma gas / Lmin-1
Auxiliary gas / Lmin-1
Forward power / W
Reflected Power / W
RF Matching / V
Sample Depth / mm
Carrier Gas / Lmin-1
Makeup Gas / Lmin-1
Nebulizer Pump / rps
S/C Temp / degC
Analyser Pressur/ Pa
FF/BK Pressure / Pa
Peristaltic pump/ rpm
15
0.2
1550
1
1.8
9
0.9
0.2
0.08
15
10-3
343
0.08
Ion Lenses
Extract 1 / V
Extract 2 / V
Omega Bias-ce / V
Omega Lens-ce / V
Cell Entrance / V
QP Focus / V
Cell Exit / V
0
-130
-16
1.8
-20
5
-20
Quadruple Parameters
AMU Gain
AMU offset
Axis gain
Axis Offset
QP Bias / V
127
128
0.9998
0
-5
Octopole Parameters
Octopole RF / V
Octopole Bias / V
180
-50
Detector Parameters
Discriminator / mV
Analog HV / V
Pulse HV / V
8
1730
1070
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2.9 X-Ray Crystallography
X-ray crystallography is an important tool for determining the 3D
coordinates of all atoms in a molecule in the solid state. The technique involves
bombarding a suitable crystal with x-rays and analysing the diffraction pattern.
2.9.1 Experimental Detail
X-ray crystallographic studies of suitable crystals of Ru(arene) complexes
synthesised in this thesis were carried out at the University of Edinburgh by
Professor Simon Parsons and colleagues, the EPSRC National Crystallography
Service, the University of Southampton or at the University of Warwick by Dr
Guy Clarkson. Details of the techniques and instrumentation used to obtain
specific structures are discussed in the relevant chapters.
2.10 CHN Analysis
CHN elemental analysis is one of the most common forms of elemental
analysis of compounds. The process of analysis is based on fully combusting
samples in excess of oxygen, leading to the production of CO2, H2O and NO2. The
masses of the combusted products are then measured and from that the initial
amounts of all carbon, hydrogen and nitrogen in the sample are then determined.
This is then compared to the initial mass of the sample to provide the percentage
of each element present and thus the molecular formula.
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2.10.1 Experimental detail
CHN analysis was carried out, following submission of ca. 3 mg samples, at St
Andrew’s University, St Andrew’s, Fife, Scotland on a Carlo Erba CHNS analyser
or Warwick Analytical Services, using an Exeter Analytical Element Analyser
(CE440).
2.11 Förster Resonance Energy Transfer (FRET)
Förster Resonance Energy Transfer (FRET), was discovered in 1948 by
the German Scientist Theodar Förster.47 FRET is used to describe the transfer of
energy from a donor chromophore to an acceptor chromophore. Energy transfer
occurs via nonradiative energy transfer from the excited state of the donor
fluorescent molecule to the acceptor molecule without emission of an electron, but
through photon transfer48. (Figure 2.15)
D
A
Non-radiative energy transfer
Figure 2.15. A schematic of how energy can transfer from the donor to the
acceptor dyes on a macromolecule.
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The efficiency of FRET is dependent on the distance, R, between the donor and
acceptor chromophores and is a function of the distance to the 6th power.
(Equation 2.2)
6
0
6 6
0
RE
R R


(Equation 2.2)
where E is the efficiency of FRET (the quantum yield of the energy transfer) and
R0 is the Förster distance, a parameter which is dye-pair dependent49.
The other requirement for FRET is that the emission spectrum of the donor
must overlap with the absorbance spectrum of the acceptor. (Figure 2.16)
D A
Wavelength (λ)
Acceptor
absorption
Donor
fluorescence
Figure 2.16 In order for FRET to occur there must be an overlap between the
emission spectrum of the donor (D) and the absorption spectrum of the acceptor
(A).
This technique is very useful for studying the distance between two sites
on a macromolecule50 and interaction distances between two large molecules51
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(eg: binding of DNA to proteins). FRET can be used to determine the distance
between the donor and acceptor dyes at distances up to 100 Å.52
In this thesis, attempts were made to study the shape change of 30-mer
duplex strands of DNA following binding to cisplatin [cis-
dichlorodiammineplatinum(II)]. Previous work53-55 has shown that when DNA
strands are platinated, kinking of the duplex strands occurs and this leads to
programmed cell death. FRET has been used in the past to investigate a DNA
duplex, which had been synthesised to be kinked.56 Studies of DNA dissociating
from nucleosomes57 and investigations into HIV reverse transcriptase interactions
with nucleic acids have also been carried out using FRET.58 A previous study,51
has looked at the effects of cisplatin binding to a 20-mer duplex and observed
FRET indicating that the DNA was bent at an angle of 58o when 1,2 GpG
intrastrand platinum crosslinks are present.
The chromophores used in this study, along with the appropriate
fluorescence data are shown in Figure 2.17.
N
HO
N
DNA
λEm = 519 nm λEm = 670 nm
λAbs = 649 nm
λAbs = 495 nm
Alexa Fluor488 Cy5
Figure 2.17. The chromophores used in this study. Alexa Fluor488 is the donor
chromophore and Cy5 is the acceptor tag.
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The overlap between the Alexa Fluor488 emission spectra and the Cy5
absorbance spectra can be seen in Figure 2.18 below.
Wavelength (nm)
λem = 519 nm
λAbs = 649 nm
Overlap
Absorbance spectrum of Cy5
Emission Spectrum of Alexa Fluor488
Figure 2.18. The emission spectrum of Alexa Fluor488 when excited at 488 nm;
this is overlapped with an absorbance spectrum of Cy5 to show that there is an
overlap, ensuring FRET can occur.
When making decisions on the sequences to be used, the ability of guanine
residues and platinum to quench fluorescence must be considered. However, to
stabilise the duplex formed, and to allow for platination, two adjacent guanine
residues must be included in the sequence. It was for this reason that the tags were
placed as far away as possible from the guanine bases.
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2.11.1 FRET analysis
Single molecule experiments were carried out at the Photonics Institute at
the University of Manchester by Ms. Anita Toulmin and Dr. Steven Magennis
using a confocal microscope with multiple photon-counting detectors for
simultaneous measuring of fluorescence colour, intensity, lifetime and
polarisation.
2.12 Computational Studies
Computational studies were employed in this thesis to investigate the
molecular orbitals on a variety of ruthenium-arene complexes. All calculations
were performed using Gaussian 0359 (G03) employing the DFT method.
2.12.1 Density Functional Theory60
Density Functional Theory (DFT) is a commonly used molecular modeling
method to investigate the molecular orbitals on molecules. DFT is not based on
wavefunctions, but rather on the Hohenberg-Kohn theorem. Hohenberg-Kohn
theorem states that ground state properties can be determined purely from the
electron density. DFT calculations optimize the electron density to determine the
most stable ground state of a molecule.
2.12.2 Experimental detail
The correlation functional PBE1PBE61,62 was tested using the LanL2DZ basis
set63 as the effective core potential for the ruthenium and 6-31G**+ basis set for
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all other atoms. The coordinates for each molecule were taken directly from the
X-ray structures (less the PF6 counterions). Geometry optimization in the ground
state was performed in the gas phase. The molecular orbitals were viewed in
GaussView 03. These computations were carried out with the advice and assistance
of Dr Luca Salassa.
2.13 Melting Points
All melting points were obtained using a Sanyo Gallenkamp melting point
apparatus with a variable heater. A mercury thermometer was used to record the
melting temperature.
2.14 Materials and Synthetic Methods
2.14.1 Chemicals
Most reagents were purchased from Sigma-Aldrich (Dorset, UK), with the
exception of the following; sodium chloride (99%) was purchased from Acros
(Geel, Belgium); dioxane from Rathburn (Walkerburn, Scotland, UK) and bench
solvents (methanol, ethanol and diethylether) were purchased from Fischer
Scientific (Loughborough, UK). Deuterated solvents were used as purchased from
either Sigma-Aldrich (Dorset, UK) or Cambridge Isotopes Limited (Cambridge,
UK). DNA samples were purchased from either Sigma-Aldrich, DNA Technology
(Aarhus, Denmark), Purimex (Grebenstein, Germany) or Eurogentec
(Southampton, UK) and used as the sodium salt. RuCl3.xH2O was purchased from
Precious Metals Online (Australia).
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2.14.2 Specific Preparation Methods
2.14.2.1 Synthesis of the dimer and the main starting material
The initial dimer, [(η
6-biphenyl)RuCl2]2 was prepared using the method described
in previous work64,65 and references therein. This was then used to prepare [(η6-
biphenyl)Ru(N,N′ – 1,2 -ethylenediamineCl].PF6 (1_PF6) using the previously
published procedure66, this was used to study exchange rates and as a starting
material for most of the complexes synthesised in this thesis.
2.14.2.2 [(η
6-biphenyl)Ru(en)OH2]2+ (1a)
This complex was prepared in solution. [(η
6-biphenyl)Ru(II)enCl].PF6 (1) (199
mg, 0.4 mmol) was dissolved in 250 mL of a 1:1 MeOH/H2O v/v. To this, 67 mg
(0.39 mmol) of AgNO3 (99.99% purity) was added and the solution left to stir at
298 K overnight and then centrifuged, decanted and filtered through celite,
microglass filter and a fritte to remove precipitated AgCl. This solution was used
without further purification as starting material for the preparation of some of the
compounds synthesised in this thesis.
2.14.2.3. [(η6-biphenyl)Ru(N2H2,N’2H2–1,2–ethylenediamine)Cl]PF6 (1D_PF6)
[(η
6-bip)Ru(en)Cl]+ (1) (4 mg, 8 nmol) was dissolved in 4 mL 154 mM NaCl
solution in D2O. This solution was allowed to stand at 313 K for 6 hours and
lyophilized. This resulted in a yellow solid which contained a mixture of 1D and
NaCl, suitable for monitoring 2H – 1H exchange on the amine in H2O.
2.14.2.4 [(η
6-biphenyl)Ru(en)(N-pyridine)]2PF6 (6_2PF6)
[(η
6-biphenyl)Ru(N,N′ – 1,2 –ethylenediamine)H2O].2PF6 (1a_2PF6) (20.5 mg,
0.043 mmol) was dissolved in ca. 20 mL of 1:1 v/w methanol/water solution. To
this pyridine (68 μL, 66.5 mg, 0.841 mmol) was added, the solution stirred for 72 
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h at room temperature. To this solution ammonium hexaflorophosphate (70.1 mg.
4.3 mmol) was added and volume reduced under vacuum and stored at 277 K for
24 h. A yellow/brown solid was filtered from the solution, washed in water,
ethanol, methanol and diethylether and left to dry under vacuum, yielding a
yellow microcrystalline solid (10 mg, 14.6 μmol, 34%) which was dried under 
vacuum. Crystals of 6_2PF6, suitable for X-ray diffraction, were obtained from a
methanol solution at 277 K. m/z (ES+) in MeOH gave two major peaks,
[RuC19H23N3]2+ = 197.98 amu (Calculated = 198.55 amu), [RuC19H23N3PF6]+ =
540.38 amu (Calculated = 540.06).
1H NMR (DMSO-d6) δH: 8.54 ppm (d, 2H, J = 5.2 Hz o-H-pyr), 7.91 ppm (t, 1H, J
= 8.75Hz, p-H-pyr), 7.53 ppm (d, 2H, J= 6.35, o-H-free phenyl), 7.43 ppm (m,
3H, m-H-pyr and p-H-free phenyl), 7.34 ppm (t, 2H, J = 7.9 Hz, m-H-free
phenyl), 6.87 ppm (b, 2H, en-NH2(up)), 6.33 ppm (d, 2H, J = 6.45Hz, o-H-bound
phenyl), 6.25 ppm (t, 2H, J = 5.9, m-H-bound phenyl), 5.87 ppm (t, 1H, J =
5.53Hz, p-H-bound phenyl), 3.53 ppm (b, 2H, en-NH2(down)), 2.36 (m, 2H, en-
CH2(up)), 1.87 ppm (m, 2H, en-CH2(down)).
1H NMR (90% H2O/10% D2O, pH 6.98) δH: 8.48 ppm (d, 2H, J = 5.0 Hz, o-H-pyr
), 7.90 ppm (t, 1H, J = 7.73Hz, p-H-pyr), 7.55 ppm (d, 2H, J = 7.55Hz, o-H-free
phenyl), 7.51 ppm (t, 1H, J= 7.45Hz, p-H-free phenyl), 7.41 ppm (m, 4H, m-H-
pyr and m-H-free phenyl), 6.63 ppm (b, 2H, en-NH2(up)), 6.36 ppm (d, 2H, J =
7.45, o-H-bound phenyl), 6.32 ppm (t, 2H, J = 6Hz, m-H-bound phenyl), 5.89
ppm (t, 1H, J = 5.58Hz, p-H-bound phenyl), 4.26 ppm (b, 2H, en-NH2(down)), 2.57
ppm (m, 2H, en-CH2(up)), 2.12 ppm (m, 2H, en-CH2(down)). Elemental analysis;
calcd (%) for C19H23N3P2F12: C 33.34, H 3.39, N 6.14, found: C 33.00, H 3.19, N
6.05.
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2.14.2.5. [(η6-biphenyl)Ru(en)(N-4-methylpyridine)]2PF6. (7_2PF6)
An aliquot of 60 mL of 1a (c.f.: 2.14.2.2) was taken from the 1.6 mM solution (ca
0.1 mmol). To this 4-picoline (4-methylpyridine) was added (1.948 mL, 1.826g,
20 mmol). The solution was stirred for 15 h at 298 K and filtered into a solution of
ammonium hexafluorophosphate (326 mg, 2 mmol) in MeOH (5 mL). The
volume of the solution was reduced under vacuum until the product began to
precipitate. This precipitate was then redissolved in a small amount of acetone and
the entire solution left at 277 K to allow the product to crystalise slowly. Yellow
crystals suitable for X-ray diffraction studies formed in the mother liquor. After
further cooling of the mother liquor yielded a golden yellow microcrystalline
product (10 mg, 13.77% yield) was collected by filtration and washed with cold
water, ethanol and diethyl ether and dried under vacuum.
Elemental analysis: calculated (%) for C20H25N3P2F12: C 34.39, H 3.61, N 6.01,
found: C 34.26, H 3.58, N 6.01.
1H NMR (DMSO-d6) δH: 8.36 ppm (d, 2H, J = 6.47 Hz, o-H-4-methylpyridine ),
7.53 ppm (d, 2H, J = 7.35 Hz, o-H-free phenyl), 7.45 ppm (t, 1H, J = 7.35 Hz, p-
H-free phenyl), 7.34 ppm (t, 2H, J = 7.65Hz, m-H-free phenyl), 7.286 ppm (d, 2H,
J = 6.05 Hz, m-H-4-methylpyridine), 6.83 ppm (t, 2H, J = 5.1 Hz, en-NH2(up)),
6.33 ppm (d, 2H, J = 6.2 Hz, o-H-bound phenyl), 6.20 ppm (t, 2H, J = 6.0 Hz, m-
H-bound phenyl), 5.88 ppm (t, 1H, J = 5.6 Hz, p-H-bound phenyl), 4.49 ppm (t,
2H, J = 5.1 Hz, en-NH2(down)), 2.35 ppm (s, 3H, pyr-CH3), 2.34 ppm (m, 2H, en-
CH2), 1.85 (m, 2H, en-CH2).
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2.14.2.6 [(η
6-benzene)Ru(en)(N-pyridine)].2PF6. [9_2PF6]
[(η
6-Benzene)Ru(en)Cl].PF6 (8, kindly donated by Dr. A. Habtemariam) (72.2 mg,
0.168 mmol) in 140 mL methanol/water (50/50, v/v) and silver nitrate (28 mg,
0.165 mmol, 99.99% purity) were stirred for 15 h at 298 K, and centrifuged,
decanted and filtered through celite, microglass filter and a fritte to remove the
AgCl precipitate. To the resulting clear yellow solution, pyridine (272 μL, 265 
mg, 3.35 mmol) was added and stirred for a further 72 h, filtered and ammonium
hexafluorophosphate (0.548 mg, 3.36 mmol) was added. The volume of the
solution was reduced under vacuum until the product began to precipitate. This
precipitate was then redissolved in a small amount of acetone and the entire
solution left at 298 K to crystallise slowly. The product, long dark yellow needle-
like crystals, which appeared (18mg, 17.2 %), this was collected by filtration and
washed with cold water, ethanol and diethyl ether and dried under vacuum.
Yellow crystals suitable for X-ray diffraction were produced by slow diffusion of
acetone into a solution of the product in methanol.
1H NMR (DMSO-d6) δH : 8.74 ppm (d, 2H, J = 5.48 Hz, o-H-pyridine ), 8.09 ppm
(t, 1H, J = 7.47 Hz, p-H-pyridine), 7.63 ppm (t, 2H, J = 6.91 Hz, m-H-pyridine),
6.98 ppm (m, 2H, en-NH2(up)), 5.85 ppm (s, 6H, bound phenyl), 4.48 ppm (m, 2H,
en-NH2(down)), 2.39 ppm (m, 2H, en-CH2), 1.88 ppm (m, 2H, en-CH2). 13C NMR
(DMSO-d6) δC : 154.7 ppm (o-CH-pyr), 139.4 ppm (p-CH-pyr), 126.2 ppm (CH-
m-pyr), 85.51 ppm (CH-bound phenyl), 45.1 ppm (CH2-en). (Insufficient sample
for a CHN analysis).
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2.14.2.7 [(η
6-biphenyl)Ru(en)(N-4-tertbutylpyridine)].2PF6. [10_2PF6]
[(η
6-biphenyl)Ru(en)H2O].2PF6 (1a_2PF6) (100 mg, 0.160 mmol) was dissolved
in 150 mL MeOH/H2O (50/50, v/v) and 4-t-butylpyridine (524 μL, 500 mg, 3.7 
mmol). The solution was stirred for 24 h, filtered and the volume of solution was
reduced and ammonium hexafluorophosphate (155 mg, 9.50 mmol) added. The
filtrate was then cooled to 277 K and left to crystalise. Dark golden needle-like
crystals precipitated (24 mg) which were collected by filtration and washed with
cold H2O, ethanol and diethylether and dried under vacuum. Crystals suitable for
X-ray diffraction were obtained from a solution of the product in methanol after
slow infusion of ethylacetate.
1H NMR (DMSO-d6) δH :8.39 ppm (d, 2H, J = 6.7 Hz, o-H-4-t-bu-pyr), 7.47 ppm
(d, 2H, J = 7.5 Hz, o-H-free phenyl), 7.41 ppm (t, 1H, J = 7.5 Hz, p-H-free
phenyl), 7.34 ppm (d, 2H, J = 6.7 Hz, m-H-4-t-bu-pyr), 7.29 ppm (t, 2H, J = 7.8
Hz, m-H-free phenyl), 6.85 ppm (b, 2H, en-NH2(up)), 6.291 and 6.288 ppm (very
close and distinguished from [1H,13C] HSQC data) (m, 4H, o-H-bound phenyl and
m-H-bound phenyl), 5.76 ppm (m, 1H, p-H-bound phenyl), 4.53 ppm (b, 2H, en-
NH2(down)), 2.35 ppm (m, 2H, en-CH2), 1.89 ppm (m, 2H, en-CH2), 1.26 ppm (s,
9H, (CH3)3-C-pyridine). 13C NMR (DMSO-d6) δC : 153 ppm (o-CH-4-t-buty-pyr),
137 ppm (p-CH-pyr), 131.5 ppm (free phenyl-C-C-bound phenyl), 130.3 ppm
(CH-p-free phenyl), 128.8 ppm (CH-m-free phenyl), 127.5 ppm (CH-o-free
phenyl), 123 (CH-m-4-t-bu-pyr), 102.5 ppm (free phenyl-C-C-bound phenyl),
88.8 ppm and 79.8 ppm (o/m-CH-bound phenyl), 79.2 ppm (p-CH-bound phenyl),
45 (CH2-en), 34.5 ppm ((CH3)3-C-pyr, 29.6 ppm ((CH3)3-t-bu-pyr).
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2.14.2.8. [(η
6-biphenyl)Ru(en)(N-4-methoxypyridine)].2PF6. [11_2PF6]
[(η
6-biphenyl)Ru(en)H2O].2PF6 (100 mg, 0.160 mmol) was dissolved in 150 mL
MeoH/H2O (50/50, v/v) and 4-methoxypyridine (376 μL, 404 mg, 3.7 mmol) was 
added to the solution. The solution was stirred for 48 h, filtered, and the volume of
solution was reduced and ammonium hexafluorophosphate (151 mg, 9.26 mmol)
was added and the solution volume further reduced under vacuum. The filtrate
was then cooled to 277 K and left to crystallise. Crystals suitable for x-ray
diffraction were obtained from the mother liquor. On further cooling, a dark
brown solid (15 mg) precipitated. This was collected by filtration and washed with
cold H2O, ethanol and diethylether and dried under vacuum.
1H NMR (DMSO-d6): δ 8.36 ppm (d, 2H, J = 6.1 Hz, o-H-4-methoxypyridine ),
7.53 ppm (d, 2H, J = 7.8 Hz, o-H-free phenyl), 7.45 ppm (t, 1H, J = 7.8 Hz, p-H-
free phenyl), 7.36 ppm (t, 2H, J = 6.1 Hz, m-H-free phenyl), 7.28 ppm (d, 2H, J =
7.8 Hz, m-H-4-methylpyridine), 6.86 ppm (b, 2H, en-NH2(up)), 6.2 ppm (d, 2H, J =
6.3 Hz, o-H-bound phenyl), 6.21 ppm (t, 2H, J = 6 Hz, m-H-bound phenyl), 5.88
ppm (t, 1H, J = 5.4 Hz, p-H-bound phenyl), 4.5 ppm (b, 2H, en-NH2(down)), 2.35
ppm (s, 3H, CH3-O-pyridine), 2.34 ppm (m, 2H, en-CH2), 1.85 ppm (m, 2H, en-
CH2). Elemental analysis; calcd (%) for C20H25N3OP2F12: C 33.62, H 3.53, N
5.88, found: C 33.28, H 3.43, N 5.88.
2.15.2.9  Synthesis of [(η
6-biphenyl)Ru(15N,15N′-15Nen)Cl].PF6 (1-15N.PF6)
In 50mL H2O, [(η6-biphenyl)RuCl2]2 (171 mg, 0.262 mmol) was dissolved and
refluxed for 4 h. To this solution, 15N-ethylenediamine.2hydrochloride (71mg,
0.524 mmol, in 5 mL H2O, pH ca 9 by addition of KOH, to activate the en) was
Chapter 2 – Experimental Methods
91
added and refluxed for a further hour. The solution was filtered hot and
ammonium hexafluorophosphate (419 mg, 2.889 mmol) was added. The resulting
yellow solution was then lyophilised and the yellow solid extracted and
recrystalised from methanol. Solution was washed with cold H2O, ethanol and
diethylether and dried under vacuum yielding a golden semi-crystalline product
(56.4mg, 21.6 %). 1H NMR (DMSO-d6): δ 7.755 ppm (2H, d, J = 7.85 Hz, o-H-
free Phenyl), 7.52 – 7.42 ppm (3H, m and p-H-free phenyl), 6.52 ppm (2H, d, J =
74.5 Hz, en-15NH2(up)), 6.14 ppm (2H, d, J = 5.96 Hz, o-H-bound phenyl), 5.90
ppm (1H, t, J = 5.39 Hz, p-H-bound phenyl), 5.8 ppm (2H, t, J = 5.7 Hz, m-H-
bound phenyl), 4.15 ppm (2H, dm, J = 74.5 Hz, en-15NH2(down)), 2.30 ppm (m, 2H,
15N-en-CH2), 2.20 ppm (m, 2H, 15N-en-CH2). [1H-15N] 2D HMBC NMR (DMSO-
d6): δ [6.52 , -24.3], en-15NH2(up), [4.15 , -24.3], en-15NH2(down).
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Chapter 3
Kinetics and mechanism of N-H/D exchange on
[Ru(II)(η
6-bip)(en)Cl]+
3.1 Introduction
Ruthenium (η
6-arene) half-sandwich, piano-stool complexes (Figure 3.1)
in which the arene, leaving group and bidentate ligand can be varied to tune the
reactivity of the complex have shown good anti-cancer activity in vitro and in
vivo1. Structure activity relationships between the cytotoxicity and the increasing
size of the arene and the ability of the Z group to undergo hydrolysis have been
reported2.
R
Ru
Y
X
Z
n+
Figure 3.1. The basic “piano-stool” geometry of the Ru (II) η6-arene complexes.
Work in this field has included extending the arene from para-cymene (p-
cym), to biphenyl (bip), dihydroanthracene (DHA) and tetrahydroanthracene
(THA). X,Y is a bidentate ligand such as ethylenediamine (en), 2,2’-bipyridine
(bipy) or acetylacetonate (acac). Z is a monodentate ligand such as chloride, water
or bromine.
Chapter 3 – Kinetics of NH/D exchange - Chlorido adducts
99
The mechanism of cytotoxic action of [Ru(η
6-bip)enCl]+ (1) is believed to
involve (i) binding of the ruthenium to N7 of guanine (the most nucleophilic site
on DNA),3 (ii) intercalation of the extended arene system into the base stacking of
DNA4 and (iii) hydrogen bonding that has been shown to occur between the
exocyclic oxygen on C6 of the purine ring of guanine and protons from the amine
of the ethylenediamine ligand (Figure 3.2)5,6
a
Figure 3.2. a) Structure of 1 [Ru(η6-Bip)enCl]- (the counterion PF6- is not shown
here for clarity). b) X-ray crystal structure of 9-Et-guanine bound via N7 to [(η
6-
bip)Ru(en)]2+ (the counter ions 2 PF6- and the solvent molecules CH3OH are
excluded for clarity). The 2 atoms involved in hydrogen bonding are shown as
green and red balls here6. Colour scheme: 9-ethylguanine: cyan, ruthenium: pink,
biphenyl: yellow. Green: hydrogen from the ethylenediamine, purple: nitrogen of
ethylenediamine, grey: carbon of ethylenediamine and red: oxygen of the
carbonyl carbon 6 on the guanine residue.
1.867Å
b
Ru NH2
H2N
Cl
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Changing the ethylenediamine ligand for an amine without any amino
hydrogens (e.g.: N,N’-tetramethylethylenediamine) removed any cytotoxic
properties7. This provides insight into the importance of the H-bonding between
guanine’s exocyclic oxygen and the hydrogens on the ethylenediamine ligand.
Further evidence of this is seen with the introduction of an ethyl group on
the nitrogen, (i.e. N-Et-en)8 to yield four diastereoisomers of the product [(η6-
bip)Ru*(N*-Et-en)Cl]+ (where Ru and N are both chiral). When in aqueous
solutions, the chlorido and aqua complexes favour the less sterically hindered
stereoisomer, (R*RuR*N) 5A over the more sterically hindered (S*RuR*N) 5B (Figure
3.3a) by 73.7:26.3 and by 77:23 for the chlorido and aqua adducts, respectively.
However, when aqueous solutions of enantiomerically pure complexes are
prepared, racemisation to give the ratios above readily occurs in solution. The
mechanism of interconversion between the stereoisomers has yet to be
investigated.8
Interestingly, when the racemic mixture is reacted with 9-ethylguanine,
conversion to the more sterically hindered (S*RuR*N) isomer 5B-9Et-Guanine is
observed in which 95% of the product is now in this form (Figure 3.3b). One of
the driving forces behind this is the favourable H-bonding between the exocylic
oxygen on the guanine and the amino protons on the ethylenediamine which this
configuration allows.
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Figure 3.3. a) Structure of complex 5A (R*RuR*N isomer), 5B (S*RuR*N) and 5B-
9Et-Guanine (S*Ru,R*N)-[(η6-bip)Ru(N7-9EtG)(Et-en)]2+ counterions of PF6- have
been excluded b) Stick model of the crystal structure of 5B-9Et-Guanine showing
the hydrogen bonding between the ethylenediamine and the exocyclic oxygen on
the 9-ethylguanine residue.8 (The counterions of 2.PF6- and the solvent molecule
CH3OH are omitted for clarity). Colour scheme: 9-ethylguanine, cyan; ruthenium,
pink; biphenyl, yellow. The 2 atoms involved in hydrogen bonding are shown as
balls. Green, hydrogen; red, oxygen of the guanine residue. The distance between
the two atoms is also highlighted.
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The aim of this Chapter is to investigate the mechanism of inversion of
chiral molecules such as 5A and 5B, and the factors that allow for inversion of
stereochemistry to take place. Are ruthenium-nitrogen and/or ruthenium chloride
bond breaking, or other, processes occurring? Given that 5A and 5B rapidly
interconvert, mechanistic studies would prove very difficult on these molecules.
To overcome this, the exchange of the protons on the nitrogens of the
ethylenediamine ligands of [(η
6-bip)Ru(en)Cl]+ (1) with deuterium was studied in
D2O solution by NMR.
To date, studies on hydrogen exchange rates on nitrogens have been
largely carried out for proteins, using either mass spectrometry,9,10 NMR11,12 or
IR13. For proteins, the rates of exchange in D2O solutions have been used to study
3o and 4o structures as amide protons on the surface exchange much more rapidly
than those in the centre of the protein14. For amides, there is a lone pair of
electrons on the nitrogen atom of the amide which facilitates the exchange of
protons for deuterons. This is not the case with the complexes investigated here as
the lone pair on the nitrogen is involved in a dative bond to ruthenium(II).
Other N-H exchange mechanisms studied recently15 include solution based
“Nitrogen Inversion/Rotation” (NIR), where tertiary amines undergo stereo
inversion via pyramidal inversion (umbrella type rotation) around the nitrogen via
the lone pair on the nitrogen “moving” from one face to another (Figure 3.4).
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Figure 3.4. The mechanism of stereocentre inversion on nitrogens where lone pair
electons (lpe-) are available to assist inversion. This mechanism is often referred
to as ‘umbrella inversion’ or ‘nitrogen inversion rotation’ (NIR) .
Research by Raymond et al15 investigated the activation energy of this
inversion using chiral trapping agents. The activation energy was found to be
between 10 and 17 kcal mol-1 for the variety of amines investigated. While this
provides some thermodynamic detail, it is only relevant for nitrogens where the
lone-pair of electrons is available to accept protons in solution and participate in
the mechanism of inversion.
Chiral encapsulation cage
L = N,N′-bis(2,3-dihydroxybenzoyl)-1,5-diaminonaphthalene 
Ga
L
Inversion observed via NMR
Figure 3.5. Monitoring the activation energy for NIR (pyramidal inversion of the
tetrahedral shape of NR3 molecules). Adapted from work by K. N. Raymond15.
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However, in the systems investigated in this thesis the amines are attached
to metals as ligands. The lone pair of electrons on the nitrogen atoms is now
involved in metal-ligand bond formation and therefore cannot partake in inversion
processes. The lack of availability of the lone pair of electrons also has an affect in
the chemistry of the ligand as will be discussed below.
3.1.1 pKa changes
The pKa values of free amines are well studied and many tables have been
published.16 However, when these are bound through the nitrogen to metal atoms,
there is a noticeable effect on the pKa values due to the change of electronic
properties of the nitrogen. This leads to a more acidic pKa value (when comparing
N+HR3 to M-NHR2). As the nitrogen donates more of its electronic density to the
metal, the N-H bond is weakened and so the pKa of HR2N → R2N- is reduced
(when viewing the properties of the ligand alone). This acidification is indicative
of the strength of the Ru-N bond, in which the more acidic the complex (the lower
the pKa value) the weaker the N-H bond and the stronger the Ru-N bond. This
increase in acidity of ligands upon coordination to metal centres is key to many
chemical reactions (not all beneficial) including the formation of hydroxido form
of cis-platin, [Cis-diamminodihydroxyplatinum(II)]. This is an inhibitory factor to
the potency of the cisplatin; in this case the pKa of the water molecule drops from
15.7 to 5.24 upon binding to the platinum and leading to the formation of the less
cytotoxic hydroxido complex and the hydroxido bridged dimer at neutral pH.
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To date, and after extensive literature searches, the only information
available on NH/ND exchange rates and mechanisms for am(m)ino ligands on
metal ions appears to be for Co(III) complexes. This thesis describes the first
extensive investigation, as far as the author is aware, into the mechanism of
inversion of stereochemistry, the effects of pH, ionic strength and temperature on
the exchange rates. In the following paragraphs a brief survey of the literature
currently available is described.
3.1.2 Catalysts
Xiao17, Noyori18,19, Wills20,21 and co-workers have studied ruthenium catalytic
asymmetric transfer hydrogenation reactions (Figure 3.6) in which a proton is
transferred from the amine to a carbonyl group on a ketone asymmetrically to
form a chiral alcohol.
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Figure 3.6. Examples of Ru(II) asymmetric hydrogenation catalysts from each of
the groups mentioned.
The catalytic mechanism for all these complexes is similar to that shown in
Scheme 3.1, where the intermediate product is a 16-electron species which has
been isolated and crystallised.
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Scheme 3.1. A catalytic cycle for asymmetric hydrogenation by a Ru(II) η6-arene
complex, with the 16-electron species indicated.22
In this cycle, there is a concerted removal of hydrogen from both the
amine and the hydride to hydrogenate the ketone. Of real interest here is the
formation of a stabilised 16-electron species, which in the case of the complex
[Ru(η
6-p-cym)((S,S)-N-p-toluenesulfonyl-1,2-diphenylethylenediamine)] has been
characterised by X-ray crystallography23. This may provide insight into a possible
mechanism for the stereo-centre inversions that are observed for complexes 5A
and 5B.
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In work of Fryzuk24, the intramolecular transfer of protons through stereo-
inversion of ruthenium (II) amidophosphine complexes as a proton exchanges
intramolecularly between two amines has been discussed. However no
suggestions were made as to a possible mechanism, or the effects of other ligands
on the exchange rate.
Work by Morris et al.25 has also involved investigation of intramolecular
transfer of protons in organometallic complexes. Shipman and co-workers have
described an example of organic synthesis using metals to control pyramidal
inversion rates.26,27 This is done by “locking” the lone pair of the nitrogen into the
dative bond with the metal, thereby preventing nitrogen inversion occurring.
To date, no studies of N-H/D exchange for amino protons on ruthenium (II)
ethylenediamine complexes have been reported. However, there is much
published on cobalt(III) complexes (vide infra). Since both metals have d6 low-
spin electronic structures, some comparisons can be made. It was with this lack of
previous studies in mind that the studies presented in this thesis were undertaken.
3.1.3 Cobalt(III) complexes
One of the earliest papers on Co(III) complexes was published by Yoneda
et al. in 1981.28 In this work, magnetic anisotropy among the amine protons on
ethylenediamine ligands on cobalt(III) ions was reported. This effect was also
observed for ammine groups on pentamminecobalt(III) complexes29,30. They noted
a difference in the exchange rates of protons which are on the same nitrogen but
pointing in different directions.
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Work of Fujita et al31 on the octahedral complex of [Co(acac)2(Ph-en)]+
(acac = 2,4 –pentanedionate ion, Ph-en = N-phenylethylenediamine) showed that
inversion of chiral nitrogen centres and chiral cobalt centres occurred in basic
solutions (Figure 3.7). Similar to the present study, they followed the proton
exchange on the amines by NMR spectroscopy. They found that the inversion
rates increased in basic conditions and were slower than the proton exchange rates
on the free ligands. It was proposed that the N-phenylethylenediamine ligands on
the Co(III) ion are stabilised by (p-p)π conjugation and this must lower the
activation energy of epimerization (compared to Me-en complexes). Also they
proposed that proton loss is essential in the activation process for stereochemical
inversion of the nitrogen.
Figure 3.7. The two complexes studied by Fujita31; these complexes not only
undergo proton exchange but also racemisation in solution.
[Co(ox)2(Me3-en)]- undergoes proton exchange an order of magnitude
faster than [Co(acac)2(Me3-en)]+. This is believed to arise from the effect of the
ligands on the metal, in this case because acac forms a chelate ring with
delocalised π-electrons. The effects of the neighbouring ligands have been noted 
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in many other papers, especially work on [Co(en)2AB]n+ complexes. Work by
Yoneda et al, has shown that AB ligands can induce a trans-effect on the
exchange rates of amines32. In other work by the same authors,33 a kinetic isotope
effect on the exchange rates was observed, providing further evidence of proton
loss being the rate limiting step on cobalt(III) complexes.
House34 has reviewed many of the observations on the exchange of amine
protons on cobalt. It was noted that the exchange rates were much slower than for
free amines and therefore coordination often makes these exchanges observable.
Further comments here34 into the catalytic effects of hydroxide ions and
observation of the kinetic isotope effect add weight to the theory that exchange
was due to a mechanism of proton abstraction prior to inversion of the stereo
centres on the nitrogen.
From the detailed discussion above, two potential mechanisms of
exchange of protons on metal-(en) complexes emerge. The Ru(II) catalysts show
inversion on the metal centre by loss of a leaving group from the metal, whereas
the cobalt(III) exchange mechanism is believed to involve proton abstraction. This
raises the question as to whether racemisation of [(η
6-bip)Ru(Et-en)Cl]+
stereoisomers in solution is due to stereochemical inversion at the Ru centre via a
16-electron intermediate, or to inversion at the nitrogen centre in a similar manner
to that seen for cobalt(III) complexes?
Chapter 3 – Kinetics of NH/D exchange - Chlorido adducts
111
3.1.4 Aim
The aim of this Chapter is to investigate the exchange rates of protons for
deuterons on the amines of the ethylenediamine ligand on [(η
6-bip)Ru(en)Cl]+
complexes in 154 mM NaCl solutions in D2O, in order to elucidate the mechanism
of proton exchange and infer the mechanism of stereocentre inversion. To
determine this, measurements of proton/deuteron exchange rates were carried out
at various temperatures, ionic strengths and pH values, using NMR spectroscopy
to monitor decreases in N-H signals with time. To the author’s knowledge, this is
the first time a comprehensive analysis of proton exchange mechanisms on
ruthenium-arene complexes has been reported. Understanding of this mechanism
is crucial to control the synthesis of chiral metal molecules and of the
epimerisation of complexes in soluition.
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3.2 Results
3.2.1 Synthesis and Characterisation
This work was concerned with the studies of [(η
6-bip)Ru(en)Cl].PF6 (1-PF6) its
deuterated amine version [(η
6-bip)Ru(N,N’-N2H2CH2CH2N2H2)Cl].PF6 (1D_PF6)
and [(η
6-bip)Ru(en)(N-pyr)].2PF6 (6_2PF6) (Figure 3.8). The latter was studied to
provide insight into the assignment of the non-equivalent NHa and NHb peaks in
the 1H NMR spectrum of 1 using NOE peaks between these protons and pyridine
protons.
1-PF6
1D-PF6
2-2PF66_ 6
1_P 6
1D_PF6
- -
-
Figure 3.8. The complexes studied in this chapter.
3.2.2 NMR of [(η
6-bip)Ru(en)Cl]PF6 (1-PF6)
NMR was carried out as described in Chapter 2, c.f. §2.1. The 1H NMR
spectrum of 1-PF6 in DMSO-d6, gives two distinct N-H peaks labelled N-Ha and
N-Hb (Figure 3.9). This was also observed in D2O and MeOD-d4 and has been
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previously observed in work by Yoneda32 and others when investigating cobalt(III)
complexes.
34567 ppm
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N-HaN-Hb
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Ring
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C
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D
D
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E
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Figure 3.9. 1H NMR of 1 in DMSO-d6 at 298 K, with signals assigned. Two
distinct N-H peaks are present labelled as N-Ha (4.17 ppm) and N-Hb (6.47 ppm)
as the spatial arrangement of these protons was yet to be defined. This magnetic
anisotropy is believed to be a result of the effects of the ring current from the
biphenyl bound to the arene.
Of interest to note when looking at Figure 3.9, is the shift of the N-Hb
peaks downfield of the normal region for the aromatic protons. This split in N-H
peaks leads to a complex multipet for the C-H peaks on the ethylenediamine
backbone, due to each proton on the carbon being non-equivalent and coupled
with the different N-H protons also. To confirm these broad peaks are amino
protons, 2D NMR was preformed and showed that Ha and Hb are bonded to the
same nitrogen (Figure 3.10).
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Figure 3.10. [1H, 15N] 500 MHz NMR of 1 in DMSO at 298K, confirming the
presence of NH peaks at ca. 4 and 6 ppm and that these protons are on the same
nitrogen. The difference in shifts is as a result of the ring current from the
aromatic ring on the ruthenium.
To identify the location of each amino proton relative to the biphenyl
ligand, the pyridine adduct [(η
6-bip)Ru(en)pyr]2PF6 (6_2PF6) was synthesised.
This was to allow NOEs to be detected between the NH protons and the pyridine
ring to provide specific NHa and NHb assignments.
3.2.3 Synthesis of [(η
6-bip)Ru(en)pyr]2PF6 (6_2PF6)
3.2.3.1 X-ray Crystal Structure
Yellow crystals of 2-2PF6 were obtained. Diffraction data were collected
by Prof. Simon Parsons (University of Edinburgh) using a Brüker Smart Apex
CCD diffractometer equipped with an Oxford Cryosystems low-temperature
device operating at 150 K. Absorption corrections for all data sets were preformed
with the multiscan procedure SADABS.35 The structure of 6_2PF6 was solved by
Chapter 3 – Kinetics of NH/D exchange - Chlorido adducts
115
using direct methods (DIRDIF-96)36 and CRYSTALS used for refinement of the
structure, based on data from 34269 reflections (Figure 3.11).
The x-ray crystallographic data of selected bond lengths and angles are
listed in Tables 3.1 and 3.2) were obtained. Interestingly the crystal structure does
not show any π-stacking between the pyridine ring and the unbound phenyl from 
biphenyl.
2.096 Å
Figure 3.11. Complex 6 [(η6-biphenyl)Ru(en)N-pyridine)]2+. The crystal structure
is shown here in ellipsoidal (50% probability) representation and the lower figure
is a stick model. The distance between the downward pointing proton of the amine
on the ethylene diamine and the ortho-proton on the pyridine ring is 2.096Å in the
crystal structure. (PF6- counterions have been omitted for clarity)
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Table 3.1. Crystallographic data and structure refinement details for 6_2PF6.
6_2PF6
Formula C19H23F12N3P2Ru
Molar mass 684.41
Crystal system Triclinic
Crystal size /mm 0.61 × 0.36 × 0.20
Space group P-1
Crystal Yellow Tablet
a / Å 9.9090(3)
b / Å 10.2134(3)
c / Å 13.3074(4)
 / deg 93.232(2)
 / deg 102.160(2)
 / deg 113.464(2)
T / K 150
Z 2
R [F > 4 (F)]a 0.0307
Rwb 0.0743
GOFc 1.0273
 max and min, / eÅ-3 0.84, -0.70
a R = ||Fo| - |Fc||/|Fo|. b Rw = [w(Fo2 - Fc2)2/wFo2)]1/2. c GOF = [w(Fo2 –
Fc2)2/(n-p)]1/2, where n = number of reflections and p = number of parameters.
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Table 3.2. Selected bond lengths (Å) and angles (º) for complex 6_2PF6
Bond/Angle 2-2PF6
Ru-N1 2.1399(18)
Ru-N2 2.1253(17)
Ru-N3 2.1315(16)
Ru-C1 2.2152(19)
Ru-C2 2.184(2)
Ru-C3 2.209(2)
Ru-C4 2.180(0)
Ru-C5 2.1948(19)
Ru-C6 2.2430(19)
N2-Ru-N1 79.09(7)
N1-Ru-N3 85.04(6)
N2-Ru-N2 88.12(7)
Comparisons between the pyridine and chlorido complex were made
(Table 3.3) and as expected, the Ru-Cl bond is longer than that of Ru-(N-Pyr); this
is due to a number of features. Firstly the chlorine is large atom compared to the
nitrogen and secondly pyridine is a σ-donor and a π-acceptor so it can form 
shorter bonds with the Ru(II), compared to an NH3 ligand for example.37
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Table 3.3. Selected bond lengths and a comparison between 1-PF6 and 2-2PF6
Bond [(η6-bip)Ru(en)Cl]+ (1)2  [(η6-bip)Ru(en)Pyridine]2+
(6)
Ru – Cl/N(py) (Å) 2.408(15) 2.1315(16)
Ru – coordinated phenyl
carbons (Å)
2.138(5) - 2.244(6) 2.180(2) - 2.2430(19)
Ru – Centroid (Co-ord-
ring) (Å)
1.663(3) 1.69
3.2.4 Assignment of N-H peaks
[(η
6-Bip)Ru(en)(N-pyr)]2PF6 (6_2PF6) was characterised by NMR and
like 1, two distinct peaks for the N-Hs in the NMR spectrum were observed,
(Figure 3.12). 2D [1H, 1H] NOESY spectra in acidic D2O showed coupling
between only one N-H resonance and the resonance of the ortho-hydrogen on the
pyridine ring.
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Figure 3.12. 1H and [1H-1H] 2D NOESY spectrum of 6_2PF6 in acidic D2O. A
clear NOE crosspeak between one N-H peak (NHa) and the ortho-proton (a) on the
pyridine ligand is highlighted. The NOE crosspeak between the N-H protons is
also highlighted. It is noticeable that the N-Hs which resonate at 6.6 ppm do not
exhibit NOEs to the ortho-protons of the pyridine.
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There is an inversely-proportional relationship between the intensity of an
NOE cross-peak and the distance between the two atoms concerned. The
relationship is shown in Equation 3.1.
6
1Crosspeak Volume k r (Equation 3.1)
Where, r is the distance between the two atoms through space and k is the
proportionality constant. In order to determine the proportionality constant for this
experiment, a comparison must be made between crosspeaks for known distances.
For this, comparisons between the NOE for C-Hm(pyr) and C-Hp(pyr) (the ortho and
meta protons on the pyridine ligand) was examined. The average crosspeak
volume was 86600 (arbitrary units) and from the crystal structure these protons
are a fixed distance of 2.347 Å from each other. Given the volume of the cross
peak had an intensity = k/(2.347Å)6, k is determined as 14474262 Å-6. Applying
the proportionality constant, k to the crosspeak for (N-H)-(o-H) with an average
intensity of 82698 a distance of 2.365 Å was determined. This is comparable to
the average distance observed in the crystal structure (2.287 Å).
From the identification of the peaks for the up and down protons in 6, an
assumption that the effect on the protons in the chlorido complex (1) from the
overhanging biphenyl system would be the same can be made. Figure 3.13
explains the meaning of up and down protons. From this point forward, upward
pointing protons will be labelled NHu and downward pointing amino protons will
be NHd.
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Hup
Hdown
Figure 3.13. Crystal structure of 1 used to explain the meaning of Hu and Hd.
3.2.5 Exchange of Hydrogen for Deuterium
Initial deuterium exchange studies were carried out on 1 following
dissolution in 154 mM NaCl in D2O at 298 K (c.f. §2.3). The presence of NaCl
ensured that the predominant species was the chlorido complex rather than the
aqua adduct, where the chlorido ligand is replaced by an aqua ligand. These initial
NMR studies showed that one of the protons (NHd) exchanges more rapidly than
the other (NHu), Figure 3.14.
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Figure 3.14. A) 500 MHz 1H NMR spectrum of 1 in 154 mM NaCl/D2O solution
at 298 K; highlighted in red and blue are the regions of interest expanded. B) Time
dependent 1H NMR signals showing the decay of the N-Hu (■) and N-Hd (▲)
signals as a function of time. (pH*= 7.37; temperature controlled at 298K)
Plots of the intensity (peak volume) of the NHu and NHd peaks against time show
exponential decay curves (Figure 3.15).
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Figure 3.15. Time dependent plot of the decay for N-Hu (■) and N-Hd (▲) NMR
peaks over time. The solid lines correspond to the best fit of the data and follow
first order exponential decay.
The reaction shows itself to be first-order, in that the best fit for the data is
an exponential decay curve. First-order reactions follow the rate equation; rate =
k[reactants], where k = the rate constant, and are described by the equation [A]t =
[A]0.e-kt, where [A]t is the concentration of A at time t, [A]0 is the concentration of
A at time = 0 s, and k is the rate constant. However, given that the solvent is a
reactant in this case but is in large excess, the reaction is pseudo first-order.
From the best fit decay curves observed in Figure 3.15 it can be seen
that NHd protons exchange with 2H approximately three times more rapidly than
NHu. Details of the average half lives, determined from 4 rate constants from the
best fits of the intensity of the peak normalised to the free phenyl ring or the
(CH2)2 of the ethylenediamine backbone and comparing the best fit of the
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intensity vs time exponential decay curve and the linear plot of ln(intensity) vs
time, are listed in Table 3.4.
Table 3.4. The average rate constants and half-lives of the N-H/D exchange
reaction at pH* = 7.36, 298K.
Proton Rate Constant (s-1) Half life (min)
N-Hu 6.55 (± 0.23) x 10-5 176.3
N-Hd 2.24 (± 0.25) x 10-4 51.5
3.2.6 Effect of temperature
For temperature-dependent NMR, the temperature was varied from 283 K
to 298 K and 313 K using the variable temperature and chiller unit attached to the
DMX500 MHz (TBI probe). Experiments at 288 K were carried out using the
AV600 MHz NMR spectrometer and a BBO Probe.
Exchange studies of 1 were carried out in 154 mM NaCl in D2O solutions
at 283 K, 288 K, 298 K and 313 K. Due to the use of sodium chloride to suppress
hydrolysis, problems with a very broad residual H2O peak led to difficulty in
observing the NHu peak intensity at 283 K. Water suppression would have
affected the reliability of the experiment as the suppression sequence would pulse
in a close to the resonance frequency of the NHd protons and could have affected
the intensity of the signal. As expected, rates increase with temperature, yet an
observable difference between the decay of the N-Hu and N-Hd peak was still
observed. The data were then used to calculate the activation parameters of the
transition states, in an attempt to further elucidate the mechanism.
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The data were gathered in the same way as for 298 K and all showed the
same underlying feature of NHd undergoing deuterium exchange substantially
faster than NHu. The time-dependent decay plots of the NH peak intensities are
shown in Figures 3.16 and 3.17. Figure 3.18 shows a comparison between
exchange rates at a variety of temperatures.
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Figure 3.16. Time-dependent plot for the decay for N-Hu (■) and N-Hd (▲) NMR
peaks over time at 288 K. The solid lines correspond to the best fits of the data to
first order exponential decays. Of note is the difference between the exchange
rates for NHu and NHd with exchange of NHd being faster.
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Figure 3.17. Time dependent plot of the decay for N-Hu (■) and N-Hd (▲) NMR
peaks over time at 313 K. The solid lines correspond to the best fits of the data to
first order exponential decays. Of interest is the fact that the N-Hd peak has almost
completely disappeared after 30 minutes.
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Figure 3.18. Dependence of A) N-Hu and B) NHd peak intensities on time at
various temperatures; 283 K (black), 288 K (blue), 298 K (green) and 313 K (red).
The solid lines represent first order best fits to the data.
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From Figure 3.19 the rate constants and half life of this exchanges were
determined and are tabulated in Table 3.5.
Table 3.5. Rate constants and half life values for the rates of 1H-2H exchange for
NHu and NHd at various temperatures.
NHu NHdProton
Temp (K)
Rate Constant
(s-1)
Half life
(min)
Rate Constant
(s-1)
Half life
(min)
283 N/A* N/A 1.740 x 10-5 663.9
288 1.44 x 10-5 802.25 8.491 x 10-5 136.1
298 6.55 x 10-5 176.3 2.24 x 10-4 51.5
313 6.06 x 10-4 19 2.36 x 10-3 4.9
* Data at this temperature could not be collected due to the broadening of the
HOD signal at high ionic strength.
3.2.7 Determination of Activation Energies
Arrhenius and Erying plots were used to obtain activation parameters for
the N-H/D exchange rates (Figure 3.19). The Arrhenius equation provides a linear
relationship between the natural log of the rate constant and the inverse of the
temperature, with the slope being a function of the activation energy (Equation
3.2). The Eyring equation provides the relationship between ln(k/T) against the
inverse of the temperature with the slope being a function of the enthalpy and the
intercept related to the entropy (Equation 3.3).
‡
aEln( k ) ln( A )
RT

  (Equation 3.2)
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‡ ‡
a b aH k Sln( k / T ) ln( )
RT h R
 
   (Equation 3.3)
Where, kb is the Boltzmann constant, h is the Planck constant, R is the gas
constant, T is the temperature, A is a constant (the intercept of the Arrhenius plot)
and ΔEa
‡
, ΔHa
‡, and ΔSa‡, are the activation energy, enthalpy and entropy
difference, respectively, between the starting material and the transition state.
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Figure 3.19. A and B: Arrhenius plots for NHu and NHd respectively. C and D:
Eyring plots for NHu and NHd respectively. The solid lines are the best fits to the
equation y = mx + c with parameters listed in Table 3.6.
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Table 3.6. Activation energy parameters for the intermediate (both NHu and NHd
values agreed to within 3%)
ΔEa
‡, 111.3 kJ mol-1
ΔHa
‡, 108.84 kJ mol-1
ΔSa
‡, 43.36 J mol-1
Although, these values are subject to large errors due to the fact they are
obtained from NMR integrals which are themselves subject to error, it is of note
that both NHd and NHu provide very similar parameters of activation. The
implication here is that both processes involve the same transition state. It is
worthy to note that the Arrhenius and Eyring plots both had R2 values of 0.997
and 0.959 for NHu and NHd respectively.
3.2.8 Effects of pH* on rates of exchange
Fresh samples of 1 were prepared in acidic and basic NaCl (154 mM)
solutions in D2O. The pH* was recorded (c.f. §2.2) before and after NMR spectra
were recorded at 298 K. Again a decrease in the integrals of the N-H peaks with
time was observed. Table 3.7 lists the exchange rates at various pH* values. The
same trends in spectra were noticed in that NHd NMR peaks disappeared faster
than NHu peaks. The data were collected in the same manner as discussed
previously and Table 3.7 provides a full list of the rate constants and half-lives for
each experiment.
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Table 3.7. Kinetic data for proton/deuterium exchange reactions of the amino
protons of 1 at various pH* values
pH*
Rate constant k
(s-1) NHu/Du
Half life
(min)
NHu/Du
Rate constant k
(s-1) NHd/Dd
Half life
(min)
NHd/Dd
6.16 1.15 x 10-5 1001 1.59 x 10-5 728
6.4 1.94 x 10-5 595.3 3.15 x 10-5 366.3
7.125 4.68 x 10-5 245.1 8.86 x 10-5 130.4
7.36 6.33 x 10-5 182.5 2.24 x 10-4 51.5
8.04 1.51 x 10-4 76.5 5.94 x 10-4 19.5
8.47 2.03 x 10-4 57 6.74 x 10-4 17.4
9.34 8.19 x 10-4 15 N/A N/A
Exchange rates increased with increasing pH*. This increase is evident for
both peaks, but there are still significant differences between the exchange rates of
both protons, with exchange of NHd being 1.4 times faster at 6.16 pH* than NHu
exchange and 3.2 times faster at 8.47 pH*.
Figure 3.20 compares the half–life of all these reactions with respect to the
pH* at which the exchange occurred. This provides clear evidence of a base-
catalysed reaction.
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Figure 3.20. Dependence of the half life for 1H/2H exchange at various pH* values.
■ NHu/Du values and ■ NHD/DD values. Exchange of downward protons was too
rapid to be observed on the NMR time scale. Above pH* = 9 the exchange on NHd
was unobservable.
Lowering of pH* led to a decrease in exchange rate for both NHu and NHd.
At pH* < 3 there was no determinable decrease in either NH peak intensity. This
information was useful experimentally and allowed 2D NOESY and COSY
experiments in acidic D2O solutions without loss of intensity of N-H peaks.
Acidic conditions allowed for spectra to be obtained without the need of H2O
suppression, leading to sharper and more reliable results. It was this method that
allowed observation of the NOESY spectrum of the pyridine adduct (6) in D2O.
The use of pH* to control the rate of exchange of the amine protons proved very
useful for higher charged species in which inversion could be too rapid at neutral
pH to observe on an NMR timescale and could be reduced using acidic solution to
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help with observations of the exchange, this will be discussed in more detail in
Chapter 4.
Combining the information from Figure 3.20 and comparing to the
concentration of free protons in solution (Log10[kobs] log vs. pH*). a linear
relationship is observed; this proved conclusively that the exchange is base-
catalysed (Figure 3.21).
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Figure 3.21. Plots of log10(kHu) and log10(kHd) vs pH* showing a linear
relationship between pH* and log10(kobs) for exchange of 1H for 2H on the
ethylenediamine amino-protons at 298 K in 154 mM NaCl solution in D2O. a) The
linear plot for NHd exchange, and b) for the NHu exchange. A clear relationship
between the rates of exchange and the basicity of the solution is observed.
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Table 3.8. Parameters from the fitting of the linear plots in Figure 3.21.
Exchange Slope Intercept R2 (G.o.F)
N-Hd 0.73066 -9.20406 0.95576
N-Hu 0.54874 -8.26142 0.99312
These data become useful when comparing solutions of a different ionic strength
to those at 154 mM NaCl solutions.
3.2.9 Effects of ionic strength on exchange
Exchange was observed for solutions of different ionic strengths, to study
the effects of ionic strength on the exchange rates. Fresh samples of 1 were
dissolved in either 300 mM, 500 mM or 1 M NaCl solutions in D2O and exchange
rates were observed and compared to those in 154 mM solutions of NaCl, as
derived using the data in Table 3.9. Direct comparisons could not be made with
each other as samples were at different pH* values. Ionic strength was determined
using equation 3.4.
2
1
1
2
n
i i
i
I c z

  (Equation 3.4)
Where; I is the ionic strength, ci is the concentration of ion i, and zi is the charge
on ion i. For NaCl I will equal the concentration in molar units, as both ions have
a charge of 1.
  
221 0 154 1 0 154 1 0 154
2
I . . .       
   
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Table 3.9. Rate constants for solutions of varying ionic strength, compared to
those of the calculated values obtained at I = 0.154 using the data from Table 3.8.
Ionic Strength
(pH*)
kobs (NHd) s-1 kcalc (NHd)‡ s-1
(0.154 M NaCl)
kobs (NHu) s-1 kcalc (NHu) ‡ s-1
(0.154 M NaCl)
0.3 (8.2) 2.13 x 10-3 6.13 x 10-4 2.04 x 10-4 1.73 x 10-4
0.5 (7.9) 1.18 x 10-3 3.7 x 10-4 9.25 x 10-5 1.18 x 10-4
1.0 (6.6) 5.71 x 10-5 4.15 x 10-5 1.77 x 10-5 2.29 x 10-5
‡ Calculated values for the exchange rates of Ionic strength = 0.154 and at the
same pH* as the samples at different ionic strengths so that comparisons can be
made.
When the exchange rates at different ionic strengths are compared to that
at I = 0.154, a definite effect of ionic strength on the exchange rates is observed.
As the ionic strength increases, the exchange rates of the NHd protons increase
substantially, whereas the effects on the NHu exchange rates are not as
pronounced.
3.2.10 2H/1H Exchange rates
The reverse reaction (exchange of 2H for 1H) was monitored. A lyophilised
deuterated sample (1D) in NaCl was prepared (c.f. § 2.15) and dissolved in 1 mL
H2O and monitored using 2H NMR. (I = 0.6, pH = 7.27) and (I = 0.3, pH = 7.2)
(Figure 3.22). Table 3.10 shows the kinetics data observed. There are many
difficulties with 2H NMR, one of which is the lower signal-to-noise ratio which
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made it difficult to monitor the signal for NHd for I = 0.6, as before monitoring
could begin, much of the signal had disappeared.
2.53.03.54.04.55.05.56.06.57.07.5 ppm
N-Du N-Dd
D2O CD3OH
ppm345678
δ 2H
345678 ppmpp
δ 1H
N-Hu N-Hd
Figure 3.22. A comparison of a 2H and 1H NMR spectrum of 1D and 1 (2H at
I=0.3, pH = 7.27, 76.7 MHz). When the 2H NMR is calibrated to CD3OH the 2H
and 1H signals for the N-2H and N-1H peaks appear in a very similar range, as
would be expected.
Table 3.10. Kinetic data observed from 2H NMR of 2H/1H exchange on 1D.
2H I pH kobs s-1 t½ (min)
N2Hu 0.60 7.3 8.308 x 10-5 139.4
N2Hu 0.30 7.2 7.17 x 10-5 161.2
N2Hd 0.30 7.2 3.59 x 10-4 32.6
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3.2.11 Computational Analysis
Using the x-ray crystal structure of [(η
6-bip)Ru(en)Cl]+ (1) the molecular
orbitals were calculated (c.f. §2.13) to look in detail at the HOMO (highest
occupied molecular orbital) and the LUMO (lowest unoccupied molecular orbital).
Analysis of the HOMO showed an overlap between the antibonding orbital of the
Ru-Cl bond and what looks very like a p-orbital around the nitrogen of the
ethylenediamine ligand. (Figure 3.23)
Ru
Cl
s * - antibonding orbital
biphenyl
Overlap between the s *-antibonding
orbitals and an orbital on the nitrogen
of the en ligand
and an orbital on the nitrogen
Figure 3.23. A representation of the HOMO of 1 [(η6-bip)Ru(en)Cl]+. There
appears to be an overlap between the σ
*-antibonding orbital of Ru-Cl and a
potential location of a p-orbital on the nitrogen of the ethylenediamine ligand.
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3.3 Discussion
3.3.1 The presence of two N-H peaks in the NMR spectra of 1_PF6 and
6_2PF6
By 1H NMR the presence of 2 non-equivalent NH protons was observed.
This is believed to be a result of the ethylenediamine-ruthenium 5-membered ring
not being in a symmetrical magnetic field. In a magnetic field a ring current is
induced in the overlying biphenyl ring which can influence the magnetic field
around the amine and ethyl protons on the ethylenediamine. Protons which occupy
the space close to the arene will be affected differently than those further away.
This phenomenon has been noted many times before.28 The observstoion of
NOESY peaks for the pyridine adduct (6) allowed NOE crosspeaks to be detected
between the ortho-proton on the pyridine (o-Hpyr) and the downward pointing
protons on the amine (N-Hd) to determine the identity of each N-H peak in the
NMR spectrum. Assuming 1 would be subject to similar effects from the ring
current, conclusive assignments of δ (N-Hu) = 6.03ppm and δ (N-Hd) = 3.99ppm
for solutions of 1 in 154 mM D2O were made.
3.3.2 Exchange rates of NHu and NHd
Studies were carried out in 154 mM NaCl solutions to monitor exchange
rates of 1H for 2H in D2O as a method of studying the mechanism for inversion of
the stereochemistry on [(η
6-bip)Ru(Et-en)Cl]+. There were two reasons for the
design of this experiment. Firstly, the NaCl suppresses hydrolysis38 and ensures
that only NH/D exchange of the chlorido species would be investigated, without
the added complications of aqua species forming. Secondly, the reason for
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studying the non-chiral complex was similar and it was to prevent the kinetics
being complicated by the interconversion between diastereoisomers.
These initial studies on the exchange rates of NHu and NHd showed two
distinct rates of exchange. The reason for this difference in exchange rates became
the main area of focus of this work. A similar effect was noted on
ethylenediamine Co(III) complexes33,39 and was believed to be a result of cis and
trans effects. However, in the complex studied here (1) both ethylenediamine
nitrogens appear to be exposed to the same cis and trans effects, so there must be
other factors leading to the difference in rates.
3.3.3 Exchange rates at various temperatures
Studies at various temperatures have shown a continuous trend with NHd
undergoing exchange substantially faster than the NHu protons. Using the rate
constants for exchange at various temperatures the activation parameters for the
exchange process were determined. The activation parameters of both NHd and
NHu exchange were almost identical to within 3%, with average activation energy
of 111.3 kJ mol-1. This clearly implies that both proceed via the same transition
state. Of further interest is the entropy of activation of 43.4 J mol-1, the positive
value being indicative of a dissociative pathway as entropy increases when an
atom dissociates. The activation energy is less than the dissociation energy of free
N-H bonds (319 kJ mol-1)40; this is to be expected as the lone pair of electrons on
the nitrogen is coordinated to the metal, weakening the N-H bond on the
ethylenediamine (Figure 3.24).
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Figure 3.24. A representation of the electron flow from the nitrogen to the
ruthenium weakening the N-H bond.
3.3.4 Effects of ionic strength on exchange rates
To confirm the mechanism is indeed dissociative, the effects of ionic
strength were investigated. It was found that ionic strength had an effect on the
exchange rates of NHd and NHu. The rates of exchange for NHd increased with
ionic strength, but decreased for NHu. The increase in the rate of reaction with
increasing ionic strength is indicative of a dissociative mechanism, adding further
weight to evidence from §3.3.3 (above). The reduction in the exchange rates of the
NHu protons may be a result of the increased ionic strength stabilising an
intermediate in the exchange mechanism.
3.3.5 Exchange rates of NDu and NDd
When the reverse reaction was studied (2H/1H exchange), the exchange
rates were reduced (when effects of ionic strength were taken into account). As
with the exchange of protons for deuterons, there is an observable difference
between the exchange rates of the up and downward pointing deuterons. This
confirms the hypotheses that the rate limiting step is the abstraction of the proton,
given the decrease in reaction rates when a heavier isotope is used.
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3.3.6 Effects of pH on exchange rates
The proportionality between the rates of exchange and the pH* (Figure
3.20) of the sample provides insight into the mechanism. The exchange of protons
for deuterons on 1 at low pH* is almost negligible, with no exchange is observed
at pH* < 3 over 48 h. This observation further supports the conclusion that the
initial step in the reaction must be proton abstraction. Unlike exchange of protons
for deuterons on proteins which are both acid and base catalsysed41, the exchange
of the ligand amino protons appears to only be base-catalysed, given that at low
pH* values, exchange was not observed. This is in agreement with observation of
the rates of interconversion of stereoisomers of the ethyl-en complexes 5A and 5B
which appear to be base catalysed.8 These results are also in agreement with much
of the previous work by Fujita,31,42 where a dependence of [-OH] on the rate of
proton exchange was also observed.
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3.4 Potential Mechanisms
The amino protons on the ethylenediamine ligand of [Ru(II)(η
6-bip)enCl]+
have been found to undergo exchange in aqueous solutions. The rates of exchange
are dependent on pH, temperature and ionic strength. However of most interest to
this study is the difference in the exchange rates of amino protons dependent on
their orientation relative to the biphenyl ring system. Protons which point towards
the ring (NHu) are found to undergo exchange at a slower rate than those protons
that point away from the ring (NHd).
In the course of this work a number of phenomena were noted, all of
which contribute towards explaining the mechanism of exchange of protons.
1. Thermodynamic data for the transition state implies that exchange of
both NHu and NHd occur via the same intermediate species.
2. The proton exchange process is base-catalysed, so the rate limiting step
must be abstraction of a proton.
3. Dependence of the rates of exchange on ionic strength further provides
proof that the process is a dissociative one, so the abstraction of a proton
corresponds to this well.
4. Further evidence of the abstraction of a proton being the rate-
determining step was provided by the kinetic isotope effect on the rate
constant for the back reaction of deuterons being exchanged for protons.
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All these observations lead to the conclusion that the complex must undergo
proton abstraction as a rate-limiting step and that it is the breaking of the N-H
bond, rather than the Ru-N or Ru-Cl bond, that is crucial to this mechanism. The
possibility of the Ru-N or Ru-Cl bonds being broken as part of this mechanism is
ruled out by the observation that both the types of protons (NHu and NHd)
exchange at different rates. If Ru-N or Ru-Cl bond breaking was occurring during
this process, as is seen with some catalytic processes where the Ru-H bond
breaks25, in order to change the stereo centres in 1 or in complexes 5A and 5B,
this bias in exchange of NHd over NHu would not occur. (Figure 3.25 and 3.26)
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Figure 3.25. Representation of how Ru-Cl bond breaking would cause inversion
of stereochemistry of 5A to form 5B. Charges have been excluded from the
complex for clarity and the arene ring system is in constant rotation.
If the mechanism shown in Figure 3.25 is the route to inversion, then the
probability of Cl- attack on either face would be equal and would not lead to the
difference in exchange rates of NHu and NHd seen for complex 1, which has been
used in this study to explain the inversion on 5A. If the mechanism involves a 16-
electron species, as with the catalytic processes,17 the probability NHu and NHd
being replaced would be equal. This is clearly not occurring and so exchange must
proceed via another mechanism.
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The N-C bond can undergo constant
rotation and a Ru-N bond can reform
to give either stereoisomer
Figure 3.26. Proposed mechanism of stereo inversion involved Ru-N bond
breaking. The overall charges on the complexes have been omitted for clarity.
While the mechanism shown in Figure 3.26 would explain how an
inversion of stereo centres can occur, it would not however, explain the difference
in exchange for up and down protons. Once Ru-N or Ru-Cl bond-breaking has
been ruled out, the only other alternative is N-H bond breaking. This agrees with
the observations confirming that the rate-limiting step of the exchange process is
proton abstraction.
Once the rate-determining step was elucidated, the issue of why NHu
exchange is so much slower than NHd needed to be addressed. Activation
parameters for the transition state species showed that the ΔEa
‡
,, ΔHa
‡
,  and ΔSa
‡,
for both exchange pathways are almost identical, so both processes are likely to
involve the same transition state. This led to the conclusion that the product
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determining step (i.e.: the step in the reaction which determines which face of the
ethylenediamine is deuterated) must occur after the transition state is formed and
be influenced by accessibility of deuterons to the nitrogen lone pair which has
been freed by the loss of a proton.
Given the fact that the two protons, NHu and NHd, are in different physical
environments, as a result of their proximity to the arene ring system, perhaps it is
the arene system that influences this difference in exchange rates. The abstraction
of a proton and addition of a deuteron might be concerted, and so the limiting step
would be access of a deutroxide ion into close enough proximity to the amine
groups in order to abstract a proton. The face of the en ligand away from the
biphenyl ring will be more accessible than that of the face nearest the biphenyl
ring. If the reaction involves a concerted exchange, then as one proton is
abstracted to form HOD, at the same time the deuteron can rapidly replace the
displaced proton. (Figure 3.27). This would explain the difference in rates of
exchange for the up and down protons, but it would not account for changes in
stereochemistry that are observed on complexes with chiral ethylenediamine
ligands.
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Leads to preferential
exchange of NHd
Figure 3.27. Proposed mechanism for a concerted mechanism which would
explain a bias for NHd exchange faster than that of NHu but would not explain the
change in stereoisomerism that is observed on complexes with chiral
ethylenediamine ligands
Following elimination of the mechanisms discussed above, there are only
two other possible explanations which would fit the experimental data for both the
difference in the exchange rates of up and down protons and the inversion of
stereochemistry. Figure 3.29 gives an overview of how proton abstraction can lead
to stereochemical inversion for complex 5A. This method confirms that ring
opening has no role in the conversion of 5A to 5B, but conversion is through the
exchange of protons in aqueous solution.
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Figure 3.28. Possible mechanism for the inversion of the stereochemistry of 5A
in aqueous solution. Here the direction in favour of one product over another is
driven more by steric factors. Charges on the complexes have been omitted for
clarity.
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While the mechanism in Figure 3.28 can explain the interconversion
between 5A and 5B, it does not explain the bias for NHd exchange over NHu
exchange. A look at all the data obtained so far, suggests that there are two
possible reasons for this bias.
1) Steric hinderance towards deuterated water molecule getting close to the
lone pair of electrons on the nitrogen’s upper face (nearest the biphenyl
ring). The possibility of hydrophobic repulsion by the biphenyl ring, which
would overlap the upperface of the 5-membered ring system, should not be
discounted as part of this theory either.
2) Molecular orbital effects of the anti-bonding orbital associated with the
Ru-Cl bond stabilising the lone pair of electrons on the upper face of the
nitrogen, therefore making them less available for protonation. Molecular
orbital calculations on an optimised structure of 1 have shown some
evidence for an overlap between the σ*-antibonding orbital of the Ru-Cl 
bond and what could be the upper face of a p-orbital on the nitrogen of the
ethylenediamine (Figure 3.29).
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Figure 3.29. A schematic representation of how the σ*-antibonding orbital on the 
Ru-Cl bonds could interact with the p-orbital housing the lone pair of electrons
(lpe-) on the nitrogen.
The calculations appear to show an overlap between a p-orbital on the
nitrogen and the Ru-Cl antibonding orbital. If this interaction is taking place it
would be a pseudo-anomeric effect on the metal where antibonding orbitals on
one bond are stabilising empty lone pairs of electrons on another. This interaction
explains the bias for NHd over NHu proton exchange. This, together with the
information so far discussed in this Chapter, leads to the conclusion that the
mechanism for exchange of amino protons for deuterons (and by implication the
stereo centre inversion on the N-ethyl-diethylamine adduct) involves a rate-
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limiting step which is proton abstraction. Abstraction is then followed by the
formation of a planar nitrogen centre. The deuteration on the nitrogen is then
biased in favour of attack on the lower face due to a number of factors including
steric hindrance from the biphenyl ring and molecular orbital effects stabilising
the lone pair on the upper face of the nitrogen. (Figure 3.30).
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Figure 3.30. A schematic representation of the overall exchange mechanism of
the 1H/2H exchange on [Ru(η6-bip)en.Cl]+ in aqueous solution. Charges on the
complexes have been omitted for clarity.
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3.5 Conclusions
From NMR investigations into the mechanism of N-1H/2H exchange on [(η6-
bip)Ru(en)Cl]+ a number of conclusions can be drawn.
1. Abstraction of a proton from the ethylenediamine is the rate limiting step.
2. There appear to be two possible factors influencing why one proton (NHd)
undergoes exchange more rapidly than the other (NHu). These appear to be
steric effects and effects of the Ru-Cl σ
*-antibonding orbital on the lone
pair of the nitrogen following proton abstraction.
Putting all this information together, leads to the following mechanism being
proposed (also Figure 3.30).
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Chapter 4
Influence of Arenes and Pyridine Derivatives on the Kinetics of
N-H/D Exchange in [Ru(η
6-arene)(en)(X)]n+ complexes
4.1 Introduction
Ruthenium(II) complexes with pyridine derivatives have many chemical
purposes, from solar cell devices1 to potential anticancer drugs2. The pyridine
derivative ligands have varying electronic effects on the ruthenium and play an
important role in tuning the electrochemistry of the compounds. Studies have
shown that changes in pyridines on metals can change many properties including
spin crossover energy3, photochemistry4 and redox chemistry.5 These studies were
found to yield well-fitting Hammett plots, showing that there is often a
relationship between the pKa of the ligand and the observed activity.
Since ruthenium and nitrogen-containing aromatics are deemed “soft”
metals and “soft” donors, respectively,6 they have a high affinity for each other
and form very stable bonds. Indeed, it is this strong affinity of ruthenium for
nitrogen which is believed to dominate the mechanism of action of ruthenium(II)
η
6-arene anticancer complexes in the body leading to their cytotoxic activity7. The
chlorido complex [(η
6-biphenyl)Ru(en)Cl]+ (1) hydrolyses to form the aqua
complex8 (1a), via an associative SN2 type reaction,9 and can bind preferentially to
N7 of guanine residues on DNA10-13, peptides14, histidine15,16, cytochrome c16,17
and enzymes13 (Figure 4.1).
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+ 2+ n+
DNA Binding
1 1a
1-DNA
Guanine Residue on DNA
Figure 4.1. The hydrolysis of 1 to 1a and subsequent binding to DNA via the N7
of guanine residues.
In Chapter 3, the effects of pH*, ionic strength and temperature on the
exchange rates of the amino protons for deuterons in the ethylenediamine ligand
on [(η
6-biphenyl)Ru(en)Cl]+ were investigated. Results showed that the reaction is
pseudo first order via a dissociative pathway (ionic strength dependent) and is pH*
dependent. The results also implied that the rate-limiting step is abstraction of a
proton from the nitrogen of the ethylenediamine ligand (Figure 4.2). More
noticeable was the difference in exchange rates for protons which point towards
the biphenyl ring system (Hu) and those which point away from the ring system
(Hd). It was observed that the upward-pointing protons exchanged much more
slowly than those which point away from the ring system. A number of theories
for this difference were proposed including; steric effects of the biphenyl ring
system, steric hindrance in the abstraction of the protons from the ethylenediamine,
and effects of the chloride–ruthenium σ
* anti-bonding orbital on stabilising the
negative charge on the nitrogen after abstraction of a proton.
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k1 k2
kd
ku
Figure 4.2. A mechanism for exchange of protons for deuterons on [(η6-
bip)Ru(en)Cl]+ (1). Hd, is the proton pointing away from the arene ring, Hu, is
the proton which points towards the arene ring. k1 is the rate constant for the rate-
determining step and is abstraction of a proton, k2 is the rate constant for the
umbrella-type inversion of the lone pair on the nitrogen, and kd and ku are the rate
constants for deuteration onto the down and up faces of the nitrogen,
respectively.
Due to the strong binding between ruthenium and nitrogen, the next
step in this study of exchange rates of the amino protons on the
ethylenediamine is to change the electron density on the ruthenium. One way to
achieve this is to synthesise a series of pyridine derivatives of different basicity
and observe the effect of the exchange of up and down protons. If the bias (for
NHd exchange over NHu) is affected by electronic effects on the ruthenium then,
as the pKa of the free pyridine increases, so should the bias of downward protons
being exchanged over upward protons.
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In this Chapter the effects of changing the arene and the effects of
changing the electron-donating ability of pyridine derivatives, in the chlorido
position on the rates of NH/D exchange are investigated. In addition to this, the
effects of ligand on the ruthenium on the isomeric bias (favourability of NHd
exchange over NHu exchange) for substitution of the up and down protons for
deuterons is investigated. The rationale for use of 4-substituted pyridines was the
ease with which the electronic character of the ligand could be changed without
steric influences. Pyridine ligands have tuneable pKa values by changing the 4-
substituent and so their effects on the ruthenium and the NH/D exchange rates as a
result of electronic effects on the ruthenium can easily be investigated. Another
benefit of using pyridine ligands is that these complexes do not readily undergo
hydrolysis and so there is no need to suppress hydrolysis, as was the case with the
chlorido complexes.
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4.2 Results
A series of [Ru(II)(η
6-arene)enX]2+ complexes was synthesised as detailed
in Figure 4.3. Crystal structures were obtained and analysed. The rate of N-H/D
exchange on the amine protons was determined for each complex and compared to
those determined in Chapter 3. This enabled the effects of different pyridine
groups and arenes on the rates of exchange to be investigated. Finally
computational analysis revealed molecular orbitals that may affect the rates of
exchange.
4.2.1 Synthesis and Characterisation
The novel complexes synthesised in this Chapter are shown in Figure 4.3.
All were made via the aqua adduct of the relevant chlorido complex, [(η
6-
biphenyl)Ru(en)Cl]+ or [(η6-benzene)Ru(en)Cl]+, were converted to the aqua
adducts by removal of the chloride ligand by precipitation with silver nitrate in
water. The aqua adduct was then reacted with the pyridine derivative. Ligand
substitution readily occurred. The synthesised pyridine complexes do not readily
hydrolyse and are stabilised by strong Ru-N bonding.
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Figure 4.3: The ruthenium complexes synthesised and studied in this chapter. All
these complexes (except 6 and 8) are novel complexes.
4.2.2 X-Ray crystal structures
X-ray diffraction data were collected and the structures solved by Dr Guy
Clarkson (University of Warwick). Diffraction data for complexes [(η
6-
bip)Ru(en)(N-4-Me-pyr)]2PF6, 7-2PF6 and [(η6-ben)Ru(en)(N-pyr)].2PF6 9-2PF6
were collected while the crystal was held at 120 K on an Oxford Cryosystem
Cryostream Cooler using a Siemens SMART three circle system with CCD
detector. The structures were solved by direct methods using SHELXS18 and
hydrogens added using Fourier methods.
Diffraction data for complexes [(η
6-bip)Ru(en)(N-4-t-Bu-pyr)].2PF6 10-
2PF6 and [(η6-bip)Ru(en)(N-4-Me-O-pyr)].2PF6 11-2PF6 were collected at 100 K
(10-2PF6) or 296 K (11-2PF6) on an Oxford diffraction Gemini four-circle system
equipped with a Ruby CCD area detector. The crystal of 10-2PF6 was held with
the Oxford Cryosystem Cryosteam Cobra in the detector. For 11-2PF6, the crystal
was glued to a glass fibre and placed in the path of the X-rays. Structures were
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solved by direct methods using SHELXS (1990)19 and refinement was carried out
with SHELXS (1997)18. Mercury 2.320,21 and Ortep 3.222 were used to view
crystal structures, to measure angles and distances and to produce the images
shown in this thesis. Only complex 10_2PF6 crystallised with a solvent molecule
(H2O) in the crystal structure. The author believes this is the first time any of these
x-ray crystal structures have been reported.
The 3D structures of these complexes and their corresponding atomic
numbering schemes are shown below in Figure 4.4 and 4.5. The corresponding
crystallographic data are listed in Tables 4.1 and 4.2. Table 4.3 contains a
comparison of all the bond lengths across the series.
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Figure 4.4:  X-ray crystal structure and atom numbering scheme for a) [(η6-
bip)Ru(en)(N-4-Me-pyr)] (7), and b) [(η6-ben)Ru(en)(N-pyr](9). The thermal
ellipsoids show 50% probability. The PF6ˉ counterions and all hydrogen atoms are
omitted for clarity
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Figure 4.5.  X-ray crystal structure and atom numbering scheme for a) [(η6-
bip)Ru(en)(N-4-t-Bu-pyr)] (10) (the water of crystallisation, all hydrogens, the
PF6ˉ counterions and the disorder of the t-butyl group are omitted for clarity), and
b) [(η
6-bip)Ru(en)(N-4-Me-O-pyr)](11). Again the PF6ˉ counterions and hydrogen
atoms are omitted for clarity. The thermal ellipsoids show 50% probability. Note:
the larger ellipsoids for 10 are due to data being acquired at higher temperature
(296 K)
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All structures showed the expected “piano-stool” geometry that is typical
of this type of complex.7 The arene is π-bound to the ruthenium atom and forms 
the “seat” of the piano stool, while the nitrogen bound ligands take the role of the
“legs” and “feet” of the stool. All complexes were found to have similar distances
between ruthenium and the centroid of the π-bound arene of 1.684 - 1.689 Å. In 
all the biphenyl complexes the free phenyl ring is in close proximity to the
aromatic ring of the pyridine ligand, however not close enough to be classified as
π-stacking. Crystallographic data are shown in Table 4.1 – 4.2 and a selection of 
bond lengths and angles are shown in Table 4.3. Within the long range packing
structure of these complexes some CH-π interactions were observed. This were 
more intermolecular interactions and as a result of packing within the matrix as
opposed to intramolecular interactions.
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Table 4.1: Crystallographic data for complexes 7_2PF6 and 9_2PF6
7_2PF6 9_2PF6
Formula C20H25F12N3P2Ru C13H19F12N3P2Ru
Molar mass 698.44 608.32
Crystal system Triclinic Monoclinic
Crystal size /mm 0.40 x 0.18 x 0.08 0.12 x 0.06 x 0.02
Space group P-1 P2(1)/n
Crystal Yellow block Yellow block
a / Å 11.3660(2) 9.7734(2)
b / Å 13.7029(4) 13.2206(2)
c / Å 17.5135(4) 15.5490(3)
 / deg 91.9920(10) 90
 / deg 91.405(2) 95.8130(10)
 / deg 108.893(2) 90
T / K 120(2) 120(2)
Z 4 4
R [F > 2 (F)]a 0.0445 0.0366
Rwb 0.1251 0.0771
GOFc 1.027 1.099
 max and min / eÅ-3 1.152, -0.963 0.466, -0.585
a R = ||Fo| - |Fc||/|Fo|. b Rw = [w(Fo2 - Fc2)2/wFo2)]1/2. c GOF = [w(Fo2 – Fc2)2/(n-p)]1/2, where
n = number of reflections and p = number of parameters.
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Table 4.2. Crystallographic data for complexes 10_2PF6 and 11_2PF6
10_2PF6.H2O 11_2PF6
Formula C22H33F12N3OP2Ru C20H25F12N3OP2Ru
Molar mass 758.53 714.44
Crystal system Triclinic Monoclinic
Crystal size /mm 0.80 x 0.14 x 0.04 0.40 x 0.08 x 0.02
Space group P-1 P2(1)/c
Crystal Light yellow block Yellow rod
a / Å 9.6369(3) 9.8194(3)
b / Å 11.2578(3) 27.6354(8)
c / Å 15.9640(3) 9.5380(3)
 / deg 102.5993(19) 90
 / deg 97.737(2) 101.396(3)
 / deg 112.388(2) 90
T / K 296 100
Z 2 4
R [F > 2 (F)]a 0.0388 0.0305
Rwb 0.1149 0.0577
GOFc 1.097 0.918
 max and min / eÅ-3 0.892, -0.556 0.852, -0.834
a R = ||Fo| - |Fc||/|Fo|. b Rw = [w(Fo2 - Fc2)2/wFo2)]1/2. c GOF = [w(Fo2 – Fc2)2/(n-p)]1/2, where
n = number of reflections and p = number of parameters
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Table 4.3. Selected bond lengths (Å) and angles (º) for complexes 7, 9, 10 and 11.
Bond/Angle
7-2PF6 9-2PF6 10-2PF6.H2O 11-2PF6
Ru1-N1 2.128(3) 2.133(3) 2.117(3) 2.127(2)
Ru1-N4 2.127(3) 2.126(3) 2.117(2) 2.1421(19)
Ru1-N5 2.106(3) 2.119(3) 2.130(3) 2.1131(18)
Ru – C (arene) 2.201(4) 2.192(3) 2.193(3) 2.176(2)
2.177(4) 2.183(3) 2.197(3) 2.190(2)
2.214(4) 2.207(3) 2.203(4) 2.198(2)
2.177(4) 2.205(3) 2.176(4) 2.204(2)
2.201(4) 2.204(3) 2.203(4) 2.212(2)
2.245(3) 2.198(3) 2.225(3) 2.235(2)
Ru – Centroid
of arene 1.688 1.685 1.689 1.685
N1-Ru-N4 79.26(13) 78.54(11) 79.21(13) 78.88(8)
N1-Ru-N5 86.99(11) 88.23(10) 88.45(11) 85.59(8)
N2-Ru-N5 89.70(11) 86.23(10) 85.94(11) 86.98(8)
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Other interesting features of these complexes are the “biphenyl
orientation” angle relative to the X ligand, and the “biphenyl twist” angle, which
is the angle through which the free (pendant) phenyl ring on the biphenyl has
twisted from the plane of the bound phenyl ring (i.e.: the seat of the piano stool)
(Figure 4.6).
Figure 4.6. Schematic of the biphenyl orientation (a) and biphenyl twist (b)
angles
These angles are detailed in Table 4.4, for complexes 4, 6, and 7.
Table 4.4. Biphenyl orientation and twist angles (o) for complexes 4, 6 – 7.
7-2PF6 10-2PF6.H2O 11-2PF6
Biphenyl
orientation
7.26 14.71 31.51
Twist angle 29.64 19.31 22.38
There appears to be no obvious cause other than a packing effect, for these twists
and the biphenyl orientation. It was noted in the packing of the crystal cell, that
there is some interaction between hydrogens on one molecule with the centre of
the π-cloud on the free phenyl ring of another molecule. This appeared to lead to 
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efficient packing within the cell. This type of interaction is called CH- π bonding 
and is widely seen in inorganic complexes packing structures.
4.2.3 N-H/D exchange rates
As was observed in Chapter 3 for [(η
6-biphenyl)Ru(en)Cl]+, the up and downward
pointing NH protons exchange with deuterium at different rates. Details of the
exchange rates and decay curves for each of the complexes studied in this chapter
are listed below. These pyridine complexes do not appear to hydrolyse and with
that in mind all the samples were prepared as low ionic-strength solutions.
Samples were prepared in acidic solution (pH* detailed in each experiment) in an
attempt to make sure 1H/2H exchange was slow enough to be observable.
4.2.3.1 Determination of rates
Rates were determined in a very similar manner to those of Chapter 3 (c.f.
§2.3 for method). Unlike 1, the NMR signals of complexes with pyridine
derivatives do not have an overlap of NHu and the bound phenyl region. This
made integration of peak areas simpler and so the method used is summarised in
Figure 4.7.
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2345678 ppm
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H2O
Figure 4.7. 1H NMR spectrum of [(η6-bip)Ru(en)(N-4-Me-O-pyr)].2PF6. [11-
2PF6] in D2O, within 20 minutes of mixing. Highlighted in green is the peak for
H-ortho-4-methyoxypyridine. The value of this integral was set at 2 and used to
normalise the integrals of the N-H peaks. (red (NH2-en) and blue (CH2-en)).
4.2.3.2 [(η
6-bip)Ru(en)N-pyr]2+ [6]
Complex 6 was dissolved in D2O at 298 K with pH* = 6.3. NMR spectra
were recorded over time and are shown in Figure 4.8. It can be seen that the peak
for the NHd protons disappears significantly faster than that for the NHu protons.
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Figure 4.8. N-H segments of the 1H NMR spectra over time of 6 in D2O at 298 K
pH* = 6.3 and the time from mixing to the first NMR acquisition was 20 min 43 s.
The upward orientated protons (■) and the downward orientated protons (■) are
marked for clarity.
Plotting the intensity of the peaks against time produced two exponential
decay curves (Figure 4.9) and yielded the rate constants and the half times for the
H – D exchange reactions (Table 4.5).
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Figure 4.9. Exponential decay curves of the intensity of the up ■ and down ▲ 
facing protons of 6 at pH* = 6.3 in D2O. The lines are best fits for the NHu (▬)
and the NHd (▬) protons.
Table 4.5. Kinetic data for the deuterium exchange of N-Hu and N-Hd on 6.
Proton Rate Constant (s-1) Half life (s)
N-Hu 5.66 x 10-5 12.5 x 103
N-Hd 55.2 x 10-5 1.26 x 103
4.2.3.3 [(η
6-ben)Ru(en)Cl]+ [8]
A sample of 8 was dissolved in 154 mM NaCl in D2O and the decay of the
intensity of the exchange of N-H/D was observed over time by monitoring the
NMR peaks, Figure 4.10.
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Figure 4.10. Decay of the N-H 1H NMR peaks over time for 8 in 154 mM NaCl
in D2O, pH* = 7.4 and at 298 K. The time from mixing to the first NMR
acquisition was 9 min 50 s. The peaks for the upward orientated NHu protons (■)
and the downward orientated NHd protons (■) are labelled.
Exponential fits to plots of the intensities of the peaks against time (Figure
4.11) yielded rate constants and half-times for the exchange and shown in Table
4.6. It is noticeable that the differences in exchange rates are not as dramatically
different for this complex as seen for others.
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Figure 4.11. Exponential decay curves of the intensity of the up ■ and down ▲ 
facing protons of 8 at pH* = 7.4 in 154 mM NaCl in D2O at 298 K. The lines are
best fits for the NHu (▬) and the NHd (▬) protons, with the decay constants in
Table 4.6.
Table 4.6. Kinetic data for the exchange of N-Hu and N-Hd on 8.
Proton Rate Constant (s-1) Half life (s)
N-Hu 2.766 x 10-5 25.4 x 103
N-Hd 6.379 x 10-5 10.9 x 103
4.2.3.4 [(η
6-biphenyl)Ru(en)(N-4-Me-py)]2PF6. [7]
When the rates of exchange for the pyridine complex (6) are compared to those for
the chlorido adduct (1), it was noted that the exchange rates increased when the
charge on the complex increased. To control this and make rates of N-H/D exchange
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observable, the pH* of the sample was lowered (as Chapter 3 has shown that exchange
is base catalysed).
A sample of 7 was dissolved in D2O and the intensity of the N-H peaks in
a 1H NMR spectrum was recorded at various time intervals. Selected NMR
spectra showing the decrease in the N-H peak intensities over time is shown in
Figure 4.12.
6.06.26.46.6 4.04.24.46. . .4 4.
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Figure 4.12. N-H segments of the 1H NMR spectra over time of 7 in D2O at 298
K pH* = 5.68 and the time from mixing to the first NMR acquisition was 9 min
10 s. The upward, N-Hu (■) and the downward N-Hd (■) orientated protons are
marked for clarity.
Plots of the intensity of the peak against time produced two very different
exponential decay curves (Figure 4.13). The rate constants and the half times for
the exchange reactions are shown in Table 4.8.
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Figure 4.13. Time dependence of the decay of the NHu (■) and NHd (■) 1H NMR
peaks for complex 7 in D2O at pH* = 5.68 and 298 K. The solid lines are the best
fits for first order exponential decays and corresponding to the rate constants in
Figure 4.7.
Table 4.7. Kinetic data for the exchange of N-Hu and N-Hd on 7 at pH* = 5.68.
Proton Rate Constant (s-1) Half life (s)
N-Hu 2.19 x 10-5 31.7 x 103
N-Hd 23.11 x 10-5 3 x 103
4.2.3.5 [(η
6-ben)Ru(en)(N-pyr)]2+ [9]
Since comparisons have been made between different charges on the biphenyl
complexes, it is interesting to look at the differences in charges on the benzene
complexes. Figure 4.14 shows the time dependence of the 1H NMR spectrum of 9
in D2O, pH* = 5.38 at 298 K.
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Figure 4.14. Time dependence 1H NMR spectra of 9 in D2O, pH* = 5.38 at 298 K
showing the decrease in the intensity of the N-Hu (■) and N-Hd (■) peaks over
time.
Exponential fits showing the effects of time on the intergrals of the NH
peaks were plotted (Figure 4.15). From this the rate constants for the exchange of
protons and deuterons were determined and are shown in Table 4.8.
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Figure 4.15. Time dependent decay of the integrals of 1H NMR peaks of the NHu
(■) and the NHd (▲) protons of 9 in D2O at pH* = 5.38 at 298 K. The best fit lines
are shown in ▬ for up and ▬ for the down protons respectively and yield the rate
constants listed in Table 4.8. The large spread of data points in the 0 – 20 x 103 s
region is due to the low signal-to-noise ratio since there is peak overlap with the
H2O signal in the NMR spectra.
Table 4.8. Kinetic data for the exchange of N-Hu and N-Hd on 9 at pH* = 5.68.
Proton Rate Constant (s-1) Half life (s)
N-Hu 1.7 x 10-5 40.8 x 103
N-Hd 13.4 x 10-5 5.2 x 103
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4.2.3.6 [(η
6-bip)Ru(en)(N-4-t-Bu-pyr)] [10]
As part of the series of pyridine complexes, 10 was synthesised and the
exchange of amino protons on the ethylenediamine ligand was observed using 1H
NMR of solutions in D2O. A selection of NMR spectra showing the decrease in
the intensity of the N-H peaks with respect to time are shown in Figure 4.16.
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Figure 4.16. Time dependent 1H NMR spectra of 10 in D2O, pH* = 5.55, T = 298
K of the N-Hu (■) and N-Hd (■) peaks.
Plotting the intensities of the N-H peaks against time produced two
exponential decay curves for both the sets of protons on the nitrogens (Figure
4.17). Upon calculation of the best fit for the decay curves, the kinetic parameters
were determined. (Table 4.9)
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Figure 4.17. Time dependent decay of the NHu (■) and NHd (▲) 1H NMR peaks
for complex 10 in D2O at pH* = 5.55 and 298 K. The solid lines are the best fit for
single exponential decays and giving the rate constants listed in Table 4.9
Table 4.9. Kinetic data for the exchange of protons for deuterons on N-Hu and N-
Hd on 10 at pH* = 5.55.
Proton Rate Constant (s-1) Half life (s)
N-Hu 2.406 x 10-5 29.3 x 103
N-Hd 12.16 x 10-5 6.0 x 103
Chapter 4 – Influences of arene and charge on NH/D exchange rates
185
4.2.3.7 [(η
6-bip)Ru(en)(N-4-Me-O-pyr)] [11]
The last of the complexes with pyridine derivatives to be synthesised was
11_2PF6, which contains a 4-methoxypyridine ligand. This was chosen as a ligand
due to its high pKa value (6.62) for the free ligand and also for the strong electron
donating abilities of the methoxy group to the pyridine ring. As with previous
studies, the exchange rates of the amino protons on the ethylenediamine group
were studied using 1H NMR. Figure 4.18 shows how the intensities of the N-H
peaks decrease with time.
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Figure 4.18. Time dependent 1H NMR spectra of 11 in D2O, pH* = 6.9, T = 298
K. The N-Hu (■) and N-Hd (■) peaks can be seen to decrease in intensity over time.
The decrease in the intensity of the downward proton was very rapid and after 40
minutes the peak was negligible.
From the NMR data, time-dependent exponential decay curves were plotted (Fig
4.19) and the kinetic parameters were determined (Table 4.10).
Chapter 4 – Influences of arene and charge on NH/D exchange rates
186
0 2
0.0
0.1
0.2
0.3
N-HuN-Hd
N
H
-in
te
ns
ity
0 2 4 6 8 10 12 14 16
0
2
N
H
pe
ak
in
te
ns
ity
Time (103 sec)
N
H
pe
ak
in
te
ns
ity
Time (103 s)
N
H
-in
te
ns
ity
N
H
pe
ak
in
te
ns
ity
N
H
pe
ak
in
te
ns
ity
Figure 4.19. Time dependent exponential decay curves of the peaks of the NHu (■)
and NHd (▲) in 1H NMR spectra of 11 in D2O at pH* = 6.9, T = 298 K. The solid
lines are the best fit which corresponds to the data listed in Table 4.10 below.
It is important to comment here that the exchange rates are very rapid for NHd and
so there is a larger error in calculating the best fit and in turn the rate constant.
These errors are of the order of 15% compared to 5% for NHu.
Table 4.10. Kinetic data for the exchange of protons for deuterons on N-Hu and
N-Hd on 11 at pH* = 5.55, T = 298 K.
Proton Rate Constant (s-1) Half life (s)
N-Hu 2.3 x 10-4 2.75 x 103
N-Hd 62.3 x 10-4 111
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4.2.4 Computational analysis
Computational studies were carried out as described in Chapter 2 (c.f.
§2.13). The aim of computational analysis was to characterise the HOMO and
LUMO molecular orbitals of each complex since these may play a role in the
mechanism of NH/D exchange. First the geometry of the biphenyl containing
complexes 6, 9, 10 and 11 as determined by X-ray crystallography was optimised.
Their molecular orbitals calculated in silico were compared to those for 1 reported
in Chapter 3. As will be discussed later, only subjective conclusions on a
qualitative level can be drawn from these results as the energy levels are only
comparative within each calculation; they are relative values and not absolute.
Also of note is the fact that all calculations were carried out on the stable
molecular ion (as found in the crystal structure) and not on the charged transition
state. It is with this caveat and understanding that any conclusions should be
drawn from these data.
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4.2.4.1 [η
6-biphenyl)Ru(en)N-pyridine]2+ [6]
Ru
Biphenyl
Pyridine
Ru-Pyridine
antibonding orbital
(π*)
Overlap between
π* orbital and p-orbital on
the Nitrogen
Figure 4.20. A series of representations, from different orientations, of the highest
occupied molecular orbital (HOMO) of 6 ([(η6-bip)Ru(en)N-pyr]2+). The central
ruthenium is obscured by the orbitals (in the upper image), but is green in colour.
Yellow lobes represents the positive phase and purple the negative phase of the
wavefunction.
The HOMO contains the π
* antibonding orbital of the Ru – N(pyridine)
bond. Of interest is the observation that there is a clear overlap between the
antibonding orbital and a p-orbital on nitrogen (and with some of the bonding
orbitals from the π-bonding to the arene ring). This could potentially play a role in 
stabilising the lone pair of electrons on the nitrogen (of the ethylenediamine)
following abstraction of a proton and explain why the exchange of NHu and NHd
protons occurs at different rates.
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4.3.4.2 [η
6-bip)Ru(en)N-4-Me-pyr]2+ [7]
The analysis of the HOMO of [η
6-bip)Ru(en)N-4-Me-pyr]2+ (7) was not as
straight forward (Figure 4.21), as the HOMO appears to contain a bonding orbital
between the ruthenium and the 4-methylpyridine. This combined orbital appears
to have very little overlap with the p-orbitals on the nitrogen; on one face there
does appear to be some overlap, but it is very small.
No interaction
en
Ru
Biphenyl
4-Methylpyridine There is overlap between the
orbitals here, possible π bonding
HOMO
Figure 4.21. Representation of the HOMO of 9 ([(η6-bip)Ru(en)N-Me-pyr]2+).
The central ruthenium is obscured by the orbitals, but is marked and is green in
colour. Yellow lobes represent the positive phase and purple lobes are the
negative phase of the wavefunction.
Upon investigation of the lowest unoccupied molecular orbital (LUMO)
the presence of what appears to be the σ
*-antibonding orbital of the {Ru-N(4-
Me-pyr)} fragment was observed and it has a small interaction with the p-orbital
on one of the nitrogens (Figure 4.22).
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LUMO
4-Methylpyridine
Biphenyl
Ru
σ*-antibonding orbital
Small overlap in the positive phase
with the p-orbitals on the nitrogen
Figure 4.21. A representation of the LUMO of 9. Labelled is a small overlap
between the σ
* of the Ru-N(4-Me-pyr) bond and what appears very similar to a p-
orbital on the nitrogen of the en ligand. The central ruthenium is obscured by the
orbitals, but is marked and is green in colour. Yellow represents the positive phase
and fuchsia is the negative phase of the wavefunction.
4.2.4.3 [(η
6-bip)Ru(en)N-4-t-Bu-pyr]2+ [10]
While the HOMO of 7 did not show overlap between the p-orbitals and the
π* or σ*-antibonding orbitals, (which as previously stated may have a role in the 
bias of exchange rates for NHd over NHu), the data for 10 are somewhat clearer.
Figure 4.22 shows that there is an overlap with a p-orbital on a nitrogen atom of
the ethylenediamine ring and the π*-antibonding orbital of the Ru-N(4-t-Bu-pyr) 
fragment. On the other side of the ethylenediamine, the sign of the phase of the
upper part of the p-orbital on the nitrogen is the same as that for the antibonding
orbital which is in very close proximity. So, potentially, in the transition state of
the exchange reaction there could be some overlap, this will be discussed further
later in this chapter.
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Ru
4-t-butylpyridine
Biphenyl
Ru
π*-antibonding orbital
Overlap between
the antibonding
with the p-
orbitals on the
nitrogen
No overlap , but the
2 orbitals are in very
close proximity and
the same phase
Figure 4.22. A representation of the HOMO of the 4-t-butylpyridine complex [10].
The π
*-antibonding orbital of the Ru-N can been seen and overlaps with a p-
orbital on the nitrogen (image on the left). The central ruthenium is obscured by
the orbitals, but is marked green in colour. Yellow represents the positive phase
and fuchsia is the negative phase of the wavefunction.
4.2.4.4 [(η
6-bip)Ru(en)N-4-Me-O-pyr]2+ [11]
As with 9 the HOMO showed some evidence of π-bonding between the N on the 
pyridine ring and the ruthenium (Fig. 4.23). There was an overlap between the Ru-
Arene bonding orbitals and a nitrogen on the ethylenediamine, but this is small
compared to those seen for 6 and 10.
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No interaction
Ru
Biphenyl
4-Methoxypyridine
Possible π bonding
HOMO
Very weak interaction
Figure 4.23. A representation of the HOMO of the 4-methoxypyridine complex
(11). There appears to be a small amount of π-bonding characteristic of the 
orbitals present. The central ruthenium is obscured by the orbitals, but is marked
and is green in colour. Yellow lobes represents the positive phase and purple
lobes are the negative phase of the wavefunction.
The energy gap between the LUMO (Fig. 4.24) and the HOMO was
calculated as 4.95 eV. There appears to be a σ
*-antibonding orbital present and a
(very) small overlap between the antibonding orbital and a p-orbital on one
nitrogen of the ethylenediamine ligand.
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LUMO
4-Methoxypyridine
Biphenyl
Ru
σ*-antibonding orbitalVery small overlap in the
Negative phase with the
p-orbitals on the nitrogen
Ru
Figure 4.24. A representation of the LUMO of 4-methoxypyridine complex (11).
The central ruthenium is obscured by the orbitals, but is marked and is green in
colour. Yellow represents the positive phase and purple is the negative phase of
the wavefunction. Here the σ* antibonding orbital of the Ru-N(pyr) bond can be 
seen and it has a small amount of overlap with the position of the p-orbitals on the
nitrogen of the ethylenediamine ligand.
The σ
*-antibonding orbital on the Ru-N(4-Me-O-pyr) bond can be seen
and a very small overlap between this orbital and the p orbital (or possibly sp3/sp2
hybrid – as the shape of the orbital around the nitrogen is highly unsymmetrical).
These orbitals may play a role in stabilising the transition state, leading to NHu
proton exchange being substantial slower when compared to NHd exchange.
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4.3 Discussion
A series of [Ru(η
6-arene)(en)X]2+, where X = 4-R-pyridine derivatives,
complexes, where R = H, Me, t-Bu and MeO, complexes 4, 7, 10 and 11 (Figure
4.3) was synthesised and the kinetics of proton exchange on the ethylenediamine
nitrogens was determined by NMR. These were then compared to the kinetics of
exchange for previously-synthesised complexes 1 and 8.
In Chapter 3 it was observed that NHu and NHd protons of complex 1
exchanged at different rates. However, thermodynamic data indicated exchange
took place via the same transition state. The bias for exchange of NHd over NHu
may arise from steric effects of the biphenyl group and the electronic effects of the
X ligand (in this case chlorine) on ruthenium and associated orbitals. This was
investigated in attempt to elucidate further the mechanism of proton exchange on
the amines and mechanism of stereochemical inversion in complexes with chiral
ethylenediamine ligands.
The effects of charge, electron density on the Ru atom and the size of the
arene group were investigated by comparing and contrasting the kinetic data.
Comparisons were also made between the crystal structures and the calculated
molecular orbitals of each complex to each other to investigate if these play a role
in the exchange mechanism.
4.3.1 Synthesis and Characterisation
The synthesis of complexes 6, 7, 9, 10 and 11 was achieved via the aqua adduct of
1 and 8, using Ag+ to abstract of chloride ligands. As was expected, all the
pyridine derivatives bound via the pyridine nitrogen to the ruthenium. Pyridine
has dual characteristics, it is both a σ-donor and a π-acceptor and to this end all the 
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bond lengths of the Ru – N(pyridine) are all shorter in length (2.11 – 2.13 Å)
compared to those of the Ru(II) – NH3 bonds of previously reported (2.15 – 2.17
Å) as shown in Table 4.11.
Table 4.11. Comparison of bond lengths.
Complex Ru – Cl/N(pyr)
(Å)
Ru – Centroida of
arene ring (Å)
[(Bip)Ru(en)Cl]+ (1) 2.408(15) 1.662
[(Bip)Ru(en)(N-pyr)]2+ (2) 2.1315(16) 1.690
[(Bip)Ru(en)(N-4-Me-pyr)]2+ (4) 2.106(3) 1.688
[(Bip)Ru(en)(N-t-Bu-pyr)]2+ (6) 2.130(3) 1.689
[(Bip)Ru(en)(N-Me-O-pyr)]2+ (7) 2.1131(18) 1.685
a as calculated using Mercury, based on the position of all 6 carbons in the arene
ring
Upon consideration of the error bars for these data (3σ) it is clear that all 
the pyridine derived complexes have very similar bond lengths. Some variation
based on the pKas of the pyridine complexes was expected, however upon
examination of Ru-N(Pyr) bond lengths versus pKa of the free pyridine derivatives,
no relationship was observed, as can be seen in Figure 4.25.
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Figure 4.25. Dependence of the Ru – N(Pyr) bond lengths (●) in the crystal
structures of 6, 7, 10 and 11 (with errors of 3σ in blue) on the pKa of the free
pyridine derivative.
All ruthenium complexes with pyridine derivatives were also found not to
hydrolyse in water at various pH* values. This was part of the design process for
this experiment, to allow kinetics to be observed at ionic strengths close to zero
without have the added complication of the complex undergoing hydrolysis while
doing so.
4.3.2 Effects of arene change on exchange rates
Two sets of complexes with different arenes (biphenyl and benzene) as the
η
6 ligand were synthesised. The objective was to investigate the effects of the
arene size on the exchange rates: i.e.: does steric bulk effects the exchange rates of
anisotropic amino protons? It was noted that upon change of the arene from
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biphenyl to benzene that the exchange rates of up and down protons became more
similar (Table 4.12).
Table 4.12. Comparisons of the half life (t½) for N-H/D exchanges on 1 and 8
Proton
1 (t½) (min)
Arene = Bip
8 (t½) (min)
Arene = Ben
N-Hu 182.48 422.8
N-Hd 49.3 181.2
t½up: t½down 3.7:1 7:3
The observation that the exchange rates for both protons on the benzene
complex (8) are slower than those in the biphenyl complex (1) is to be expected,
some studies23 have shown that in a series of  [(η6-arene)Ru(en)Cl]+ complexes
the hydrolysis rates are proportional to the size of the arene system. While 8 is not
mentioned in study23 which deals with [(η6-arene)Ru(en)Cl]+, where the arene is
biphenyl, tetrahydroanthracene and dihyfroanthracene, by extrapolation of the
results an assumption can be made that since benzene is the smallest of all arene
systems, the hydrolysis rate must be slower than that of the biphenyl analogue.
This is possibly a reflection of the overall reactivity of 8 and therefore it could be
the arene that is affecting the activity of the amine protons on the ethylenediamine,
slowing down the exchange rates.
Of most interest is the similarity in the rates of exchange of the up and
down protons. For [(η
6-ben)Ru(en)Cl]+, the rates of proton-for-deuteron exchange
are much more similar, compared to those of [(η
6-bip)Ru(en)Cl]+ (1) under the
same conditions, 154 mM NaCl, pH*=7.4, T = 298 K (Table 4.13). When
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comparisons are made to the exchange rates of the N-pyridine derivatives, it can
be seen that the trend holds (Table 4.13).
Table 4.13. Comparisons of the half time (t½) for N-H/D exchanges on 7 and 9
Arene
(pH*)
6 (t½) (min)
Biphenyl
(6.3)
9 (t½) (min)
Benzene
(5.4)
N-Hu 204.8 679.4
N-Hd 21.1 85.5
t½up: t½down 9.7:1 7.95:1
Although in this case the conditions are not exactly the same (different pH*
values), based on the trends observed in Chapter 3, a number of conclusions can
be drawn.
1. In the chlorido adduct, as the pH* decreases so does the ratio between the
up and down exchange rates, therefore the same would be expected for
pyridine adducts.
2. Rates of exchange slow down as pH* is reduced, so the absolute rates
cannot be compared.
3. All these pyridine complexes have a 2+ charge and so the rates cannot be
compared to those of the chlorido adduct, due to effects of the additional
positive charge on the complex, as will be discussed later.
It was observed that the rates of exchange of amino protons on the pyridine
adducts (6 and 9) are very much increased compared to those of the chlorido
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adduct (1 and 8) and also that the downward proton exchange is considerably
faster than the upward proton exchange in both cases. However, in the case of 6
and 9, the pH* value is not the same so we can not make comparisons on absolute
rates. It seems likely that rates of exchange on the biphenyl complexes are larger
than those on the benzene analogue, as was the case for the chlorido adducts.
At this point it is appropriate to mention that attempts were made to study
the effects of larger arenes (arene = tetrahydroanthracene) on the exchange rates
of the up and down amino protons. Unfortunately solubility problems in NaCl
solutions (to suppress hydrolysis of chlorido complexes) led to reduced signal-to-
noise ratios in the NMR spectra, and the data therefore proved to be unreliable for
determining kinetic parameters.
From comparisons of the exchange rates of NHu and NHd protons on 1 to
those of 8 it can be clearly seen that when there is a smaller arene on the complex,
the up and down protons exchange at a more similar rate. This could be indicative
of there being a steric effect from the arene on top of the ruthenium on the
exchange rates. The larger arene may block the upper face of the ethylenediamine
making entry of the deuterated water into the upperface of the nitrogen more
difficult, as shown in Scheme 4.2.
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k1 k2
kd
ku
Scheme 4.1. A scheme of how the reduced arene bulk may cause ku and kd to
become more similar. When there is less bulk, as in the case of benzene as the
arene, there is less hindrance to entry of D2O to the unpaired electrons on the
upper-face of the nitrogens.
In Chapter 3, it was proposed that the mechanism involves abstraction of
the proton from the nitrogen of the ethylenediamine (k1). This abstraction is then
followed by the formation of an sp2 hybridised nitrogen with a lone pair in a p-
orbital, which undergoes rapid umbrella type inversion (k2), and finally addition
of a deuteron to the lone pair on the nitrogen. The reason that downward protons
maybe replaced more rapidly could be due to steric hindrance and also the
hydrophobicity of the overlying biphenyl ring system, resulting in kd >> ku. The
observation that the kd and ku for the benzene complex are closer together than
those of the biphenyl complexes provides evidence that this is a factor in the
difference of exchange rates for NHu and NHd.
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4.3.3 Effects of Ruthenium (II) electronic density on the exchange rate
The purpose of attaching a variety of pyridines to the central ruthenium atom to
yield complexes 6, 7, 10 and 11 was to look at the effects of different electron
densities on the ruthenium on the exchange rates on the amino protons. The ratio
of NHu and NHd proton exchange relative to the chlorido species (1) at the same
pH* was also observed. The aim was to also investigate whether or not the
antibonding orbitals of the Ru-N(pyr) bond had a role in the stabilisation of the
negative charge on the nitrogen post abstraction of the proton, to make one face of
the nitrogen more favourable to exchange over the other.
Table 4.14 and 4.15 lists details of the exchange rates for each complex,
the pH* of the exchange and the ratio between up and down exchange rates. Also
listed are the predicted exchange rates for up and down protons for the chlorido
adduct as determined by the linear equation in Table 3.8 (Chapter 3) of which an
abridged version is reproduced here.
Table 3.8. (Chapter 3) Parameters for the linear equation of the best fit on Log10k
= m.pH* + c for predicting the exchange rates of up and down protons at various
pH* values and I = 0.154.
Exchange Slope (m) Intercept (c)
N-Hd 0.73066 -9.20406
N-Hu 0.54874 -8.26142
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Table 4.14a. Half-times for the H/D exchange of 6, 7, 10 and 11
Complex/pH*
t½ [N-Hu]
(min)
t½ [N-Hd]
(min)
Ratioa
up/down
6 / 6.3 204.8 21.1 9.7
7 / 5.68 527.5 50 10.55
10 / 5.5 488.3 100.5 4.86
11 / 6.97 45.9 1.85 24.8
a Ratio of up/down half-lives for exchange [t½(Hu)/t½(Hd)]
Table 4.15 Half-time for NH/NDexchange for 1 determined at various pH* values
[(Bip)Ru(en)Cl]+ (1)b
pH* t½ [N-Hu]
(min)
t½ [N-Hd]
(min)
Ratioa
up/down
6.3 736.3 460.9 1.6
5.68 1611.6 1307.9 1.23
5.5 2023.1 1770.5 1.14
6.97 315.7 149.9 2.1
b As calculated from Chapter 3, Table 3.8 and associated information
The first observation is that when the complex has a 2+ charge, as is the
case with the N-pyridine derivatives, the half lives are significantly reduced
compared to those of the 1+ chlorido complex. This was observed early on in this
study and so the addition of acid (HCl in D2O, solutions at 1, 0.1 and 0.01 M) to
reduce the pH* was used to reduce the exchange rate and allow for observable
exchange rates.
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In Chapter 3, it was noted that the rates of exchange of up and down
protons exchange rates increase linearly with pH*. The difference between up and
down exchange rates is however not always the same. It was of interest to note
that at higher pH* the exchange of NHd is almost four times faster than that for
NHu. However, in the examples studied in this Chapter the gap between up and
down proton exchange rates is larger than those explored in Chapter 3. These
differences do not appear to be a result of pH* changes alone, but as a result of the
effects of the pyridine derivative on the ruthenium. The pyridine may be exerting
some long range effects on the nitrogen lone pair of electrons, or stabilising the
transition state. It was there for prudent to investigate this. Table 4.16 highlights
the increase in the bias for NHd exchange over NHu with changing pKa of the
pyridine ligand when compared to the chlorido complex.
Table 4.16. Comparisons between the kd:ku ratios of 6, 7, 10, and 11 relative to
those of 1 are shown.
Complex (ligand) (kd:ku)complex: (kd:ku)1
6 (pyr) 6.01
7 (4-Me-Pyr) 8.58
10 (4-t-Bu-Pyr) 3.47
11 (4-Me-O-Pyr) 11.81
The pKa values of the pyridine ligands (Table 4.17), are a measure of the
electron donating ability if the ligand. The higher the pKa the better an electron
donor the ligand is. When these are compared as a Hammett plot to the values
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from Table 4.17, a clear trend can be seen. (Figure 4.26) For these studies σ is 
calculated as:
(-pKa(free 4-pyridine derivative) + pKa(free pyridine) = σ 
Table 4.17. pKa and σ values of the free ligands 
Ligand pKa of ligand24,25, 26 σ 
Pyridine 5.14 0
4-Methylpyridine 6.02 - 0.88
4-t-Butylpyridine 5.99 - 0.85
4-Methoxypyridine 6.58 - 1.44
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Figure 4.26. A Hammett plot of the difference in the relative up and down proton
exchange rates of 6, 7, 10, and 11 compared to 1. Complex 10 is an outlier and
was not used to determine the best fit linear plot.
Chapter 4 – Influences of arene and charge on NH/D exchange rates
205
A clear relationship between σ and the relative exchange rates was 
observed in these reactions. With the exception of 10, which has been marked
here as an outlier, data from 6, 7 and 11 clearly have a linear relationship. The
best fit line has a slope of -3.92 with a 92% fit on the 3 data points. Hammett plots
can provide information on mechanisms and there are two interesting trends that
can be observed27 from Figure 4.26.
Firstly, the sign of the slope, in this case the slope is negative. A negative
slope in a Hammett plot implies that the greater the electron donating ability of the
ligand, the greater the difference between the NHu and NHd exchange rates, in
favour of faster down rates. Secondly, in a Hammett plot points which are large
outliers are usually indicative of the fact that the comparisons may not be easily
made as steric effects (from the outlier) may have a greater influence than
electronics on the reaction. This is reasonable given the fact that complex 10
contains the bulkiest ligand of all those investigated. A large t-butyl group may
cause some form of steric hindrance as it is in constant motion and effect the
accessibility of water molecules to the amino protons to allow exchange.
The link between the electron donating ability of the ligand and the
increased preference for exchange on the down face first may be explained by the
effects of the electron density on the N-Ru σ-, π-bonding and the π*- and σ*-
antibonding orbitals as will now be discussed.
4.3.4 Effects of HOMO and LUMO of the Ru-N(pyr) bond on exchange rates
of NHd and NHu
As was postulated in Chapter 3, the difference in the up and down proton
exchange rates cannot result solely from the steric effects of the biphenyl ring.
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Further evidence and confirmation of this theory is provided in the results
discussed so far. While a bias in favour of exchange of the downward protons first
is still observed for smaller arenes, the bias is smaller. These results imply that
there is some influence from the aromatic ring system on exchange rates.
However, the biphenyl is in constant motion (as can be seen by the lack of NMR
splitting of the signals) so the steric hindrance is clearly not a constant effect. In
the pyridine derivatives discussed in this Chapter we see that the bias for
downward protons is increased compared to the chlorido adduct. While the same
arene is present in all the complexes, this would conflict with the suggestion that
the overhanging biphenyl ring is solely responsible for the difference in NHu and
NHd exchange rates.
To this end, computational analysis of the highest occupied molecular
orbitals (HOMOs) and lowest unoccupied molecular orbitals (LUMOs) of each
complex was studied. Comparisons were made and interesting overlaps between
orbitals were observed which may provide further insight into the effects of the
electron donating ability of the ligand on the bias towards faster downward proton
exchange.
 In Chapter 3, it was observed that there was an overlap between the σ*-
antibonding orbital on the Ru-Cl bond with the probable location of the p-orbital.
This overlap could potentially have a role that this may have in affecting the bias
for NHd is discussed below. (Figure 4.27)
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Figure 4.27. A possible transition state for N-H/D exchange. The lower image is a
schematic of the some of the important orbitals present in the Cl-Ru-N(en) bond
following proton abstraction. (lpe- = lone pair of electrons)
The hypothesis is as follows; the lone pair electrons (lpe-) on the upper
face of the nitrogen can be more readily stabilised in the empty antibonding
orbital of the Ru-Cl bond and therefore is less available for deuteration. When the
lpe- is in the downward face of the nitrogen there is no such orbital available for
stability, making these electrons available to nucleophilically attack any deuterons
in solution.
Figures 4.20 – 4.24 show images obtained by computational analysis of
the HOMO and LUMO of complexes 6, 7, 10 and 11. As previously mentioned, in
Chapter 3, there was an overlap between the antibonding orbitals of the Ru-Cl
bond and the p-orbitals on the nitrogen observed. In this Chapter, some similarly
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interesting trends can be observed. In complex 6 the π*-antibonding orbital 
overlaps with the p-orbital on the nitrogens as shown in Figure 4.27.
π*-antibonding orbital
p-orbitals on the nitogens.
Overlap with the antibonding orbitals
Figure 4.28. A representation of the HOMO of 6 with important characteristic
orbitals highlighted.
In Figure 4.28 the overlaps of orbitals can be seen and are highlighted.
While these are not seen in all the complexes, this may be as a result of the
calculations not being carried out on the intermediate species (i.e.: the
deprotonated species). Although all molecular orbitals could not be determined,
other interesting effects are observed that would imply that a similar effect is
taking place. The potential for antibonding orbitals on the Ru-N(pyr) bond to
stabilise p-orbitals containing the lpe- after proton abstraction appears as a
recurring trend.
Chapter 4 – Influences of arene and charge on NH/D exchange rates
209
Further investigation into the HOMO +/- 10 levels of 9 and 11, did not
show any clear π*-antibonding orbitals. However some σ*-antibonding orbitals 
were seen in the LUMOs of these species, with small overlap to the p-orbitals on
the nitrogen of the ethylendiamine.
4.4 Conclusions
A series of investigations into the effects of arene size, charge on the
ruthenium and electron donating qualities of the monodentate ligand on the rates
of exchange of amino protons on the ethylenediamine was carried out. These
results provided much insight into the mechanism of exchange. A number of
conclusions can be drawn about the mechanism and what effects both the rates of
product formation and why one product is more kinetically favoured than the
others.
It can be seen that there appears to be a number of factors that affect the
rates of exchange of the amino protons on the ethylenediamine ligands. As
discussed in Chapter 3, ionic strength and pH* both have a proportional effect on
the rates of exchange. While these are external conditions that have an effect on
the rates of exchange, they have little influence on the difference in bias towards
the formation of one isomer (up or down replacement) over another.
In this Chapter the constituents of the complex are shown to have varying
effects on not only the exchange rates but also on the bias of exchange rates for
one isomer over another. Firstly, decreasing the size of the arene reduces the bias
for downward proton exchange over the upward exchange. The implication being
that there are some steric effects which control which face of the nitrogen is
available for electrophillic attack from deuterons in solution (Scheme 4.3). The
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absolute rates were found to slow down with smaller arenes leading to slower
overall rates of exchange. This however is expected as previous work has shown
that smaller arene ruthenium (II) complexes are less reactive compared to those
with larger arene systems.23
Upperface insertion is sterically unfavoured
as can clash with the overhanging phenyl ring
However, if the water molecule enters from
the bottom face, there is no steric hindrance
Scheme 4.2. Steric effects of the over hanging phenyl on the insertion of a water
molecule into the reaction sphere of the nitrogen lone pair
Secondly, when neutral ligands are used, in this case pyridine derivatives,
leading to an overall charge of 2+ on the complex, there is an increase in the rates
of exchange. This is due to movement of electron density from the nitrogen –
hydrogen bond to the nitrogen (en) – ruthenium bond making the N-H bond
weaker and so more labile. In Chapter 3, it was proposed that the rate limiting step
is the abstraction of the proton. The fact that the protons in 2+ species are more
labile than those in 1+ correlates well with this theory. (Figure 4.29)
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e- induced flow
Increase lability of protons
Figure 4.29. The direction of e- flow to make a more stable central ruthenium
atom. This reduced the strength of the N-H bonds, making it easier for protons to
be abstracted.
With regard to the bias for downward pointing proton exchange, a more
interesting trend is observed other than the impact of the arene size. There is a
direct correlation between bias for downward proton replacement and the electron
donating ability of the pyridine derived ligand. The electron donation to the
ruthenium from the nitrogen shortens the Ru-N bond (N on the pyr ligands),
through both σ-donation and π-backbonding. In addition to this the electron 
donating ability of the pyridine ligands appears to increase the bias for downward
proton exchange (up to 11 times as much for the greatest electron donating ligand).
This appears to provide evidence for an involvement of molecular orbitals in
stabilising the transition state in favour one type of product over another.
One theory for how this occurs is that an anomeric-like effect exists in
metals also and not just in cyclic organic systems. (Figure 4.30)
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Figure 4.30.  The stabilising effect of the C-OH σ*-antibonding orbital interacting 
with the lone pair on the oxygen – the anomeric effect. While equatorial OH
positions are usually preferred for 6-membered rings in boat or chair formation,
the anomeric effect allows for formation of (a) is much more preferred than (b).
In the studies discussed here, the less electronegative a ligand (i.e.: the
more electron donating it is, across the pyridine complexes) the more there
appears to be some stabilising effect on the up facing nitrogen compared to those
of the chlorido adduct. So the theory for stabilisation on the chloride adduct, 1,
holds, perhaps also for complexes 6, 9, and 11 the stabilisation is not so much on
the σ*-orbital but the π*-orbital of the back-bonding (Figure 4.30). Indeed, the 
computational analysis of some of the complexes in the ground state would imply
that there is overlap between the π*-antibonding orbitals and the p-orbitals on the 
nitrogen of the ethylenediamine. This overlap may play a role in stabilising the
lpe- in the transition state. Ligands which have the best σ-donors (higher pKa) will
partake in more back bonding through the π-orbitals on the pyridine interacting 
with the d-orbitals on the ruthenium (Figure 4.30a). This is seen from the crystal
data showing shorter bond lengths in Ru-N(Pyr) bond with increasing pKa. As the
electrons are pulled away from the ruthenium, the antibonding orbital is more
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accessible to the lpe- in the p-orbital, stabilising the electron charge and making
that face of the nitrogen less prone to electrophilic attack from deuterons in
solution (Figure 4.31b).
RuN
π – bonding orbital 
π *– antibonding orbital 
No overlap on the lowerface
Overlap between π* and p-orbital
on the upperface of the nitrogen
a)
b)
Figure 4.31. a) The orbitals involved in π bonding and b) those orbitals involved
in antibonding which may interact with the p-orbital on the nitrogen to stabilise
the intermediate transition state.
While this is only a theory, it fits well with the experimental data that is
presented in this chapter, and would explain the role played by each constituent of
the complex plays on the exchange of amino protons on the ethylenediammine
ligand.
This ability to tune the exchange rate and the selectivity of replacement of
the up and down NH protons may be useful in the synthesis of chiral amine
ligands on the ruthenium. By attempting to both slow down exchange and allow a
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strong electrophile to bind to the lone pair on the nitrogen in a fixed position
stereoselective synthesis can be carried out. This can all be controlled by the
electron-donating or -withdrawing character of the monodentate ligand. The
author believes this is one of the first studies to show evidence of an anomeric
effect existing in metal complexes.
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Chapter 5
Investigation of Shape Modifications of Oligoneucliotides
Following Binding to Metal-Based Anticancer Agents.
5.1 Introduction
The earliest work on complexes of the type [(η
6-arene)Ru(en)Cl]+ has
showed strong interaction of the ruthenium molecules with oligonucleotides, this
has been observed both experimentally1,2 and in silico3,4. This is important, as
binding to DNA is believed to be a key part of the mechanism of action of these
types of drugs5.
Cisplatin (cis-diamminedichloroplatinium(II)) is also believed to work in a
similar manner. Much more work into DNA binding with cisplatin has been
carried out and has shown some very interesting results. The shape changes
induced to DNA strands and the subsequent recognition by high mobility group
proteins of these kinked strands is believed to play an integral part in the
mechanism6,7 of action in instigating intracellular processes that lead to cell death.
The key differences between [(η
6-arene)Ru(en)Cl]+ and cisplatin, is the
fact that the Ru has only one active site versus the two active sites on cisplatin.
This can lead to a variation in the mechanism of action compared to that of
cisplatin.
Unlike cisplatin, there are no x-ray crystal structures of the ruthenium
arene adducts DNA. During the course of this work, efforts to crystallise
ruthenium-DNA adducts were made and have so far been fruitless. However, it is
believed that with some effort these may be successful in the future.
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In the absence of a crystal structure, other attempts are being made to
investigate the shape changes brought about by metallation of DNA strands. In
this Chapter two potential methods for the investigation of shape changes to DNA
strands upon binding of ruthenium or cisplatin complexes are examined. These
methods are ion-mobility mass spectrometry (IM-MS) (c.f. §2.4) and Förster
Resonance Excitation Transfer (FRET) (c.f. §2.11). Both methods show potential
for investigating shape changes. Below the rationale behind the development of
each method, the main hurdles and the potential for use of each method are
discussed.
5.2 Method Development – Ion Mobility Mass Spectrometry
5.2.1 Introduction
Previously Ion-Mobility Mass Spectrometry (IM-MS) has been used to
investigate the 3D shape of proteins in the gas phase.8 Recent investigations have
shown IM-MS is capable of separating isomers of larger Ru(η
6-arene) complexes.9
Prior to this work, no studies have reported the use of IM-MS to determine the
Collision Cross Section (CCS) of molecules < 100 Å2.
This work appears to be the first to use IMMS to determine the CCS of
small molecules. To develop this, a new method of calibration using glycine
oligomers was employed.
Traditionally collision cross-sections (the molecular equivalent of an area
of gyration in proteins and other large biomolecules) have been calculated using
the open source software MOBCAL10. MOBCAL provides outputs which are
based on the three different models, Projection Approximation (PA) and Exact
Hard Sphere Scattering (EHSS), which both model the ion as a series of
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overlapping hard sphere, and the trajectory method, in which all atoms in the ion
are modelled, using the ions three-dimensional coordinate file. However, in the
work presented here, a new approach is used; this is an algorithm developed by
Waters Corp. (Manchester, UK).This new algorithm is included in their
Windows® based ion mobility software (Driftscope) and together with Waters a
study was carried out to test the efficiency of the new algorithm both compared to
MOBCAL results and those obtained through IM-MS.
5.2.2 Experimental Design
The binding of {Ru(η
6-bip)(en)}2+ to DNA through the N7 on guanine
residues has been well documented.5,11-16 Prior to this, IM-MS had not been used
to investigate shape changes to DNA strands.8,17,18 It was hoped that this technique
could be used for future studies of the interaction between ruthenium complexes
and DNA. If successful, then information on the shape changes to DNA (and other
biomolecules) may provide insight into possible cell death pathways initiated by
this class of compounds.
In the design of this process, careful consideration was given to the sequence of
DNA to be chosen. Since binding to guanine is well known, it was essential to
include at least one guanine residue. Previous mass spectrometry studies
investigating cisplatin binding to small oligonucleotides used the sequence 5’-
CACGTG-3’.19 It was therefore considered useful to use this sequence. While this
strand is self-complementary, it was hoped to prevent the stabile formation of
duplexes by maintaining a low salt concentration. For other studies not discussed
here the 15N labelled [Ru(η6-bip)(15N-en)Cl]PF6 (1-15N_PF6) was synthesised (c.f.
§2.15.2.9) and a fixed concentration solution was prepared and concentration
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determined by ICP-MS. Due to the limited supply of DNA used, some of this
sample was used in some of the later studies.
5.2.3. Systematic approach and results
5.2.3.1 Preparation of d(CACGTG)-[(η
6-bip)Ru(en)]2
A 25 μL aliquot of the d(ACAGTG) (stock solution 530 μM in H2O,
determined by UV/Vis) was added to 25 μL of 1_PF6 (stock solution 2.017 mM,
determined by ICP-MS); this was then incubated at 310 K for 14 h. (total
concentrations, DNA: 265 μM, Ru: 1.085 mM, DNA:Ru = 1:4). This was then 
diluted approximately 100 times with aqueous acetonitrile prior to MS analysis.
5.2.3.2 MS Analysis of d(CACGTG)-[(η
6-bip)Ru(en)]2
After mixing of 1-PF6 with d(CACGTG), MS was obtained showing that
two {Ru(η
6-bip)en}2+ had bound to the 6-mer (Figure 5.1). Mass spectrometry
was carried out as per §2.4.2 by Dr Jonathon Williams, University of Warwick
using the facilities at Waters Corps. Manchester. An insert showing the isotopic
distribution pattern for the 2- species seen in the spectrum is also shown. Negative
electospray ionisation mass spectrometry (ESI-MS) is of particular useful in the
analysis of oligonucleotides due to the negative phosphate back bone of DNA
strands.
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Figure 5.1. Negative ion ESI mass spectrum from a sample of d(CACGTG)
mixed with 1-PF6 at 310 K after 14 h. Inset: Expansion of the major ion seen in
the spectrum – 1208.7 as a 2- ion, and the simulated isotope pattern (▲).
(Difference between calculated and obtained = 0.5 Da)
To confirm that binding of the ruthenium complex was to the guanine
residues, tandem MS/MS was carried out. There was difficulty in fragmenting the
negative ions, however the positive ions fragmented easily using low energy CID
on the ion of interest, using SF6 as a collision gas. (Figure 5.2)
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Figure 5.2. The expanded MS/MS spectrum of 3+ ion, [CACGTG-2.Ru(η6-bip)en-
H]3+ species with m/z 807.5. The inset image is the expansion of 650 – 1120 m/z
region and highlights the location of the wnz+ ion species observed in the m/z
range 650 – 1120.
Collision-induced decay breaks bonds along the phosphate back bone of
the DNA.20 Figure 5.3 defines ions classed as w-ion which are identified and
listed in Table 5.1
Chapter 5 – Shape changes following metal binding to DNA
225
Figure 5.3. A scheme showing the fragmentation pattern of [CACGTG-2.Ru(η6-
bip)en-H]3+ forming a variety of w-ions. {Ru} = {Ru(η6-bip)en}2+.
Table 5.1. Identity of each of the w ions observed in Figure 5.2
wnz+ ion m/z Identity
w5+ 1106 3’-GpTpGpCpAp + Ru(η6-bip)en
w42+ 949 3’-GpTpGpCp + 2.Ru(η6-bip)en
w32+ 805 3’-GpTpGp + 2.Ru(η6-bip)en
w2+ 966 3’-GpTp + Ru(η6-bip)en
w1+ 662 3’-Gp
Of interest is the presence of w32+ which confirms that two ruthenium
complexes are attached to the 5’-GTG-3’ portion of the hexamer. However upon
further examination, the w2+ ion was identified as containing the 5’-pTpG-3’ with
one ruthenium complex attached. This confirms that one ruthenium complex is
bound to the guanine in the 4 position. Further fragmentation produced a 5’-pG-3’
ion (w1+) without a ruthenium complex attached. Thymine residues have only
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shown very weak binding to ruthenium-arene complexes and so the distinct
absence of a [3’-Gp-Ru(η
6-bip)en] species was unexpected. A G-{Ru} ion was
observed at m/z 466, however this could be from the G4-{Ru} or the G6-{Ru}
fragment being cleaved from the hexamer during the CID process. Interestingly no
[T-Ru(η
6-bip)en]+ ion was observed either. It was postulated that the
fragmentation energy of the w2+ ion may have been sufficient to fragment the N7-
Ru bond on the guanine at the 3’ end of the sequence. To investigate if binding of
the ruthenium complex is exclusive to the guanine residues, binding to an
alternative hexamer, d(CACGTA), was studied.
5.2.3.3 Preparation of d(CACGTA)-[(η
6-bip)Ru(en)]2
A 300 μL aliquot of the d(ACAGTA) (stock solution 11.6 μM in H2O) was
added to 3 μL of 1-15N-PF6 (stock solution 2.0165 mM); this was then incubated
at 310 K for 14 h. (total concentrations, DNA: 3 μM, Ru: 32 μM, DNA:Ru = 1:10). 
This solution was injected directly into the mass spectrometer.
5.2.3.4 Analysis of d(CACGTA)-[(η
6-bip)Ru(en)]2
The 15N-labelled form (1_15N-PF6) was bound to d(CACGTA) to confirm
that binding indeed is selective for guanine residues. Figure 5.4 shows the mass
spectrum obtained on a Bruker MaXis instrument (c.f. §2.3). The spectrum clearly
shows that despite a ten fold molar excess of the ruthenium complex, only one
Ru(II) is attached to this strand of oligo hexamer. This provides strong evidence
that binding is exclusively to guanine residues.
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Figure 5.4. A mass spectrum of a mixture of d(CACGTA) and 1-15N-PF6 after 24
h at 310 K. The main species and charges are highlighted.
There are three main clusters of peaks visible in the spectrum; these have
been identified and the isotopic simulation pattern is shown in Figure 5.5a, b and c.
The large remaining complex (1_15N) peak at 317 amu. The peak at 509 amu can
be identified as 1_15N flying with as an ethanol molecule and PF6- ion. At 1046.7
amu the 2+ species which corresponds to [d(CACGTA)-Ru(η6-bip)(15N-en)]2+
species.
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Figure 5.5. Expansion of the main species found in the MS of d(CACGTA)-1_15N
mixture after 24 h at 310K. The spectrum is in black and the simulated isotope
pattern, ▲ is also shown for A) m/z centred at 317.1, B) m/z centred at 509.0 and
C) m/z centred at 1046.7. (Labels define each peak)
5.2.3.5 Ion-mobility mass spectrometric analysis of [Ru(η
6-bip)enCl]+ (1)
Previously, ion-mobility mass spectrometry studies were carried out using
singly-charged peptide ions produced from human haemoglobin (Hb) which had
undergone tryptic digestion, to calibrate the T-Wave mobility device21. The
limiting factor to this approach was that only collision cross sections (CCS) values
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of 94 – 279 Å2 can be determined. A new approach using protonated gylcine
oligomers [Glyn=2-6 + H]+, of which all the CCS values was used for the first time
in this work to calibrate the T-Wave mobility device over a range of 62 – 107 Å.22
Using this technique the CCS values for [Ru(η
6-bip)en-H]+ and [Ru(η6-bip)enCl]+
(1) ions in the gas phase were analysed. These results were then compared to CCS
values calculated from the crystal structure using a variety of algorithms and also
to the radius of the molecule as determined by Diffusion Ordered SpectroscopY
(DOSY) NMR of 1-PF6 in solution.23
A sample of 1-PF6 was prepared from a 2.17 mM solution in H2O to ca. 1
ng/mL in methanol and injected at a rate of 4 μL min
-1 into the mass spectrometer.
Two major peaks were observed (Figure 5.6) at m/z 315 and 351; these
correspond to 1+ and [1-HCl]+ as detailed below.
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Figure 5.6 Positive ion mass spectrum of 1 in solution (ca 1 ng/mL) in methanol.
The expected isotope pattern ▲and an expansion shown in the inset for the 2
species centred at 315 and 351 m/z.
The two major species observed in Figure 5.6 were isolated in the
quadrupole and then each one entered the T-Wave chamber separately (c.f. §2.4).
Once the ions had entered the T-Wave chamber the mobility drift times
(sometimes referred to as arrival time distribution, ATD) could be recorded. This
was then calibrated against the ATD for the protonated glycine oligomers. Figure
5.7 shows the chromatograph of the ion-mobility cell and the corresponding ion
and ATD.
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Figure 5.7. Drift times for A) [Ru(η6-bip)en-H+]+ and B) [Ru(η6-bip)enCl]+ ions
in a T-Wave Ion mobility device.
These data, along with those from MOBCAL calculations and the Waters®
algorithm produced CCS values shown in Table 5.2. Complementary to this,
Diffusion Ordered Spectroscopy was carried out to determine the radius of the
[Ru(η
6-bip)enCl]+ species in solution. DOSY NMR is an NMR technique which
allows a diffusion constant for a molecule in solution to be determined.24 DOSY
NMR applies a magnetic gradient along the z-axis and the effects of magnetisation
as the protons pass through the magnetic gradient provide insight into the
diffusion constant of the complex. Together with the Stokes-Einstein equation the
hydrodynamic radius can be determined, and from that the CCS. The DOSY NMR
spectrum is shown in Figure 5.8 and the data are further added to that of Table 5.2.
DOSY NMR applies a magnetic gradient along the z-axis and the effects of
magnetisation as the protons pass through the magnetic gradient provide insight
into the diffusion constant of the complex
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Figure 5.8. 1H diffusion spectrum of [Ru(η6-bip)enCl]+ in 154 mM NaCl in D2O
(to suppress hydrolysis) at 298 K at 600 MHz. From log (D) = -9.399, the
diffusion constant of 3.989 x 10-10 m2/s is determined.
Using D = 3.989 x 10-10 m2/s and the viscosity of the solution25 at 0.9037 x
10-3 Pa.s and applying to the Stokes Einstein equation, yields a radius of 6.05 Å
and a cross section of 114.99 Å2 .This is comparable to those determined by
calculations when considering that this radius also includes water molecules in the
solvation sphere, which would increase the radius somewhat.
Table 5.2. CCS (Å2) values as determined by calculation and experiment.
m/z ion MOBCAL
Projection
approx
MOBCAL
Exact hard
sphere
MOBCAL
Trajectory
Method
Waters
Algorit
hm
T-Wave
(± 1.0)
DOSY
NMR
315 [Ru(η
6-bip)enCl]+ 93.5 99.0 93.9 ± 6.3 95.8 97.5 114.99
351 [Ru(η
6-bip)en-H+]+ 91.6 96.5 90.9 ± 4.7 89.0 93.0 N/A
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5.2.3.6 Ion-mobility mass spectrometric analysis of d(CACGTG)-
{(bip)Ru(en)}2
Next of interest was a study through ion-mobility into the shape change of
oligonucleotide strands upon addition of this ruthenium complex. Cisplatin has
been shown to cause shape changes to DNA strands.26-28 However, cisplatin has 2
active sites whereas [Ru(η
6-bip)enCl]+ has only one and so will interact with DNA
differently.
Firstly, the CCS of the oligonucleotide d(CACGTG) was determined using
IM-MS to acquire the arrival time distribution of both the 2- and 2+ species
(Figure 5.9). These were calibrated against the human haemoglobin and against
sperm whale myoglobin, of which there is a variation of <1 %.
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Figure 5.9. Arrival Time distributions (ATD) or drift times for A) [CACGTG -
2H+]2- and B) [CACGTG + 2H+]2+ ions.
Figure 5.9 shows two different, possibly three, conformations ATDs (2.82
and 3.39 ms, and shoulder to the left of 2.82 ms peak) for the 2- species. These
conformations are clearly stable in gas phase as interconversion is not seen on the
timescale of the experiment. The different conformations are more than likely a
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result of different distributions of H+ ions on the five phosphates on the back bone
of the 6-mer. (The phosphates on the back bone of DNA structures tend to be
deprotonated). The observation that the ATD for the positive species is larger than
the negative ion is not unexpected, positive molecular ions generally, are larger in
size than negative molecular ions due to the extra hydrogen atoms.
Once the ATDs of the non-ruthenated DNA have been observed, the ATDs
for the 6-mer bound to two ruthenium molecules, [Ru(η
6-bip)en]2+ were next to be
studied. Again, it is noticeable that the ATD of the negative ion is less than that of
the positive ion. (Figure 5.10)
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Figure 5.10. ATDs of A) [CACGTG + 2[Ru(η6-bip)en] – 6H+]2- and B)
[CACGTG + 2[Ru(η
6-bip)en] – 2H+]2+
It was observed once more, that there appears to be more than one
configuration of each species. This is again probably due to distributions of
protons on the backbone phosphate backbone on the oligonucleotide, for the
negative ion mode (Figure 5.10A). However for the positive ion, the 2 ATDs are
significantly separated (by 2.11 ms). Individual mass spectra of each peak
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explained this very easily. The peak at 3.46 ms is a 4+ species of an associative
dimer (m/z = [(CACGTG + 2[Ru(η
6-bip)en] – 2H+)2]4+). While a dimer was not
expected due to the low ionic strength of the solution, it appears in this case that
there has been some associative binding in the gas phase.
Table 5.3 shows a compiled list of all CCS values as determined from the
drift times, when calibrated against human haemoglobin and sperm whale
myoglobin.
Table 5.3. CCS values for both the 6-mer oligonucleotide and the ruthenated
oligonucleotide for both 2+ and 2- species.
Ions Collision Cross Section (CCS) , Å2
[CACGTG - 2H+]2- 289.5, 300.3
[CACGTG + 2H+]2+ 312.8
[CACGTG + 2[Ru(η
6-bip)en] – 6H+]2- 315.8, 337.4
[CACGTG + 2[Ru(η
6-bip)en] – 2H+]2+ 350.2
5.2.4 Discussion
It has long been known that [Ru(η
6-bip)en]2+ residues bind to N7 of
guanine bases on DNA strands5,11,13,14,29-31. Reactions between 1-PF6 and
d(CACGTG) and d(CACGTA) yielded exclusive binding to the guanine residues.
Following confirmation of the binding positions, ion-mobility mass spectrometry
was carried out on both d(CACGTG) bound to two ruthenium complexes and of
the ruthenium complex on its own.
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5.2.4.1 Ion mobility of [Ru(η
6-bip)enCl]+ (1) ions.
Ion-mobility studies on 1 and the subsequent determination of the collision
cross section (CCS) compared well to the computationally-derived CCS values
and the cross section as determined by DOSY NMR. This study is the first
reported where a CCS of < 100 Å2 is determined.23 This was made possible by
using new calibration method of using protonated glycine oligomers. Also
investigated was the accuracy of the Waters® algorithm in accurately predicting
the CCS of complexes from their 3D coordinate file (crystal structure). All
calculated CCS values were within 5% of the values determined by IM-MS,
indicating that a good correlation between solid state (crystal structure) and gas
phase (MS) CCS values exists. Of interest is the DOSY NMR determined CCS
value of 114.99 Å2; the difference between this and the IM-MS value, can be
explained by the presence of a solvation shell around the complex. With 1 being a
charged molecule the probability of a water solvation shell is large.
5.2.4.2 Ion mobility of d(CACGTG) and [d(CACGTG) + 2.[Ru(η
6-bip)en]]2+
ions.
Ion-mobility mass spectrometry was also used for analysis of shape
changes that occur in oligomers when bound to ruthenium complexes. Initial
measurements on the 2- and 2+ species of d(CACGTG) showed some interesting
results. Firstly negative ions were found to have a smaller CCS than positive ions;
this is not unexpected and has been observed before.8 Secondly, more than one
conformation was observed in the negative ion studies. This is most likely due to
the location of protons on the backbone of the oligonucleotide. DNA strands are
very stable as -(n-1) ions, where n is the number of base pairs present when in
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solution. The negative charges are on the phosphate backbone, where each diester
link has one negative charge. (Figure 5.11)
Figure 5.11 A schematic diagram of d(CACGTG) showing the location of the
negatively charged sites. In the neutral 6-mer species these are protonated.
This leaves five places for three protons to reside on the back bone and
electrostatic repulsive and attractive forces would lead to different folding patterns
and therefore different 3D conformations. The effects of the positive charges on
the backbone of the oligomer must be considered when comparing with the CCS
values of the diruthenated strand. While CCS values were obtained for both the
[d(CACGTG) - 6H+ + 2.[Ru(η6-bip)en]2+]2- species and for [d(CACGTG) - 2H+ +
2.[Ru(η
6-bip)en]2+]2+, comparisons can only be made accurately when looking at
the two species which have lost two protons from the backbone. This means to
compare the shape change upon ruthenation [d(CACGTG) - 2H+ + 2.[Ru(η6-
bip)en]2+]2+ must be compared with [d(CACGTG) - 2H+]2-. Changes in the shape
of these species are more likely to be a result of ruthenation only. Table 5.4 shows
the difference between the two species.
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Table 5.4. CCS values for the non-ruthenated and bi-ruthenated strands of
d(CACGTG)2-
Ion CCS (Å2)
[CACGTG - 2H+]2- 289.5, 300.3
[CACGTG + 2[Ru(η
6-bip)en]2+ – 2H+]2+ 350.2
The above results show that the addition of two ruthenium complexes of
CCS 93 Å2 (loss of chlorido group from the ruthenium when attached to
oligonucleotides), to this oligonucleotide results in a change to the size overall of
50–60 Å2. This suggests that binding the ruthenium complex to the
oligonucleotide compresses the shape or is bound in such a way as to have little
effect on the overall shape of the product. This would agree well with some
previous studies of 14-mer oligonucleotides in which the biphenyl ring system on
the ruthenium complex has been shown to intercalate between the guanine and
thymine base pairs of DNA.14
5.3 Method Development – Förster Resonance Energy Transfer
5.3.1 Introduction
Previous work26,28,32 has shown that when DNA strands are platinated,
kinking of the duplex strands occurs and this leads to programmed cell death.
Förster Resonance Energy Transfer (FRET) has been used in the past to
investigate the shape of DNA duplexes, which have been synthesised to be
kinked33. Studies of DNA dissociating from nucleosomes34 and investigations
into HIV reverse transcriptase interactions with nucleic acids35 have also been
carried out. A previous study7, has looked at the effects of cisplatin binding to a
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20-mer duplex and observed FRET indicating that the DNA was bent at an angle
of 58o when 1,2 GpG intrastrand platinum crosslinks are present. It was with this
in mind that attempts were made to study a platinated 30-mer DNA duplex using
FRET and to develop the method for use on ruthenated sequences.
5.3.2 Experimental design
A fundamental part of the design of this experiment involved choosing a
suitable DNA sequence. When making decision on the sequences to be used, the
ability of guanine residues to quench fluorescence must be considered. However,
to allow for platination, two adjacent guanine residues must be included in the
sequence. In addition to this guanine and cytosine residues must be used as
“zipper” points at the end of the DNA strands to stabilise the duplex. To this end,
it was decided to have the two guanine residues in the middle of the sequence to
allow for platination. The choice of FRET tags must also be considered and has
been discussed previously (c.f. §2.11). To allow for significant FRET between
tags, they would initially be placed 12 base pairs apart on complementary strands.
The initial 30-mer DNA sequence chosen was the following;
d(TATCATAAATAAATGGTATATT(Alexa488)TTATAACT) and the
d(ATAGTATTT(Cy5)ATTTACCATATAAAATATTGA) complementary strand.
These sequences took into account the need for a GG portion to allow platination,
a large amount of A and T, C and G residues to “zip” the duplex and a lack of self
complementarily of the sequence so only the donor and acceptor strand will pair
with each other. Once the DNA sequence was decided upon, a variety of
approaches were then attempted. Scheme 5.1 shows the variety of approaches
considered and the subsequent changes to optimise the procedure.
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5.3.3 Preparation and analysis of fluorescent DNA samples.
Parts of this work was carried out in collaboration with Ms Anita Toulmin and Dr
Steven Magennis in the Photonics Institute, University of Manchester, UK.
5.3.3.1 (A) Formation of a duplex and subsequent binding of cisplatin
5.3.3.1.1 Sample preparation.
In this initial approach, the two strands of DNA were annealed and then platinated.
In addition to this, a duplex with only a donor label was also synthesised to
confirm that any FRET signals observed would be from the Donor-Acceptor
strands only. Table 5.5 lists the DNA strands and their short code labels as used in
this approach. Figure 5.12 shows a photograph of the vials of DNA. It is clearly
evident how coloured and fluorescent these DNA samples are.
Table 5.5. DNA sequences, short codes and concentrations.
Sequence Code Conc.
(µM)
d(TATCATAAATAAATGGTATATT(Alexa488)TTATAACT) D 70
d(ATAGTATTT(Cy5)ATTTACCATATAAAATATTGA) A 80
d(ATAGTATTTATTTACCATATAAAATATTGA) U 77
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D A U
Figure 5.12. Photograph of solutions of each of the strands of 30-mer used;
clearly it can be seen that the donor (D) strand is yellow/green, the acceptor (A)
strand blue, and the unlabelled (U) strand is colourless.
Solutions of D (64 µL), A (56 µL) and 45 µL of NaClO4 (2 M solution)
were combined and diluted to a total volume of 500 μL in H2O. This solution was
annealed by heating to 363 K, slowly cooled over 4 hours and the left to stand at
277 K overnight (total duplex concentration: 4.48 µM, NaClO4; 90 mM). The
product was labelled SMDA1. Follow annealation, cisplatin (0.32 µL, 9.857 mM
solution in DMF) was added to 350 µL of SMDA1 and 149.68 µL of deionised
H2O, and incubated at 310 K for 48 h. (Total duplex concentration 3.14 µM;
NaClO4 90 mM, Pt 6.3 µM) . The product was labelled SMDA1-Pt.
The unlabelled duplex was synthesised in a similar manner. A solution of
D (64 µL), U (58.1µL) was annealed in the same manner. (Total duplex
concentration 4.48 µM, NaClO4 90 mM) . The product is labelled SMDU1.
Following annealation, cisplatin (0.32 µL, 9.857 mM solution in DMF) was added
and the duplex was platinated as described above. (Total duplex concentration
3.14 µM, NaClO4 90 mM, Pt 6.3 µM) . The product is labelled SMDU1-Pt.
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5.3.3.1.2 CD, HPLC and FRET analysis of samples.
After annealing a sample of each duplex (SMDA1 and SMDU1) CD
analysis was used to ensure annealing had occurred. The CD spectrum (Figure
5.13) showed that bands characteristic of B-DNA had formed; a negative signal in
the region of 240 – 250 nm and a positive signal close to 275 nm. Once platination
had occurred, another sample was extracted for CD analysis. Again, the CD
spectrum was characteristic of B-DNA, but despite both platinated and non-
platinated) samples being at the same concentration, there was a decrease in the
intensity of the CD signal.
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Figure 5.13. CD spectra of A) the duplex with a donor and acceptor tag (SMDA1)
and the platinated duplex in blue. B) A duplex formed with only a donor tag
(SMDU1) and the platinated duplex.
The difference in the magnitude of absorbance in the CD spectra for
platinated and non platinated duplex suggests some loss of chirality. This can
occur due to distortions of the double helix and similar effects on the CD of DNA
strand upon binding of cisplatin have been observed previously.36
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Once binding to cisplatin had been confirmed, reverse phase HPLC was
carried out in an attempt to separate the complexes to allow for FRET analysis to
be carried out on purified species. Figure 5.14 shows the HPLC chromatogram
acquired. Identification of the peaks was by elimination of the peaks of the
starting materials (i.e.: chromatographs of the starting material were recorded).
While cisplatin peaks are generally observed at 305 nm,37 UV data has shown that
the intensity of UV signals at 254 nm is approximately a half that intensity at 305
nm. As a result all HPLC chromatograms were recorded at 254 nm, which is best
for DNA samples where λmax is 260 nm. Separation was carried out using a C18-
PLRPS column. The benefit of C18 columns for DNA separation in this case is
the hydrophobic DNA and the fluorescent tags will interact with the column and
so elute later than the hydrophilic platinum salts. A major draw back with using a
C18 column is that the complex may be binding to the stationary phase as
recovery rates were very low.
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Figure 5.14. HPLC chromatogram of the purification of SMDA1-Pt with the
important peaks identified. HPLC was carried out using a C18-PLRPS analytical
column. A linear gradient from buffer A (H2O, 10 mM NH4OAc) to buffer B (60
% ACN in H2O. 10 mM NH4OAc) with a flow rate of 1 mL min-1. The best
separation was found to occur with a gradient of B from 5 – 30 % over 30 minutes
at a 1 mL min-1 shown in red. HPLC gradient was developed based on a method
previously used for DNA-cisplatin complexes19. Absorbance was recorded at 254
nm.
The HPLC fractions were collected and purified a second HPLC cycle
with 5% HPLC grade methanol at a rate of 1 ml min-1 for 15 minutes followed by
95% methanol for 15 minutes, with a desalted fraction eluting at 16 minutes. Once
confirmation of the formation of SMDA1-Pt was confirmed, FRET experiments
were attempted on the products purified from HPLC . However no FRET was
observed. This may have been due to photobleaching of the fluorescent tags from
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the UV in the HPLC machine or from daylight. While it had been shown that
annealing and binding of cisplatin to the duplex had occurred the lack of FRET
indicated not everything had worked as planned. This led to the development of
method B (c.f. Scheme 5.1) in a further attempt to get samples for FRET analysis.
5.3.3.2 (B) Formation of a duplex using a different approach and subsequent
binding of cisplatin
Following difficulty in obtaining FRET results from SMDA1-Pt, a new
method was developed. Fresh batches of the two labelled oligos were purchased to
ensure that if there had been no photobleaching of the previous samples, this
would not carry over. Table 5.6 lists the concentration and short codes for the new
batches of DNA. This time it was decided to use an excess of the acceptor strand
to ensure as much duplex formation as possible occurred. Following annealing
cisplatin was added and the sample incubated to aid binding. Aside from this, an
attempt to bind cisplatin to the FRET donor strand and following binding anneal
the donor and acceptor strand together.
Table 5.6. Concentrations and short codes of the second batch of FRET donor and
acceptor DNA strands.
Sequence Code Conc.
(µM)
d(TATCATAAATAAATGGTATATT(Alexa488)TTATAACT) D2 99.6
d(ATAGTATTT(Cy5)ATTTACCATATAAAATATTGA) A2 81.1
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5.3.3.2.1 (B) Sample preparation
Solution of D2 (50.2 μL, 5 nmol), A2 (123.2 μL, 10 nmol) and NaClO4 (1 μL, 2 
μmol) were mixed to give a total volume of 500 μL, and annealed as before 
(SMDA2). (This was confirmed by UV/Vis melting curves; concentration of
duplex 0.5 μM). Once annealed, 50 μL was abstracted for analysis and to the 
remaining solution cisplatin (1 μL, 9.857 mM solution in DMF) was added and 
incubated at 310 K for 48 h (SMDA-Pt). This sample was sent without further
purification to Manchester for FRET analysis. The decision not to use HPLC for
purification at this point was to ensure no losses as such small amounts of material
were in use and also there were concerns that the UV lamp in HPLC and the
exposure of fragments to light may have detrimental effects on the photoactivity
of the Alexa488 or Cys5 tags. In a similar manner D2 was reacted with U to
produce SMDU2 which was also sent for FRET analysis. The colour of the
duplexes is one identifying feature and is shown below in Figure 5.15.
Figure 5.15. Solutions of dimer of the D2 and U strands (SMDU2) and the dimer
of the D2 and A2 strands (SMDA2).
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5.3.3.2.2 FRET analysis of SMDU2, SMDA2 and SMDA2-Pt
Single molecule FRET studies were carried out at the Photonics Institute in the
University of Manchester. Some of these complexes yielded results as shown in
Table 5.7 below. These plots of Fg/Fr vs τ provide the most accurate results and 
rule out any artefact signals. In these studies an ensemble of ca. 5 – 10,000
molecules are having their FRET observed. Molecules that undergo fluorescence
decay through the same pathway, either FRET or through photon release, will
have the same decay time, so by plotting Fg/Fr vs τ any artefacts are eliminated.  
When looking at Table 5.7 the following must be pointed out; the first
image shows a large Fg/Fr value which is indicative of no FRET occurring and
only green light fluorescing. This is a result of the presence of only the donor
strand on the DNA duplex. In the absence of the acceptor tag, no FRET can occur.
In the second image, which is the FRET of a non-platinated donor and acceptor
duplex, FRET is observed between the donor and acceptor tag. The presence of
some unannealed donor strand is identified by the large Fg/Fr value. Finally the
last image shows the presence of some unannealed donor strands, some donor
acceptor strands, but no FRET is observed from a platinated strand.
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Table 5.7. Details of the observed single molecule FRET experiments
Comments
Unannealed Donor
strand
Fg/Fr = 14
Tau = 4.1 ns
Sample: SMDU2
This contained no acceptor
strand and so no FRET signal is
seen here.
Fg/Fr is the intensity of green
fluorescence to red fluorescence.
Unannealed
Donor strand
Fg/Fr = 13
Tau = 4.1 ns
FRET
SMDA2
Fg/Fr = 1.9
Tau = 2.9 ns
Sample: SMDA2
The presence of FRET shows
that the two strands have
annealed and the donor and
acceptor tags on the 30-mer are
in close proximity
Tau, is the lifetime of
fluorescence.
FRET
SMDA2
Fg/Fr = 1.9
Tau = 2.9 ns
Unannealed
Donor strand
Fg/Fr = 12
Tau = 4.1 ns
Sample: SMDA2-Pt
Here there appears to be
fluorescence from the donor
strand only and some FRET
from SMDA2 but no observed
FRET from SMDA2-Pt
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5.3.3.3 (C) Binding of Donor strand to cisplatin, followed by annealing of
acceptor to platinated donor strand.
Given that the results of §5.3.3.2 contained no evidence for FRET for the
platinated duplex SMDA2-Pt, concern was raised over the possibility of the
heating process (310 K) required for platination damaging the fluorescent tags. As
a result the donor tagged DNA strand was platinated prior to annealing with the
acceptor strand and then analysed for any FRET activity.
5.3.3.3.1 Sample Preparation
To a solution of D2 (25 μL, 2.5nmol), cisplatin (0.25 μL, 9.857 mM 
solution in DMF, 2.5 nmols) was added and the solution volume increased to 100
μL and left to stand for 72 h at 310 K.  Following incubation, A2 (30.8 μL, 2.5 
nmol) was added and the solution volume increased to 300 μL with a final 
NaClO4 concentration of 200 mM. (SMDA3-Pt) Due to low concentrations of
solution (7.5 μM) and difficulties in purifying, no further analysis was carried out 
before being sent for annealing and FRET analysis.
5.3.3.3.2 FRET analysis SMDA3-Pt
Results similar to those shown for SMDA2-Pt in Figure 5.7 were obtained.
As a result of this it was decided to change the sequence and approach the whole
problem differently.
5.3.3.4 (D) Change of sequence and use of a doubly labelled strand.
Following difficulties in observing efficient FRET signals from the
previous studies, a new method was employed. In this new approach an unlabelled
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30-mer would be platinated and then annealed to a 30-mer DNA strand which has
a donor and an acceptor FRET tag attached. Table 5.8. details the new sequence
used along with their concentrations and short codes.
Table 5.8. Non-labelled sequences used.
Sequence Conc. (μM) Code 
TAT CAT AAA TAA ATG GTA TAT TTT ATA ACT 265.07 U_GG
AGT TAT AAA ATA TAC CAT TTA TTT ATG ATA 332.36 U_CC
The changes in these compared to D and A used previously are the moving
of one guanine base closer to the end of the sequence to increase the stability to
the duplex. The presence of G-C base pairings in a duplex prevents “unzipping” of
AT bonds at the ends which can unravel more easily. Annealing of the unlabelled
duplex occurred and the melting temperature was found to be 325.8 K.
5.3.3.4.1 Preparation of samples
Following determination that duplexes could stably form of this duplex,
the single strand of U_GG was platinated by preparing an aqueous solution
containing 100 μM of U_GG ( 188.6 μL) and 200 μM of cisplatin (12 μL of 8.25 
mM solution in DMF) and leaving the solution to stand at 310 K for 72 h.
5.3.3.4.2 MS and FRET analysis of samples
Following binding to the 30-mer over one week, MS was obtained and
showed that binding of one cisplatin residue to the 30-mer strand. Figure 5.16
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shows the expanded MS spectrum. A large number of negatively-charged ions
was observed; this is very common for DNA strands.
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Figure 5.16. Mass spectrum of 30-mer (U) after reaction with cisplatin for 7 days.
Each charge envelope is highlighted and labelled. Acquired using a Bruker MaXis
instrument.
On expansion of the 13- charge envelope the major species present can be
identified. Figures 5.17 a, b, and c compare the charges observed to those
predicted in the isotope models.
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Figure 5.17. Expanded spectra and the simulated isotope pattern for the species
centred at a) 724.335 amu b) 741.950 and c) 759.564 m/z. U = unlabelled 30-mer.
Given the fact that only one cisplatin has bound to the 30-mer, the
assumption can be made that this binding is to the GpG section in the middle of
the sequence. This is based on the favourability for 1,2-GG intrastrand cross links
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being formed6,38. These samples were sent directly to the Photon Institute in
Manchester where there were annealed with the complimentary strand (AGT
TAT(Cy5) AAA ATA TAC CAT TTA TTT ATG ATA-Alexa488) for FRET
analysis. However, no FRET efficiency for the platinated duplex was observed.
In a final attempt to investigate why no FRET was observed a large excess
(10:1) of platinated DNA was annealed with the double tagged strand. The large
excess was to ensure that all fluorescent tagged DNA annealed. Upon
fluorescence, no FRET whatsoever was observed, either from the fluorescent
DNA single strand or from the platinated duplex. This would imply that the
platinum may be quenching all fluorescence in the molecule. This was an
unexpected result as previous studies of FRET on platinated species have been
observed before.32,33
The initial aim of this work had been to try the procedure on long strands
of DNA bound to cisplatin using FRET to calculate the kinking angle as a proof of
concept, if that worked then studies into the effects of ruthenium binding would
have been made in a similar way.
5.3.3.4.3 Discussion
The initial aim of this work had been to develop a procedure to determine
the kinking angle for long strands of DNA bound to cisplatin using FRET. It was
hoped to further utilise the technique to monitor the effects of binding {Ru(η
6-
arene)en}+ fragments to DNA. Currently the only mention in the literature of
ruthenium FRET studies, is in the use of fluorescent tags39.
From the experiments carried out to date, the principle of using FRET to
study to monitor formation of long chained DNA duplexes is feasible. However,
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platinum adducts on the DNA appear to cause some form of quenching of
fluorescence, making FRET analysis impossible. This result was unexpected as
previous studies have shown FRET can be observed for platinated
biomolecules.32,33
5.4 Conclusions
A number of different types of experiments have been listed in this chapter
and a variety of conclusions that can be drawn.
5.4.1 Ion Mobility Mass Spectrometry
The IM-MS study discussed in this chapter is an exciting piece of work
using this technique and was the first to be published23 which uses the technique
to determine the collision cross section (CCS) of molecules < 100 Å2. The study
showed that the CCS values can be accurately determined from IM-MS,
comparable to both the X-ray crystal form and, within a reasonably acceptable
range to the radius of gyration of the sample of 1 in solution. This ability to
determine CCS for small molecules can play a major role in drug discovery.
Where compounds are required to be within a certain size, i.e. to enter an enzyme
cleft (active site) or to fit into transporter or transmembrane proteins, whole
libraries of complexes can be studied to ensure their CCS is within the range.
Further work on the binding of ruthenium complexes to short stranded
oligos showed exclusive binding to the guanine residues. IMMS studies also
showed that the shape of the oligo changed when bound to the ruthenium complex,
but not in an additive way. This indicates that intercalation and conformational
folding effects may be exhibited by the ruthenium complex causing the DNA to
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fold differently from when it is non-ruthenated. If the shape change of DNA
strands upon ruthenation plays a crucial role in the mechanism of action leading to
cell death, IMMS may provide a key to studying this. The DNA shape changes
observed with cisplatin are believed to play an important part in the mechanism of
action of cisplatin in inducing programmed cell death in cancer cells as the shape
change caused HMG-Protein recognition40. There is a great potential for using
IM-MS to look at shape changes of oligonucleotides and biomolecules upon
binding to metal drugs9,41. This technique could easily be used to scan a library of
complexes to understand the shape changes they cause to DNA strands.
5.4.2 FRET studies on 30-Mer oligonucleotides
While several methods were employed analysis platinated DNA using
FRET, to date no positive results have been obtained. It appears that one
inhibiting factor is potential quenching of FRET by the platinum, as has been
suggested by some of the work. Other problems included attempts to purify such
small amounts with HPLC leading to heavy losses. However, a similar technique
has worked in the past32 and there is much potential for its use in the future. With
more tuning, this technique for examining shape changes of DNA after binding of
metal anticancer drugs could be coupled with IM-MS for comparison purposes.
Alternatively, as with Lippard’s work,32 potential binding targets can be FRET
labelled to confirm binding, or at least that the drug (also FRET labelled). These
experiments are in their infancy and it is hoped that the work described here will
stimulate further studies.
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Chapter 6
Closing Comments and Future work
This Chapter is designed to summarise the work presented in this thesis
and to place it into the context of previous work in the field. Also in this Chapter
future work which may be carried out in this field will be proposed. As with any
piece of scientific work, there is always scope for improvement and development,
always more questions to be answered and this chapter will deal with some of the
challenges that remain.
6.1 Kinetics and mechanism of N-H/D exchange on [(η
6-
arene)Ru(en)X]n+ complexes
In Chapters 3 and 4 of this thesis the kinetics of N-H/D exchange on a
variety of complexes were observed (Figure 6.1).
1 1a 2 3
4 5 6 7
Figure 6.1. The complexes investigated in this thesis.
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The aim of this was to proposed a mechanism of stereochemical inversion
which had been found to occur on [(η
6-bip)Ru(N-Et-en)Cl]+ (5A and 5B).1 During
the course of these studies a number of observations were made. Of interest was
the observation that protons nearer the η
6-bound biphenyl ring (NHup) exchanged
much more slowly than those which were further away from the arene (NHdown).
(Figure 6.2)
Hup
Hdown
Figure 6.2. Identification of the up and down protons on the ethylenediamine
chelating ligand, Hdown and Hup are marked.
It was initially hypothesised that the difference in the exchange rates may
simply be a related to the steric hindrance due the biphenyl ring being in close
proximity to NHu. Further analysis in Chapter 4, where the effects of electron
donation from the Z ligand (Figure 6.3) were analysed, showed that the
monodendate ligand in the Z-position appears to play a role in controlling the
rates of N-H/D exchange and the favourability of NHd exchange over NHu.
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Ru NH2
H2N
Z
n+R
Figure 6.3. The structure of the [(η6-arene)Ru(en)X]n+ complexes investigated in
this work.
Also of interest in Chapter 4 was the correlation between increasing
electron donation of the p-pyridine derivatives and the favourability for NHd to
undergo rapid exchange. Further analysis and computational studies suggested
there is a stabilisation affect from the π
*-antibonding orbitals of the Ru-Z bonds
on the p-orbital on the nitrogen atom after deprotonation. There is no presedence
in the literature which proposes this type long range, almost anomeric-like effect
on metals ligands, whereby the antibonding orbitials of one metal-ligand bond will
affect the stability of another ligand in the cis position. Unlike the trans-effect of a
number of different ligands on metal complexes which is well documented,2 as far
as the author is aware there are no reports about effects on cis-ligands, let alone
the effects on the liability of protons on the ligands themselves.
Previous work on cobalt(III)(am(m)ine) complexes observed similar
effects in that anisotropic N-H protons exchanged at different rates, but no
detailed explanation for this effect had been postulated.3-10 These studies3-10 have
suggested that exchanges of stereochemistry may be as a result of proton
abstraction followed by rotation of the nitrogen stereocentre. Also of note in these
cobalt studies was the observation that the rates of exchange were base catalysed,
similar results were observed in the work presented in this thesis. Other work on
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ruthenium catalysts provided evidence for the potential of stereoinversion to occur
via a 16 electron species.11-16
When all the observations in Chapter 3 and 4 were combined the following
mechanism for exchange was proposed. (Figure 6.4)
kd
ku
RDS
k1
k2
1. Rate determining step
Base catalysed proton
abstraction
2. Formation of a planar
nitrogen
3. Rapid interconversion k2
3. Deuteration of the up of down position
ku < kdSteric hindrance
Lpe- stabilised by
Ru-Cl antibonding orbital
Reducing availability of
electrons.
Figure 6.4. The proposed mechanism for NH exchange. The Ru-Cl antibonding
orbital can stabilise the upper face of the p-orbital making it less susceptible to
protonation.
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When the mechanism is applied to the original problem of stereochemical
inversion between 5A and 5B the following mechanism is postulated (Figure 6.5);
Ru
R
NH2
N
Cl
H
Ru
R
NH2
N
Cl
-OH
H+
Ru
R
NH2
N
Cl
H
HOH
Ru
R
NH2
N
Cl
H+
Ru
R
NH2
N
Cl
H
Proton abstraction by
hydroxide ion leading
to formation and loss
of H2O
Formation of a planar
nitrogen in which is
possibly sp2 hybridised
and the lone pair in the
p-orbital.
2a 2b
H+ addition can occur on either face to facilitate the formation either 5Aor 5B
The lone pair of electrons on
the N can occupy either the
up of down face of the
nitrogen, as a trigonal N
undergoes “Umbrella” type
inversion
5A 5B
Figure 6.5. The proposed mechanism for the interconversion of 5A to 5B in
aqueous solutions.
6.1.1 Future work in this field
Further work in this field is the potential to study a variety of electron
donating ligands in the Z position. Attempts were made to use 4-Cl-pyridine, 4-
Br-pyridine and 4-CF3-pyridine ligands, however difficulties arose during
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synthesis, this may require further tuning. If the electron withdrawing groups
allow for stabilisation of the lone pair electron on upper face of the nitrogen after
deprotonation, electron donating groups should have the reverse effect.
 Comparisons with a series of σ-donor ligands may also prove useful in 
investigating the long range of effects on the antibonding orbitals of the Ru-Z
bond and their stabilising effect on the deprotonated nitrogen of ethylenediamine.
Solid state 99Ru NMR may also prove useful in understanding the effects of
electron donating and withdrawing groups on the electron density of the
ruthenium ion.
6.2 Ion-Mobility Mass Spectometry
In Chapter 5, a series of Ion-mobility Mass Spectrometry (IM-MS)
experiments were carried out to analyse the 3D shape of small molecules and
ruthenated oligomer strands. These results were the first reported studies of this
type17 and produced many interesting results. Firstly, the use of glycine polymers
had been shown as an excellent calibrant to determine the collision cross section
(CCS) of less than 100 Å2. Secondly, the use of IM-MS to study the effects of
ruthenating small strands of DNA has also been validated. The results showed that
the ruthenation of DNA does not cause and additive effect on the shape of the
oligomer. This could be indicative of the type of binding by the ruthenium, i.e.:
intercalating or kinking of the DNA strand.
6.2.1 Future work in this field
Future work in this area would be to use IM-MS to analyse the shape
changes upon binding to larger oligonucleotides (>30 mer). By using larger
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strands, if any kinking occurred, a larger change in collisional cross section would
be observed. In a similar manner, duplexes could potentially be investigated to
observe any changes in shape upon binding to ruthenium complexes.
Also of interest would be to study the effects of a series of ruthenium-
arene complexes on DNA strands. If the ligand is intercalating then the changes to
the CCS should be roughly the same irrespective of the size of the arene. For these
studies a series of potential intercalators (extended arene systems) and non-
intercalators could be bound to DNA oligomers. It would be of interest to observe
if there is a difference in the CCS when DNA strands are ruthenated by non-
intercalators compared to intercalators. Once these details are established, the
potential to investigate shape changes as a function of the location of guanine
residues on the DNA sequences can also be investigated.
Since this field is very new and very few ion-mobility studies on short
strands of DNA have been studied, much work still needs to be done to
understand how to fully interpret the data. As previously mentioned, difficulty
arose in making comparisons between the ruthenated and non-ruthenated DNA
and that the effects of charge on the phosphate backbone of the DNA must be
considered. In this study, comparisons were made between the duplex with three
protons on the phosphate backbone. Questions need to be asked, is this approach
accurate? Traditionally when comparisons are made between mobility data, ions
are usually in the same charge state. However, in theses studies the addition of a
charged complex to the molecule changes the charge and charge distribution on
the oligomer. What is the best way to handle this? Is the approach of comparing
molecular ions of different charges, but would have the same charges when the
metal is removed accurate? Also, what, if any, are the effects from the T-wave on
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unravelling the small DNA strands which are not stabilised by duplex binding?
Work by Bowers et. al.18 has shown some results showing conformations of
longer DNA strands changing at various charge states, therefore these are
problems that must be considered when investigating longer strands of DNA.
Would computational modelling of the strands of DNA with charges in
different positions on the phosphate backbone provide similar results for CCS
values? Modelling of DNA strands with the negative charges in a variety of
positions on the phosphate back bone may provide some insight into the accurate
understanding of the results of ion-mobility mass spectrometry for DNA
complexes.
6.3 FRET analysis of platinated oligonucleotides
Results in Chapter 5 showed difficulty in obtaining FRET on platinated
30-mers of oligonucleotides. A number of approaches were attempted and all to
no avail. This result was most unusual as previous studies have shown that using
FRET to study DNA kinking of metallated duplexes is possible.19,20
6.3.1 Future work in this field
The initial plan for this experiment was to investigate the potential of
FRET in investigating shape changes on DNA following ruthenium-arene
complex binding. While the cisplatin binding studies have proved difficult,
potential for this difficulty may be quenching of fluorescence by platinum. Further
work is required to investigate this. Separation of the platinated unlabelled
oligonucleotide prior to binding with the FRET tagged strand will be essential in
this. If upon formation of the duplex no FRET is still observed then the
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probability that the problem is with either quenching or other photophysics based
issues will be greatly increased. This in itself will provide an interesting problem
to be solved, and a potential solution may be to change the FRET donor and
acceptor tags.
An example of other tags with potential use are; coumarin 120 and
coumarin 151 (Figure 6.6) which have previously been bound directly to platinum
without quenching.21
Figure 6.6. The chemical structure of the potential FRET tags coumarin 120 and
coumarin 151.
Work with ruthenium complexes would hopefully be more successful
given that ruthenium complexes are commonly used in FRET studies successfully
(implying no quenching).22,23 In some cases the ruthenium complexes themselves
are the FRET acceptors.24 Calf-thymus-DNA and NMR studies of binding of {(η6-
bip)Ru(en)}2+ to DNA 25,26 have shown a unwinding of supercoiled DNA and no
evidence of kinking. This is unlike those results observed with cisplatin which
have shown kinking of the DNA strands. It would be of interest to understand if
changes to long strands of DNA are bending in someway or if unwinding of the
DNA leads to a lengthening of the strand.
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